ID;Pays;Institution;;Equipes;Titre;TypeCoop;Motcle1;Motcle2;Motcle3;Motcle4;Motcle5;Budget;Bailleurs;Debut;Fin;Nb Copublications;;Role;StatutGM;NumGM;Lien;Nbpartenaires;Resume
ZIKAlliance;Allemagne;UNIVERSITATSKLINIKUM HEIDELBERG;Universitatsklinikum Heidelberg;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Allemagne;UNIVERSITATSKLINIKUM BONN;Universitatsklinikum Bonn;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EVÿ;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Evÿ;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Allemagne;STIFTUNG TIERAERZTLICHE HOCHSCHULE HANNOVER;Stiftung Tieraerztliche Hochschule Hannover;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Allemagne;BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN;Bernhard-Nocht-Institut Fuer Tropenmedizin;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Allemagne;OTTO-VON-GUERICKE-UNIVERSITAET MAGDEBURG;Otto-Von-Guericke-Universitaet Magdeburg;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Allemagne;CHARITE - UNIVERSITAETSMEDIZIN BERLIN;Charite - Universitaetsmedizin Berlin;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Belgique;UNIVERSITE DE LIEGE;Universite De Liege;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Belgique;JANSSEN PHARMACEUTICA NV;Janssen Pharmaceutica Nv;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Br‚sil;FUNDACAO OSWALDO CRUZ;Fundacao Oswaldo Cruz;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Br‚sil;FUNDACAO BAHIANA DE INFECTOLOGIA;Fundacao Bahiana De Infectologia;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Br‚sil;UNIVERSIDADE FEDERAL DE MINAS GERAIS;Universidade Federal De Minas Gerais;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Br‚sil;UNIVERSIDADE FEDERAL DE GOIAS;Universidade Federal De Goias;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Br‚sil;FUNDACAO FACULDADE DE MEDICINA;Fundacao Faculdade De Medicina;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Br‚sil;Laboratorio Nacional de Computacao Cientifica;Laboratorio Nacional De Computacao Cientifica;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Cambodge;INSTITUT PASTEUR DU CAMBODGE FOUNDATION;Institut Pasteur Du Cambodge Foundation;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Chine;INSTITUT PASTEUR OF SHANGHAI, CHINESE ACADEMY OF SCIENCES;Institut Pasteur Of Shanghai, Chinese Academy Of Sciences;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Colombie;Universidad Industrial de Santander;Universidad Industrial De Santander;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Cuba;INSTITUTO DE MEDICINA TROPICAL PEDRO KOURI;Instituto De Medicina Tropical Pedro Kouri;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Equateur;SOSECALI C LTDA;Sosecali C Ltda;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Espagne;UNIVERSITAT DE BARCELONA;Universitat De Barcelona;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Espagne;INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES;Institut De Recerca I Tecnologia Agroalimentaries;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;Institut national de la sant‚ et de la recherche m‚dicale;Institut National De La Sant‚ Et De La Recherche M‚dicale;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;coordinateur;;;;;
ZIKAlliance;France;Institut Pasteur;Institut Pasteur;Arbovirus et Insectes Vecteurs;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;INSERM TRANSFERT SA;Inserm Transfert Sa;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT;Institut De Recherche Pour Le Developpement;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;AGENCE NATIONALE DE LA SECURITE SANITAIRE DE L ALIMENTATION DE L ENVIRONNEMENT ET DU TRAVAIL;Agence Nationale De La Securite Sanitaire De L Alimentation De L Environnement Et Du Travail;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;UNIVERSITE LYON 1 CLAUDE BERNARD;Universite Lyon 1 Claude Bernard;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;UNIVERSITE RENNES II;Universite Rennes Ii;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;INSTITUT PASTEUR DE NOUVELLE-CALEDONIE;Institut Pasteur De Nouvelle-Caledonie;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France (Polyn‚sie);INSTITUT LOUIS MALARDE;Institut Louis Malarde;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Italie;UNIVERSITA DEGLI STUDI DI SIENA;Universita Degli Studi Di Siena;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Italie;FONDAZIONE EDMUND MACH;Fondazione Edmund Mach;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Mexique;INSTITUTO NACIONAL DE SALUD PUBLICA;Instituto Nacional De Salud Publica;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Mexique;INSTITUTO MEXICANO DEL SEGURO SOCIAL;Instituto Mexicano Del Seguro Social;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;NorvŠge;FOLKEHELSEINSTITUTTET;Folkehelseinstituttet;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Pays-Bas;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Erasmus Universitair Medisch Centrum Rotterdam;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Pays-Bas;STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS;Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Pays-Bas;ACADEMISCH ZIEKENHUIS GRONINGEN;Academisch Ziekenhuis Groningen;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Pays-Bas;WAGENINGEN UNIVERSITY;Wageningen University;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;P‚rou;UNIVERSIDAD PERUANA CAYETANO HEREDIA;Universidad Peruana Cayetano Heredia;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Portugal;UNIVERSIDADE NOVA DE LISBOA;Universidade Nova De Lisboa;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Royaume-Uni;LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER;London School Of Hygiene And Tropical Medicine Royal Charter;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;S‚n‚gal;INSTITUT PASTEUR DE DAKAR;Institut Pasteur De Dakar;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Suisse;EIDGENOESSISCHES DEPARTEMENT DES INNERN;Eidgenoessisches Departement Des Innern;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Suisse;UNIVERSITAT ZURICH;Universitat Zurich;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Suisse;FONDAZIONE PER L ISTITUTO DI RICERCA IN BIOMEDICINA;Fondazione Per L Istituto Di Ricerca In Biomedicina;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 ?;Commission Europ‚enne;01/10/2016;30/09/2021;;;;;;;;
SoNAR-Global;Allemagne;LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN;Ludwig-Maximilians-Universitaet Muenchen;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Autriche;MEDIZINISCHE UNIVERSITAET WIEN;Medizinische Universitaet Wien;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Bangladesh;BRAC UNIVERSITY;Brac University;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;France;Institut Pasteur;Institut Pasteur;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;coordinateur;;;;;
SoNAR-Global;Italie;FONDAZIONE CENTRO STUDI INVESTIMENTI SOCIALI - CENSIS;Fondazione Centro Studi Investimenti Sociali - Censis;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Malte;UNIVERSITA TA MALTA;Universita Ta Malta;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Ouganda;MAKERERE UNIVERSITY;Makerere University;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Pays-Bas;STICHTING AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT;Stichting Amsterdam Institute For Global Health And Development;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Pays-Bas;STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG;Stichting Nederlands Instituut Voor Onderzoek Van De Gezondheidszorg;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Royaume-Uni;UNIVERSITY COLLEGE LONDON;University College London;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Royaume-Uni;INSTITUTE OF DEVELOPMENT STUDIES;Institute Of Development Studies;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;S‚n‚gal;CENTRE REGIONAL DE RECHERCHE ET DE FORMATION A LA PRISE EN CHARGE CLINIQUE DU VIH SIDA ET MALADIES ASSOCIEES DE DAKAR CRCF;Centre Regional De Recherche Et De Formation A La Prise En Charge Clinique Du Vih Sida Et Maladies Associees De Dakar Crcf;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Slov‚nie;UNIVERZA V LJUBLJANI;Univerza V Ljubljani;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Thailande;MAHIDOL UNIVERSITY;Mahidol University;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Ukraine;STATE INSTITUTION PUBLIC HEALTH CENTER OF THE MINISTRY OF HEALTH OF UKRAINE;State Institution Public Health Center Of The Ministry Of Health Of Ukraine;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 ?;Commission Europ‚enne;01/01/2019;31/12/2021;;;;;;;;
LeiSHield-MATI;Alg‚rie;Institut Pasteur d'Alg‚rie;Institut Pasteur D'Alg‚rie;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 ?;Commission Europ‚enne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;Belgique;PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE;Prins Leopold Instituut Voor Tropische Geneeskunde;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 ?;Commission Europ‚enne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;France;Institut Pasteur;Institut Pasteur;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 ?;Commission Europ‚enne;01/04/2018;31/03/2022;;;coordinateur;;;;;
LeiSHield-MATI;France;ACOBIOM;Acobiom;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 ?;Commission Europ‚enne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;France;INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT;Institut De Recherche Pour Le Developpement;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 ?;Commission Europ‚enne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 ?;Commission Europ‚enne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;Iran;INSTITUT PASTEUR D'IRAN;Institut Pasteur D'Iran;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 ?;Commission Europ‚enne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;Maroc;Institut Pasteur Du Maroc;Institut Pasteur Du Maroc;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 ?;Commission Europ‚enne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;R‚publique TchŠque;UNIVERZITA KARLOVA;Univerzita Karlova;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 ?;Commission Europ‚enne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;SuŠde;GOETEBORGS UNIVERSITET;Goeteborgs Universitet;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 ?;Commission Europ‚enne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;Tunisie;INSTITUT PASTEUR DE TUNIS;Institut Pasteur De Tunis;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 ?;Commission Europ‚enne;01/04/2018;31/03/2022;;;;;;;;
AFRIPOX;Centrafrique;Institut Pasteur de Bangui;Institut Pasteur De Bangui;Arbovirus, emerging viruses and zoonos;A One Health study of monkeypox: human infection, animal reservoir, disease ecology and diagnostic tools;Projet scientifique;monkeypox;one health;zoonoses ;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;;
AFRIPOX;France;Institut Pasteur;Institut Pasteur;Unit‚ de Recherche et d'Expertise Epid‚miologie des Maladies Emergentes;A One Health study of monkeypox: human infection, animal reservoir, disease ecology and diagnostic tools;Projet scientifique;monkeypox;one health;zoonoses ;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
AFRIPOX;France;Institut Pasteur;Institut Pasteur;Anthropologie et Ecologie de l'Emergence des Maladies;A One Health study of monkeypox: human infection, animal reservoir, disease ecology and diagnostic tools;Projet scientifique;monkeypox;one health;zoonoses ;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
AFRIPOX;France;Institut Pasteur;Institut Pasteur;Unit‚ de recherche et d'expertise Environnement et risques infectieux;A One Health study of monkeypox: human infection, animal reservoir, disease ecology and diagnostic tools;Projet scientifique;monkeypox;one health;zoonoses ;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
LoveFood2Market;Allemagne;JOBST TECHNOLOGIES GMBH;Jobst Technologies Gmbh;;A portable MicroNanoBioSystem and Instrument for ultra-fast analysis of pathogens in food: Innovation from LOVE-FOOD lab prototype to a pre-commercial instrument;Projet scientifique;foodborne pathogen;data analysis;food safety;;;3 151 732,50 ?;Commission Europ‚enne;01/02/2016;30/04/2019;;;;;;;;
LoveFood2Market;France;SENSEOR SAS;Senseor Sas;;A portable MicroNanoBioSystem and Instrument for ultra-fast analysis of pathogens in food: Innovation from LOVE-FOOD lab prototype to a pre-commercial instrument;Projet scientifique;foodborne pathogen;data analysis;food safety;;;3 151 732,50 ?;Commission Europ‚enne;01/02/2016;30/04/2019;;;;;;;;
LoveFood2Market;France;INSTITUT PASTEUR;Institut Pasteur;;A portable MicroNanoBioSystem and Instrument for ultra-fast analysis of pathogens in food: Innovation from LOVE-FOOD lab prototype to a pre-commercial instrument;Projet scientifique;foodborne pathogen;data analysis;food safety;;;3 151 732,50 ?;Commission Europ‚enne;01/02/2016;30/04/2019;;;;;;;;
LoveFood2Market;GrŠce;IDRYMA TECHNOLOGIAS KAI EREVNAS;Idryma Technologias Kai Erevnas;;A portable MicroNanoBioSystem and Instrument for ultra-fast analysis of pathogens in food: Innovation from LOVE-FOOD lab prototype to a pre-commercial instrument;Projet scientifique;foodborne pathogen;data analysis;food safety;;;3 151 732,50 ?;Commission Europ‚enne;01/02/2016;30/04/2019;;;coordinateur;;;;;
LoveFood2Market;GrŠce;"""NATIONAL CENTER FOR SCIENTIFIC RESEARCH """"DEMOKRITOS""""""";"""National Center For Scientific Research """"Demokritos""""""";;A portable MicroNanoBioSystem and Instrument for ultra-fast analysis of pathogens in food: Innovation from LOVE-FOOD lab prototype to a pre-commercial instrument;Projet scientifique;foodborne pathogen;data analysis;food safety;;;3 151 732,50 ?;Commission Europ‚enne;01/02/2016;30/04/2019;;;;;;;;
LoveFood2Market;GrŠce;MAKEDONIKI VIOMIHANIA GALAKTOS ANONIMOS ETERIA (MEVGAL SA);Makedoniki Viomihania Galaktos Anonimos Eteria (Mevgal Sa);;A portable MicroNanoBioSystem and Instrument for ultra-fast analysis of pathogens in food: Innovation from LOVE-FOOD lab prototype to a pre-commercial instrument;Projet scientifique;foodborne pathogen;data analysis;food safety;;;3 151 732,50 ?;Commission Europ‚enne;01/02/2016;30/04/2019;;;;;;;;
LoveFood2Market;R‚publique TchŠque;UNIVERZITA PARDUBICE;Univerzita Pardubice;;A portable MicroNanoBioSystem and Instrument for ultra-fast analysis of pathogens in food: Innovation from LOVE-FOOD lab prototype to a pre-commercial instrument;Projet scientifique;foodborne pathogen;data analysis;food safety;;;3 151 732,50 ?;Commission Europ‚enne;01/02/2016;30/04/2019;;;;;;;;
AEGIS;Allemagne;HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH;Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;coordinateur;;;;;
AEGIS;Allemagne;PHILIPPS UNIVERSITAET MARBURG;Philipps Universitaet Marburg;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Allemagne;TECHNISCHE UNIVERSITAET MUENCHEN;Technische Universitaet Muenchen;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;3;
AEGIS;Allemagne;UNTERNEHMERTUM GMBH;Unternehmertum Gmbh;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;3;
AEGIS;Allemagne;Boeters & Lieck;Boeters & Lieck;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;3;
AEGIS;Allemagne;RUHR-UNIVERSITAET BOCHUM;Ruhr-Universitaet Bochum;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Espagne;ASTEX;Astex;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;France;INSTITUT PASTEUR;Institut Pasteur;Bio-Informatique Structurale;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;France;INSTITUT PASTEUR;Institut Pasteur;Plate-Forme de criblage ch‚mog‚nomique et biologique (PF-CCB);Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;France;INSTITUT PASTEUR;Institut Pasteur;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;France;EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION;Eurordis - European Organisation For Rare Diseases Association;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Italie;GIOTTO BIOTECH SRL;Giotto Biotech Srl;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Italie;UNIVERSITA DEGLI STUDI DI FIRENZE;Universita Degli Studi Di Firenze;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Pays-Bas;RIJKSUNIVERSITEIT GRONINGEN;Rijksuniversiteit Groningen;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Pays-Bas;TECHNISCHE UNIVERSITEIT EINDHOVEN;Technische Universiteit Eindhoven;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Pays-Bas;TelesisPharma;Telesispharma;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Pologne;UNIWERSYTET JAGIELLONSKI;Uniwersytet Jagiellonski;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Pologne;Jagiellonian University in Krakow;Jagiellonian University In Krakow;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;SuŠde;UPPSALA UNIVERSITET;Uppsala Universitet;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;SuŠde;RIDGEVIEW INSTRUMENTS AB;Ridgeview Instruments Ab;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;SuŠde;ASTRAZENECA AB;Astrazeneca Ab;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Suisse;NOVARTIS PHARMA AG;Novartis Pharma Ag;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Ukraine;ENAMINE LIMITED LIABILITY COMPANY,RESEARCH AND PRODUCTION ENTERPRISE;Enamine Limited Liability Company,Research And Production Enterprise;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 ?;Commission Europ‚enne;01/01/2016;31/12/2019;;;;;;;;
AMR-1;Australie;Peter Doherty Institute for Infection and Immunity;Peter Doherty Institute For Infection And Immunity;;Accord collaboratif de recherche sur AMR ;Juridique;Recherche AMR;Financement;;;;;;01/01/2019;01/01/2021;;;;;;;;
AMR-1;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;Accord collaboratif de recherche sur AMR ;Juridique;Recherche AMR;Financement;;;;;;01/01/2019;01/01/2021;;;;;;;;
AMR-1;France;Institut Pasteur;Institut Pasteur;;Accord collaboratif de recherche sur AMR ;Juridique;Recherche AMR;Financement;;;;;;01/01/2019;01/01/2021;;;;;;;;
IPBBR-2;Br‚sil;Funda‡Æo Oswaldo Cruz (Fiocruz);Funda‡Æo Oswaldo Cruz (Fiocruz);;Accord de coop‚ration;Juridique;coop‚ration;accord;Institut Pasteur au Br‚sil;;;;;31/12/2020;31/12/2025;;;;;;;;
IPBBR-2;Br‚sil;Universidade de SÆo Paulo (USP);Universidade De SÆo Paulo (Usp);;Accord de coop‚ration;Juridique;coop‚ration;accord;Institut Pasteur au Br‚sil;;;;;31/12/2020;31/12/2025;;;;;;;;
IPBBR-2;France;Institut Pasteur;Institut Pasteur;;Accord de coop‚ration;Juridique;coop‚ration;accord;Institut Pasteur au Br‚sil;;;;;31/12/2020;31/12/2025;;;;;;;;
IVO-1;Australie;Walter & Eliza Hall Institute of Medical Research ;Walter & Eliza Hall Institute Of Medical Research ;;"Accord de coop‚ration g‚n‚rale portant sur l'affectation du Pr Ivo Mueller … l'IP pour une p‚riode d‚finie, ainsi que sur des projets ou activit‚s de recherche conjoints ; prolong‚ 2 fois via des avenants";Juridique;Affectation du Pr Ivo Muller;;;;;;;01/01/2016;01/01/2021;;;;;;;;
IVO-1;France;Insitut Pasteur;Insitut Pasteur;;"Accord de coop‚ration g‚n‚rale portant sur l'affectation du Pr Ivo Mueller … l'IP pour une p‚riode d‚finie, ainsi que sur des projets ou activit‚s de recherche conjoints ; prolong‚ 2 fois via des avenants";Juridique;Affectation du Pr Ivo Muller;;;;;;;01/01/2016;01/01/2021;;;;;;;;
?;Australie;Monash University;Monash University;;Accord de coop‚ration sur des activit‚s de recherche conjointes, des programmes doctoraux et les conseil scientifiques dans le RIIP;Juridique;;;;;;;;01/01/2015;01/01/2020;;;;;;;;
?;France;Institut Pasteur;Institut Pasteur;;Accord de coop‚ration sur des activit‚s de recherche conjointes, des programmes doctoraux et les conseil scientifiques dans le RIIP;Juridique;;;;;;;;01/01/2015;01/01/2020;;;;;;;;
GVN-1;Australie;Peter Doherty Institute for Infection and Immunity;Peter Doherty Institute For Infection And Immunity;;Accord de coop‚ration sur des activit‚s de recherche conjointes, des programmes doctoraux, les conseil scientifiques dans le R‚seau et l'‚dition 2017 du symposium Global Virus Network (GVN);;;;;;;;;01/01/2016;01/01/2021;;;;;;;;
GVN-1;France;Institut Pasteur;Institut Pasteur;;Accord de coop‚ration sur des activit‚s de recherche conjointes, des programmes doctoraux, les conseil scientifiques dans le R‚seau et l'‚dition 2017 du symposium Global Virus Network (GVN);;;;;;;;;01/01/2016;01/01/2021;;;;;;;;
?;Australie;Monash University;Monash University;;Accord de coop‚ration sur un programme doctoral;Juridique;;;;;;;;01/01/2018;01/01/2023;;;;;;;;
?;France;Institut Pasteur;Institut Pasteur;;Accord de coop‚ration sur un programme doctoral;Juridique;;;;;;;;01/01/2018;01/01/2023;;;;;;;;
WorldMosquitoProgram;Australie;Monash University;Monash University;;Accord de coop‚ration sur World Mosquito Program;Juridique;dengue;arboviral diseases;;;;;;01/01/2018;;;;;;;;;
WorldMosquitoProgram;France;Institut Pasteur;Institut Pasteur;;Accord de coop‚ration sur World Mosquito Program;Juridique;dengue;arboviral diseases;;;;;;02/01/2018;;;;;;;;;
WorldMosquitoProgram;France;Institut Pasteur de Nouvelle Cal‚donie;Institut Pasteur De Nouvelle Cal‚donie;;Accord de coop‚ration sur World Mosquito Program;Juridique;dengue;arboviral diseases;;;;;;03/01/2018;;;;;;;;;
WorldMosquitoProgram;France;Ville de Noum‚a;Ville De Noum‚a;;Accord de coop‚ration sur World Mosquito Program;Juridique;dengue;arboviral diseases;;;;;;04/01/2018;;;;;;;;;
BIRDY2-MTA;Australie;Burnet Institute;Burnet Institute;;Accord de transfert de mat‚riel (MTA) dans le cadre du projet BIRDY2;Juridique;sepsis;n‚onatal;biomarqueur;neutrophile;diagnostic;;;;;;;;;;;;
BIRDY2-MTA;France;Institut Pasteur;Institut Pasteur;;Accord de transfert de mat‚riel (MTA) dans le cadre du projet BIRDY2;Juridique;sepsis;n‚onatal;biomarqueur;neutrophile;diagnostic;;;;;;;;;;;;
BIRDY2-MTA;Madagascar;Institut Pasteur de Madagascar;Institut Pasteur De Madagascar;;Accord de transfert de mat‚riel (MTA) dans le cadre du projet BIRDY2;Juridique;sepsis;n‚onatal;biomarqueur;neutrophile;diagnostic;;;;;;;;;;;;
LEPTOXINFECTION;France;Institut Pasteur;Institut Pasteur;Biologie des SpirochŠtes;Adaptation of pathogenic Leptospira to oxidative stress: its contribution to virulence and host colonization;Projet scientifique;leptospirosis;transcriptomics;proteomics;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;;
LEPTOXINFECTION;France;Institut Pasteur;Institut Pasteur;Biologie et G‚n‚tique de la paroi bact‚rienne;Adaptation of pathogenic Leptospira to oxidative stress: its contribution to virulence and host colonization;Projet scientifique;leptospirosis;transcriptomics;proteomics;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
LEPTOXINFECTION;Uruguay;Institut Pasteur de Montevideo;Institut Pasteur De Montevideo;;Adaptation of pathogenic Leptospira to oxidative stress: its contribution to virulence and host colonization;Projet scientifique;leptospirosis;transcriptomics;proteomics;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
TBVAC2020;Afrique du Sud;STELLENBOSCH UNIVERSITY;Stellenbosch University;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Afrique du Sud;UNIVERSITY OF CAPE TOWN;University Of Cape Town;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Afrique du Sud;KWAZULU NATAL RESEARCH INSTITUTE FOR TB-HIV (K-RITH) NPC;Kwazulu Natal Research Institute For Tb-Hiv (K-Rith) Npc;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Allemagne;UNIVERSITAET ULM;Universitaet Ulm;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Allemagne;FRIEDRICH LOEFFLER INSTITUT - BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT;Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer Tiergesundheit;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Australie;THE UNIVERSITY OF SYDNEY;The University Of Sydney;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Belgique;SCIENSANO;Sciensano;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Belgique;UNIVERSITE LIBRE DE BRUXELLES;Universite Libre De Bruxelles;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Belgique;GLAXOSMITHKLINE BIOLOGICALS SA;Glaxosmithkline Biologicals Sa;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Cor‚e du Sud;YONSEI UNIVERSITY;Yonsei University;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Cor‚e du Sud;INTERNATIONAL TUBERCULOSIS RESEARCH CENTER;International Tuberculosis Research Center;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Danemark;STATENS SERUM INSTITUT;Statens Serum Institut;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Espagne;UNIVERSIDAD DE ZARAGOZA;Universidad De Zaragoza;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Espagne;INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL;Institut De Investigacio En Ciencies De La Salut Germans Trias I Pujol;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Etats-Unis;AERAS GLOBAL TB VACCINE FOUNDATION;Aeras Global Tb Vaccine Foundation;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;France;Institut Pasteur;Institut Pasteur;Pathogenomique mycobacterienne integree;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;France;INSTITUT PASTEUR DE LILLE ;Institut Pasteur De Lille ;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;France;TRANSGENE SA;Transgene Sa;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Irlande;UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN;University College Dublin, National University Of Ireland, Dublin;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Italie;AZIENDA OSPEDALIERA UNIVERSITARIA POLICLINICO PAOLO GIACCONE DI PALERMO;Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Di Palermo;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Italie;ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO;Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Italie;ISTITUTO SUPERIORE DI SANITA;Istituto Superiore Di Sanita;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Pays-Bas;STICHTING TUBERCULOSIS VACCINE INITIATIVE;Stichting Tuberculosis Vaccine Initiative;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;coordinateur;;;;;
TBVAC2020;Pays-Bas;STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER;Stichting Biomedical Primate Research Center;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Royaume-Uni;BANGOR UNIVERSITY;Bangor University;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Royaume-Uni;Department of Health;Department Of Health;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;http://cordis.europa.eu/project/id/730879;;
TBVAC2020;Royaume-Uni;UNITED KINGDOM RESEARCH AND INNOVATION;United Kingdom Research And Innovation;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Royaume-Uni;LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER;London School Of Hygiene And Tropical Medicine Royal Charter;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Royaume-Uni;IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE;Imperial College Of Science Technology And Medicine;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Royaume-Uni;THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;The Secretary Of State For Environment, Food And Rural Affairs;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Royaume-Uni;UNIVERSITY OF STRATHCLYDE;University Of Strathclyde;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Suisse;UNIVERSITE DE GENEVE;Universite De Geneve;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Suisse;UNIVERSITAT ZURICH;Universitat Zurich;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Suisse;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS;Centre Hospitalier Universitaire Vaudois;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Suisse;UNIVERSITE DE LAUSANNE;Universite De Lausanne;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Suisse;UNIVERSITAT BASEL;Universitat Basel;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 ?;Commission Europ‚enne;01/01/2015;30/06/2019;;;;;;;;
Afribiota;Centrafrique;Institut Pasteur de Bangui;Institut Pasteur De Bangui;;Afribiota;Sant‚ publique;Malnutrition;;;;;2 084 126,00 ?;"Fondation Total; Nutricia Research Fondation; Fondation Pasteur Suiss";07/07/1905;;;;;;;;;
Afribiota;France;Institut Pasteur;Institut Pasteur;Unit‚ de Pathog‚nie Microbienne Mol‚culaire;Afribiota;Sant‚ publique;Malnutrition;;;;;2 084 126,00 ?;"Fondation Total; Nutricia Research Fondation; Fondation Pasteur Suisse";07/07/1905;;;;;;;;;
Afribiota;Madagascar;Institut Pasteur de Madagascar;Institut Pasteur De Madagascar;;Afribiota;Sant‚ publique;Malnutrition;;;;;2 084 126,00 ?;"Fondation Total; Nutricia Research Fondation; Fondation Pasteur Suiss";07/07/1905;;;;;;;;;
ALPACA;Allemagne;UNIVERSITAET BIELEFELD;Universitaet Bielefeld;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 ?;Commission Europ‚enne;01/01/2021;31/12/2024;;;coordinateur;;;;;
ALPACA;Allemagne;HEINRICH-HEINE-UNIVERSITAET DUESSELDORF;Heinrich-Heine-Universitaet Duesseldorf;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 ?;Commission Europ‚enne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 ?;Commission Europ‚enne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 ?;Commission Europ‚enne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 ?;Commission Europ‚enne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;France;INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE;Institut National De Recherche En Informatique Et Automatique;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 ?;Commission Europ‚enne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;France;INSTITUT PASTEUR;Institut Pasteur;Algorithmes pour les s‚quences biologiques - Bioinformatics;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 ?;Commission Europ‚enne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Italie;UNIVERSITA DI PISA;Universita Di Pisa;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 ?;Commission Europ‚enne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Italie;UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA;Universita' Degli Studi Di Milano-Bicocca;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 ?;Commission Europ‚enne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Pays-Bas;STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTEN;Stichting Nederlandse Wetenschappelijk Onderzoek Instituten;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 ?;Commission Europ‚enne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 ?;Commission Europ‚enne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Slovaquie;UNIVERZITA KOMENSKEHO V BRATISLAVE;Univerzita Komenskeho V Bratislave;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 ?;Commission Europ‚enne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Slovaquie;GENETON S.R.O.;Geneton S.R.O.;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 ?;Commission Europ‚enne;01/01/2021;31/12/2024;;;;;;;;
AnEiCA;Cameroun;Institut Pasteur du Cameroun;Institut Pasteur Du Cameroun;;Animal Enteroviruses in Central Africa, from field to assay tubes: search for zoonotic enterovirus transmission and study of genetic exchanges between animal and human enteroviruses;Projet scientifique;enterovirus;zoonoses;;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
AnEiCA;Centrafrique;Institut Pasteur de Bangui;Institut Pasteur De Bangui;;Animal Enteroviruses in Central Africa, from field to assay tubes: search for zoonotic enterovirus transmission and study of genetic exchanges between animal and human enteroviruses;Projet scientifique;enterovirus;zoonoses;;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
AnEiCA;France;Institut Pasteur;Institut Pasteur;Epig‚nomique, Prolif‚ration et Identit‚ Cellulaire;Animal Enteroviruses in Central Africa, from field to assay tubes: search for zoonotic enterovirus transmission and study of genetic exchanges between animal and human enteroviruses;Projet scientifique;enterovirus;zoonoses;;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;;
RESIST-3;Cambodge;Institut Pasteur in Cambodia;Institut Pasteur In Cambodia;;Antibody persistence after abridged intradermal rabies PEP: The RESIST-3 study ;Projet scientifique;rabies;antibody response;;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
RESIST-3;France;Institut Pasteur;Institut Pasteur;Lyssavirus ;Antibody persistence after abridged intradermal rabies PEP: The RESIST-3 study ;Projet scientifique;rabies;antibody response;;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
RESIST-3;Madagascar;Institut Pasteur in Madagascar;Institut Pasteur In Madagascar;;Antibody persistence after abridged intradermal rabies PEP: The RESIST-3 study ;Projet scientifique;rabies;antibody response;;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;;;;https://cordis.europa.eu/project/id/676559;;
AReST;Allemagne;Leibniz-Institut fr Naturstoff-Forschung und Infektionsbiologie?Hans-Kn”ll-Institut?;Leibniz-Institut Fr Naturstoff-Forschung Und Infektionsbiologie?Hans-Kn”ll-Institut?;;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;998 553,52 ?;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant sign‚;;;;
AReST;Allemagne;Universit„t zu K”ln;Universit„t Zu K”ln;;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;998 553,52 ?;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant sign‚;;;;
AReST;Allemagne;Helmholtz Zentrum fr Infektionsforschung GmbH;Helmholtz Zentrum Fr Infektionsforschung Gmbh;;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;998 553,52 ?;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant sign‚;;;;
AReST;Allemagne;Helmholtz-Institut fr Pharmazeutische Forschung Saarland;Helmholtz-Institut fr Pharmazeutische Forschung Saarland;;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;998 553,52 ?;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant sign‚;;;;
AReST;France;Institut Pasteur;Institut Pasteur;Biologie et Pathogenicite Fongiques;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;998 553,52 ?;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant sign‚;;;;
AReST;France;Institut Pasteur;Institut Pasteur;Mycologie Mol‚culaire;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;998 553,52 ?;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant sign‚;;;;
AReST;France;Institut Pasteur;Institut Pasteur;Neuropathologie exp‚rimentale;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;998 553,52 ?;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant sign‚;;;;
AReST;France;H“pital Saint-Louis;H“pital Saint-Louis;;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;998 553,52 ?;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant sign‚;;;;
VITAL;Centrafrique;Institut Pasteur de Bangui;Institut Pasteur De Bangui;;Ascorbate-deficiency: a novel diarrhea risk-factor?;Projet scientifique;Diarrheal diseases;case-control study;epidemics;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
VITAL;France;Institut Pasteur;Institut Pasteur;Epid‚miologie des Maladies Emergentes;Ascorbate-deficiency: a novel diarrhea risk-factor?;Projet scientifique;Diarrheal diseases;case-control study;epidemics;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;coordinateur;;;;;
VITAL;France;Institut Pasteur de Guyane;Institut Pasteur De Guyane;;Ascorbate-deficiency: a novel diarrhea risk-factor?;Projet scientifique;Diarrheal diseases;case-control study;epidemics;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
ASEAN-1;Australie;Australian National University (ANU);Australian National University (Anu);;ASEAN-Australia Health Security Fellowships aimed at improving regional capacity to deliver field epidemiology training;Formation;Epid‚miologie;;;;;;;01/01/2018;01/01/2022;;;;;;;;
ASEAN-1;Cambodge;Institut Pasteur du Cambodge (IPC);Institut Pasteur Du Cambodge (Ipc);;ASEAN-Australia Health Security Fellowships aimed at improving regional capacity to deliver field epidemiology training;Formation;Epid‚miologie;;;;;;;01/01/2018;02/01/2022;;;;;;;;
ASEAN-1;Laos;National Center for Laboratory and Epidemiology (NCLE);National Center For Laboratory And Epidemiology (Ncle);;ASEAN-Australia Health Security Fellowships aimed at improving regional capacity to deliver field epidemiology training;Formation;Epid‚miologie;;;;;;;01/01/2018;03/01/2022;;;;;;;;
ASEAN-1;Myanmar;Central Epidemiology Unit (CEU);Central Epidemiology Unit (Ceu);;ASEAN-Australia Health Security Fellowships aimed at improving regional capacity to deliver field epidemiology training;Formation;Epid‚miologie;;;;;;;01/01/2018;04/01/2022;;;;;;;;
ADONIS;Autriche;™sterreichische Agentur fr Gesundheit und Ern„hrungssicherheit GmbH;™sterreichische Agentur Fr Gesundheit Und Ern„hrungssicherheit Gmbh;;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;;
ADONIS;Belgique;Sciensano;Sciensano;;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;;
ADONIS;Danemark;Statens Serum Institut;Statens Serum Institut;;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;;
ADONIS;Espagne;UNIVERSIDAD COMPLUTENSE DE MADRID;Universidad Complutense De Madrid;;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;;
ADONIS;France;Agence Nationale S‚curit‚ Sanitaire Alimentaire Nationale;Agence Nationale S‚curit‚ Sanitaire Alimentaire Nationale;;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;;
ADONIS;France;Institut Pasteur;Institut Pasteur;CNR Escherichia coli, Shigella et Salmonella;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;;
ADONIS;Italie;Istituto Superiore di Sanit…;Istituto Superiore Di Sanit…;;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;;
ADONIS;Italie;"Istituto Zooprofilattico Sperimentale della Lombardia e dell?Emilia Romagna ""Bruno Ubertini"" ";"Istituto Zooprofilattico Sperimentale Della Lombardia E Dell?Emilia Romagna ""Bruno Ubertini"" ";;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;;
ADONIS;Pays-Bas;National Institute for Public Health and the Environment;National Institute For Public Health And The Environment;;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;coordinateur;;;;;
ADONIS;Pays-Bas;Wageningen Bioveterinary Research;Wageningen Bioveterinary Research;;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;;
ADONIS;Pologne;Pa?stwowy Instytut Weterynaryjny-Pa?stwowy Instytut Badawczy;Pa?stwowy Instytut Weterynaryjny-Pa?stwowy Instytut Badawczy;;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;;
ADONIS;Portugal;Instituto Nacional de Sa£de Dr. Ricardo Jorge;Instituto Nacional De Sa£de Dr. Ricardo Jorge;;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;;
ADONIS;Portugal;National Institute for Agrarian and Veterinarian Research I. P;National Institute For Agrarian And Veterinarian Research I. P;;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;;
ADONIS;Royaume-Uni;The Secretary of State for Environment, Food and Rural Affairs;The Secretary Of State For Environment, Food And Rural Affairs;;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;;
ADONIS;Royaume-Uni;Public Health England;Public Health England;;Assessing Determinants of the Non-Decreasing Incidence ofÿSalmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;;
nonapplica;France;Institut Pasteur;Institut Pasteur;Arbovirus et Insectes Vecteurs;Assessing the entomological risk of emergence of massive Dengue, Zika and Chikungunya outbreaks;Post-doc;entomology;dengue;zika;chikungunya;;314 569,21 ?;Wellcome Trust;01/02/2018;28/02/2019;;;;;;;;
nonapplica;Royaume-Uni;Liverpool School of Tropical Medicine;Liverpool School Of Tropical Medicine;;Assessing the entomological risk of emergence of massive Dengue, Zika and Chikungunya outbreaks;Post-doc;entomology;dengue;zika;chikungunya;;314 569,21 ?;Wellcome Trust;01/02/2018;28/02/2019;;;coordinateur;;;;;
AIMS-2-TRIALS;Afrique du Sud;STELLENBOSCH UNIVERSITY;Stellenbosch University;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Allemagne;ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT;Zentralinstitut Fuer Seelische Gesundheit;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Allemagne;JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN;Johann Wolfgang Goethe-Universitaet Frankfurt Am Main;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Allemagne;UNIVERSITAET ULM;Universitaet Ulm;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Allemagne;KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN;Klinikum Rechts Der Isar Der Technischen Universitat Munchen;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;http://cordis.europa.eu/project/id/676559;;
AIMS-2-TRIALS;Allemagne;GEORG-AUGUST-UNIVERSITAET GOETTINGEN ;Georg-August-Universitaet Goettingen ;Universitatmedizin Goettingen;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Belgique;BIOSCI CONSULTING BVBA;Biosci Consulting Bvba;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Belgique;JANSSEN PHARMACEUTICA NV;Janssen Pharmaceutica Nv;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Belgique;UCB BIOPHARMA SRL;Ucb Biopharma Srl;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Belgique;AUTISME-EUROPE AISBL;Autisme-Europe Aisbl;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Espagne;SerVICIO MADRILENO DE SALUD;Servicio Madrileno De Salud;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Espagne;UNIVERSIDAD DE SALAMANCA;Universidad De Salamanca;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Espagne;FUNDAZIOA POLICLINICA GIPUZKOA FUNDACION;Fundazioa Policlinica Gipuzkoa Fundacion;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Espagne;FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA;Fundacio Clinic Per A La Recerca Biomedica;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Espagne;STARLAB BARCELONA SL;Starlab Barcelona Sl;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Etats-Unis;AUTISM SPEAKS INC. NON PROFIT CORPORATION;Autism Speaks Inc. Non Profit Corporation;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Etats-Unis;THE SIMONS FOUNDATION, INC;The Simons Foundation, Inc;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;France;Institut Pasteur;Institut Pasteur;G‚n‚tique humaine et fonctions cognitives;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;France;ASSISTANCE PUBLIQUE HOPITAUX DE PARIS;Assistance Publique Hopitaux De Paris;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;France;ARTTIC;Arttic;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;France;CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS;Centre Hospitalier Regional Universitaire De Tours;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Irelande;THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN;The Provost, Fellows, Foundation Scholars & The Other Members Of Board, Of The College Of The Holy & Undivided Trinity Of Queen Elizabeth Near Dublin;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Isra‰l;TEVA PHARMACEUTICAL INDUSTRIES LIMITED;Teva Pharmaceutical Industries Limited;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Italie;Fondazione Stella Maris;Fondazione Stella Maris;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Pays-Bas;RIJKSUNIVERSITEIT GRONINGEN;Rijksuniversiteit Groningen;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Pays-Bas;STICHTING BURO ECNP;Stichting Buro Ecnp;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Pays-Bas;NOLDUS INFORMATION TECHNOLOGY BV;Noldus Information Technology Bv;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Pays-Bas;DEMCON ADVANCED MECHATRONICS ENSCHEDE B.V;Demcon Advanced Mechatronics Enschede B.V;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Pays-Bas;UNIVERSITAIR MEDISCH CENTRUM UTRECHT;Universitair Medisch Centrum Utrecht;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Portugal;UNIVERSIDADE DE COIMBRA;Universidade De Coimbra;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Royaume-Uni;King's College London;King'S College London;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;coordinateur;;;;;
AIMS-2-TRIALS;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Royaume-Uni;BIRKBECK COLLEGE - UNIVERSITY OF LONDON;Birkbeck College - University Of London;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Royaume-Uni;UNIVERSITY OF NEWCASTLE UPON TYNE;University Of Newcastle Upon Tyne;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Royaume-Uni;AUTISTICA;Autistica;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Royaume-Uni;UNIVERSITY OF BRISTOL;University Of Bristol;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;SuŠde;KAROLINSKA INSTITUTET;Karolinska Institutet;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;SuŠde;UPPSALA UNIVERSITET;Uppsala Universitet;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Suisse;F. HOFFMANN-LA ROCHE AG;F. Hoffmann-La Roche Ag;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Suisse;Universitat Basel;Universitat Basel;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
AIMS-2-TRIALS;Suisse;NOVARTIS PHARMA AG;Novartis Pharma Ag;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 ?;Commission Europ‚enne;01/06/2018;31/05/2023;;;;;;;;
BlockRabies;Cote d'Ivoire;Swiss Centre for Scientific Research;Swiss Centre For Scientific Research;;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 ?;Commission Europ‚enne;01/04/2020;01/03/2024;;;;;;;;
BlockRabies;Cote d'Ivoire;Institut National d'HygiŠne Publique;Institut National D'HygiŠne Publique;;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 ?;Commission Europ‚enne;01/04/2020;01/03/2024;;;;;;;;
BlockRabies;Cote d'Ivoire;MinistŠre de Resources Animales et Halieutiques;MinistŠre De Resources Animales Et Halieutiques;;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 ?;Commission Europ‚enne;01/04/2020;01/03/2024;;;;;;EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS | ERA4TB Project | H2020 | CORDIS | European Commission (europa.eu);;
BlockRabies;France;Institut Pasteur;Institut Pasteur;Lyssavirus, ‚pid‚miologie et neuropathologie;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 ?;Commission Europ‚enne;01/04/2020;01/03/2024;;;;;;;;
BlockRabies;Mali;Universit‚ des Sciences, des Techniques et des Technologies de Bamako;Universit‚ Des Sciences, Des Techniques Et Des Technologies De Bamako;;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 ?;Commission Europ‚enne;01/04/2020;01/03/2024;;;;;;;;
BlockRabies;Mali;Laboratoire Central V‚t‚rinaire;Laboratoire Central V‚t‚rinaire;;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 ?;Commission Europ‚enne;01/04/2020;01/03/2024;;;;;;;;
BlockRabies;Suisse;Swiss Tropical and Public Health Institute*;Swiss Tropical And Public Health Institute*;;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 ?;Commission Europ‚enne;01/04/2020;01/03/2024;;;Coordinateur;;;;;
BlockRabies;Suisse;Health Information Traceability;Health Information Traceability;;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 ?;Commission Europ‚enne;01/04/2020;01/03/2024;;;;;;;;
FRMPTC;Autriche;University of Vienna;University Of Vienna;;c-di-AMP in bacterial metabolism and host-pathogen interactio;Projet scientifique;Infectious diseases;Streptococcus infections;;;;370 258,00 ?;Fondation pour la Recherche M‚dicale;01/02/2019;01/02/2022;;;;Projet financ‚;;;;
FRMPTC;Etats-Unis;University of Massachusetts Medical School;University Of Massachusetts Medical School;;c-di-AMP in bacterial metabolism and host-pathogen interactio;Projet scientifique;Infectious diseases;Streptococcus infections;;;;370 258,00 ?;Fondation pour la Recherche M‚dicale;01/02/2019;01/02/2022;;;;Projet financ‚;;;;
FRMPTC;France;Institut Pasteur;Institut Pasteur;Biologie Bact‚ries pathog.… Gram-positif;c-di-AMP in bacterial metabolism and host-pathogen interaction;Projet scientifique;Infectious diseases;Streptococcus infections;;;;370 258,00 ?;Fondation pour la Recherche M‚dicale;01/02/2019;01/02/2022;;;Coordinateur;Projet financ‚;;;;
BIGPICTURE;Allemagne;FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.;Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Allemagne;TECHNISCHE UNIVERSITAET MUENCHEN;Technische Universitaet Muenchen;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Allemagne;DIN DEUTSCHES INSTITUT FUER NORMUNG E.V.;Din Deutsches Institut Fuer Normung E.V.;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Allemagne;PHILIPPS UNIVERSITAET MARBURG;Philipps Universitaet Marburg;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Allemagne;GBG FORSCHUNGS GMBH;Gbg Forschungs Gmbh;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Allemagne;BAYER AKTIENGESELLSCHAFT;Bayer Aktiengesellschaft;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Allemagne;BOEHRINGER INGELHEIM INTERNATIONALGMBH;Boehringer Ingelheim Internationalgmbh;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Autriche;MEDIZINISCHE UNIVERSITAT GRAZ;Medizinische Universitat Graz;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Autriche;BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC);Biobanks And Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric);;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Autriche;MEDIZINISCHE UNIVERSITAET WIEN;Medizinische Universitaet Wien;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Belgique;UNIVERSITE DE LIEGE;Universite De Liege;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Belgique;THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA;The European Institute For Innovation Through Health Data;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Belgique;EUROPEAN SOCIETY OF PATHOLOGY;European Society Of Pathology;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Belgique;CYTOMINE;Cytomine;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Belgique;TIME.LEX;Time.Lex;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Belgique;JANSSEN PHARMACEUTICA NV;Janssen Pharmaceutica Nv;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Belgique;UCB BIOPHARMA;Ucb Biopharma;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Danemark;NOVO NORDISK A/S;Novo Nordisk A/S;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Etats-Unis;DIGITAL PATHOLOGY ASSOCIATION INC;Digital Pathology Association Inc;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Finlande;CSC-TIETEEN TIETOTEKNIIKAN KESKUS OY;Csc-Tieteen Tietotekniikan Keskus Oy;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Finlande;HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMŽ;Helsingin Ja Uudenmaan Sairaanhoitopiirin Kuntayhtym„;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;France;OWKIN FRANCE;Owkin France;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;France;SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT;Sanofi-Aventis Recherche & Developpement;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;https://cordis.europa.eu/project/id/777394;;
BIGPICTURE;France;INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS;Institut De Recherches Internationales Servier Iris;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;France;INSTITUT PASTEUR;Institut Pasteur;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Hongrie;SEMMELWEIS EGYETEM;Semmelweis Egyetem;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Irlande;DECIPHEX LIMITED;Deciphex Limited;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Italie;AZIENDA OSPEDALIERA PER L EMERGENZA CANNIZZARO;Azienda Ospedaliera Per L Emergenza Cannizzaro;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;coordinateur;;;;;
BIGPICTURE;Pays-Bas;UNIVERSITAIR MEDISCH CENTRUM UTRECHT;Universitair Medisch Centrum Utrecht;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Pays-Bas;TECHNISCHE UNIVERSITEIT EINDHOVEN;Technische Universiteit Eindhoven;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Pays-Bas;STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS;Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Pays-Bas;TTOPSTART BV;Ttopstart Bv;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Pays-Bas;STICHTING LYGATURE;Stichting Lygature;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Pays-Bas;PHIT BV;Phit Bv;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Royaume-Uni;THE LEEDS TEACHING HOSPITALS NATIONAL HEALTH SERVICE TRUST;The Leeds Teaching Hospitals National Health Service Trust;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Royaume-Uni;THE UNIVERSITY OF WARWICK;The University Of Warwick;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Royaume-Uni;PFIZER LIMITED;Pfizer Limited;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;SuŠde;LINKOPINGS UNIVERSITET;Linkopings Universitet;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;SuŠde;UPPSALA UNIVERSITET;Uppsala Universitet;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;SuŠde;OSTERGOTLANDS LANS LANDSTING;Ostergotlands Lans Landsting;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;SuŠde;SECTRA AB;Sectra Ab;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Suisse;HAUTE ECOLE SPECIALISEE DE SUISSE OCCIDENTALE;Haute Ecole Specialisee De Suisse Occidentale;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Suisse;NOVARTIS PHARMA AG;Novartis Pharma Ag;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
BIGPICTURE;Suisse;F. HOFFMANN-LA ROCHE AG;F. Hoffmann-La Roche Ag;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 ?;Commission Europ‚enne;01/02/2021;31/01/2027;;;;;;;;
APPRISE-1;Australie;Peter Doherty Institute for Infection and Immunity;Peter Doherty Institute For Infection And Immunity;;Collaboration sur l'‚pid‚miologie et la recherche clinique visant … faciliter la formation professionnelle et … d‚velopper puis … mettre en ?uvre la recherche clinique en contexte ‚pid‚mique (APPRISE?REACTING workshop);;;;;;;;;;;;;;;;;;
APPRISE-1;Cambodge;Institut Pasteur du Cambodge ;Institut Pasteur Du Cambodge ;;Collaboration sur l'‚pid‚miologie et la recherche clinique visant … faciliter la formation professionnelle et … d‚velopper puis … mettre en ?uvre la recherche clinique en contexte ‚pid‚mique (APPRISE?REACTING workshop);;;;;;;;;;;;;;;;;;
CANDY;Allemagne;UNIVERSITAET ULM;Universitaet Ulm;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;Allemagne;ARTTIC INNOVATION GMBH;Arttic Innovation Gmbh;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;Belgique;AUTISME-EUROPE AISBL;Autisme-Europe Aisbl;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;France;INSTITUT PASTEUR;Institut Pasteur;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;France;ASSISTANCE PUBLIQUE HOPITAUX DE PARIS;Assistance Publique Hopitaux De Paris;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;France;ARTTIC;Arttic;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;coordinateur;;;;;
CANDY;Pays-Bas;RIJKSUNIVERSITEIT GRONINGEN;Rijksuniversiteit Groningen;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;Pays-Bas;NOLDUS INFORMATION TECHNOLOGY BV;Noldus Information Technology Bv;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;Royaume-Uni;KING'S COLLEGE LONDON;King'S College London;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;Royaume-Uni;ADD INFORMATION SERVICES;Add Information Services;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;Royaume-Uni;BIRKBECK COLLEGE - UNIVERSITY OF LONDON;Birkbeck College - University Of London;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;SuŠde;KAROLINSKA INSTITUTET;Karolinska Institutet;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
CANDY;Suisse;UNIVERSITAT BASEL;Universitat Basel;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;http://cordis.europa.eu/project/id/777394;;
COSYN;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Allemagne;UNIVERSITATSKLINIKUM BONN;Universitatsklinikum Bonn;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Allemagne;CEGAT GMBH;Cegat Gmbh;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Allemagne;LIFE AND BRAIN GMBH;Life And Brain Gmbh;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Danemark;REGION HOVEDSTADEN;Region Hovedstaden;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Danemark;H. LUNDBECK AS;H. Lundbeck As;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2020;;;;;;;;
COSYN;France;INSTITUT PASTEUR;Institut Pasteur;G‚n‚tique humaine et fonctions cognitives;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Pays-Bas;STICHTING VU;Stichting Vu;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Pays-Bas;SYNAPTOLOGICS BV;Synaptologics Bv;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Pays-Bas;VERENIGING SAMENWERKENDE OUDER- EN PATIENTENORGANISATIES;Vereniging Samenwerkende Ouder- En Patientenorganisaties;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Royaume-Uni;CARDIFF UNIVERSITY;Cardiff University;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2020;;;;;;;;
COSYN;SuŠde;KAROLINSKA INSTITUTET;Karolinska Institutet;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2020;;;coordinateur;;;;;
COSYN;Suisse;F. HOFFMANN-LA ROCHE AG;F. Hoffmann-La Roche Ag;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2020;;;;;;A global alliance for Zika virus control and prevention | ZIKAlliance Project | H2020 | CORDIS | European Commission (europa.eu);54;
IGNITE;Allemagne;LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN;Ludwig-Maximilians-Universitaet Muenchen;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;coordinateur;;;A global alliance for Zika virus control and prevention | ZIKAlliance Project | H2020 | CORDIS | European Commission (europa.eu);54;
IGNITE;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Allemagne;HITS GGMBH;Hits Ggmbh;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Allemagne;GENERALDIREKTION DER STAATLICHE NATURWISSENSCHAFTLICHEN SAMMLUNGEN BAYERNS;Generaldirektion Der Staatliche Naturwissenschaftlichen Sammlungen Bayerns;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Allemagne;BAYERISCHE AKADEMIE DER WISSENSCHAFTEN;Bayerische Akademie Der Wissenschaften;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Australie;Board of the Queensland Museum;Board Of The Queensland Museum;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Belgique;UNIVERSITE LIBRE DE BRUXELLES;Universite Libre De Bruxelles;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Belgique;Fourmy;Fourmy;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Bulgarie;PENSOFT PUBLISHERS;Pensoft Publishers;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Croatie;FACULTY OF SCIENCE UNIVERSITY OF ZAGREB;Faculty Of Science University Of Zagreb;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;France;INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT;Institut National De Recherche Pour L'Agriculture, L'Alimentation Et L'Environnement;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;France;INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE;Institut National De Recherche En Informatique Et Automatique;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;France;INSTITUT PASTEUR;Institut Pasteur;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Irlande;NATIONAL UNIVERSITY OF IRELAND GALWAY;National University Of Ireland Galway;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;NorvŠge;UNIVERSITETET I BERGEN;Universitetet I Bergen;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Portugal;CENTRO INTERDISCIPLINAR DE INVESTIGACAO MARINHA E AMBIENTAL;Centro Interdisciplinar De Investigacao Marinha E Ambiental;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Royaume-Uni;UNIVERSITY OF BRISTOL;University Of Bristol;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Royaume-Uni;UNIVERSITY COLLEGE LONDON;University College London;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;54;
HERCULES;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 ?;Commission Europ‚enne;01/01/2016;30/06/2021;;;coordinateur;;;;54;
HERCULES;Finlande;VARSINAIS-SUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA;Varsinais-Suomen Sairaanhoitopiirin Kuntayhtyma;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 ?;Commission Europ‚enne;01/01/2016;30/06/2021;;;;;;;54;
HERCULES;Finlande;TURUN YLIOPISTO;Turun Yliopisto;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 ?;Commission Europ‚enne;01/01/2016;30/06/2021;;;;;;;54;
HERCULES;France;INSTITUT PASTEUR;Institut Pasteur;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 ?;Commission Europ‚enne;01/01/2016;30/06/2021;;;;;;;54;
HERCULES;Italie;UNIVERSITA DEGLI STUDI DI TRIESTE;Universita Degli Studi Di Trieste;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 ?;Commission Europ‚enne;01/01/2016;30/06/2021;;;;;;;54;
HERCULES;Italie;ISTITUTO SUPERIORE DI SANITA;Istituto Superiore Di Sanita;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 ?;Commission Europ‚enne;01/01/2016;30/06/2021;;;;;;;54;
HERCULES;Italie;AB ANALITICA SRL;Ab Analitica Srl;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 ?;Commission Europ‚enne;01/01/2016;30/06/2021;;;;;;;54;
HERCULES;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 ?;Commission Europ‚enne;01/01/2016;30/06/2021;;;;;;;54;
HERCULES;SuŠde;KAROLINSKA INSTITUTETÿ;Karolinska Institutetÿ;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 ?;Commission Europ‚enne;01/01/2016;30/06/2021;;;;;;;54;
MECHABIOME;France;Institut Pasteur;Institut Pasteur;Analyse d'images biologiques;Computational imaging of the spatiotemporal distribution of forces in gut tissue: a study of the cross talk between cell mechanics, microbiome and infectious processes;Projet scientifique;cell mechanics;;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;54;
MECHABIOME;France;Institut Pasteur;Institut Pasteur;Biologie Cellulaire et Infection;Computational imaging of the spatiotemporal distribution of forces in gut tissue: a study of the cross talk between cell mechanics, microbiome and infectious processes;Projet scientifique;cell mechanics;;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;54;
MECHABIOME;Hong-Kong;Hong-Kong University-Pasteur Research Centre;Hong-Kong University-Pasteur Research Centre;;Computational imaging of the spatiotemporal distribution of forces in gut tissue: a study of the cross talk between cell mechanics, microbiome and infectious processes;Projet scientifique;cell mechanics;;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;54;
IF-EBOla;Canada;UNIVERSITY OF MANITOBA;University Of Manitoba;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;54;
IF-EBOla;Etats-Unis;ORION INTEGRATED BIOSCIENCES INC.;Orion Integrated Biosciences Inc.;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;54;
IF-EBOla;France;INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT;Institut De Recherche Pour Le Developpement;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;coordinateur;;;;54;
IF-EBOla;France;INSTITUT PASTEUR;Institut Pasteur;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;54;
IF-EBOla;France;FABENTECH;Fabentech;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;54;
IF-EBOla;France;ABSISKEY;Absiskey;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;54;
IF-EBOla;Isra‰l;BEN-GURION UNIVERSITY OF THE NEGEV;Ben-Gurion University Of The Negev;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;54;
IF-EBOla;Italie;ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO;Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;54;
FunHoMic;Allemagne;LEIBNIZ-INSTITUT FUR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS-KNOLL-ISTITUT;Leibniz-Institut Fur Naturstoff-Forschung Und Infektionsbiologie Ev Hans-Knoll-Istitut;Department Microbial Pathogenicity Mechanisms & Research Group Microbial Immunology;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
FunHoMic;Belgique;PRODIGEST;Prodigest;R&D technology;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
FunHoMic;Belgique;UNIVERSITEIT GENT;Universiteit Gent;Department of Biotechnology;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
FunHoMic;Espagne;FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA;Fundacio Hospital Universitari Vall D'Hebron - Institut De Recerca;Gastroenterol ogy Department;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
FunHoMic;France;Institut Pasteur;Institut Pasteur;Biologie et Pathogenicite Fongiques;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;coordinateur;;;;54;
FunHoMic;France;BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE;Bioaster Fondation De Cooperation Scientifique;Microbiota Program -Proteomics & Metabolomics Technology Unit;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
FunHoMic;France;BIOSE;Biose;R&D Department;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
FunHoMic;France;UNIVERSITE CLERMONT AUVERGNE;Universite Clermont Auvergne;UMR Fromage;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
FunHoMic;France;UNIVERSITE DE PARIS Diderot;Universite De Paris Diderot;Ecole Doctorale BioSPC;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
FunHoMic;France;UNIVERSITE DE PARIS Descartes;Universite De Paris Descartes;Ecole Doctorale Bio SPC;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
FunHoMic;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;Department of Internal Medicine;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
FunHoMic;Pays-Bas;MIMETAS BV;Mimetas Bv;Application Development R&D;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
FunHoMic;Pays-Bas;UNIVERSITEIT LEIDEN;Universiteit Leiden;Division of Systems Biomedicine and Pharmacology;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
FunHoMic;Royaume-Uni;THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN;The University Court Of The University Of Aberdeen;Rowett Institute/MRC Centre for Medical Mycology;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
FunHoMic;Royaume-Uni;EVOTEC (UK) LIMITED;Evotec (Uk) Limited;Anti-infectives Discovery;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
FunHoMic;Suisse;UNIVERSITAT ZURICH;Universitat Zurich;Section of Immunolgy, Vetsuisse Faculty;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;54;
DeSiReS: Dengue Severe Immune Response Studies;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;Dengue virus-mosquito-host interactions: assessing type I interferon mediated immune processes and immunological effects of mosquito salivary glands on Dengue infection;Projet scientifique;dengue;entomology;immunology;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards. | One Health EJP Project | H2020 | CORDIS | European Commission (europa.eu);45;
DeSiReS: Dengue Severe Immune Response Studies;C“te d'Ivoire;Institut Pasteur de C“te d'Ivoire;Institut Pasteur De C“te D'Ivoire;;Dengue virus-mosquito-host interactions: assessing type I interferon mediated immune processes and immunological effects of mosquito salivary glands on Dengue infection;Projet scientifique;dengue;entomology;immunology;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards. | One Health EJP Project | H2020 | CORDIS | European Commission (europa.eu);45;
DeSiReS: Dengue Severe Immune Response Studies;France;Institut Pasteur;Institut Pasteur;Immunologie Translationnelle;Dengue virus-mosquito-host interactions: assessing type I interferon mediated immune processes and immunological effects of mosquito salivary glands on Dengue infection;Projet scientifique;dengue;entomology;immunology;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;45;
DeSiReS: Dengue Severe Immune Response Studies;Italie;Cenci Bolognetti Foundation;Cenci Bolognetti Foundation;;Dengue virus-mosquito-host interactions: assessing type I interferon mediated immune processes and immunological effects of mosquito salivary glands on Dengue infection;Projet scientifique;dengue;entomology;immunology;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;45;
E-DYNAMICS;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;Determinants of the expansion of dengue minority stereotypes;Projet scientifique;dengue;arbovirus;serotype;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;45;
E-DYNAMICS;France;Institut Pasteur de Nouvelle Cal‚donie;Institut Pasteur De Nouvelle Cal‚donie;;Determinants of the expansion of dengue minority stereotypes;Projet scientifique;dengue;arbovirus;serotype;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;45;
E-DYNAMICS;France;Institut Pasteur;Institut Pasteur;G‚nomique ‚volutive des virus … ARN;Determinants of the expansion of dengue minority stereotypes;Projet scientifique;dengue;arbovirus;serotype;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;45;
SHERLOCK4HAT;France;Institut Pasteur;Institut Pasteur;Biologie cellulaire des Trypanosomes;Development of a field-adapted CRISPR-based method   for the diagnosis of sleeping sickness.;Projet scientifique;trypanosomes;tsetse fly;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;45;
SHERLOCK4HAT;France;Institut Pasteur;Institut Pasteur;Plate-forme ICAReB - Investigation clinique et acc‚s aux ressources Biologiques;Development of a field-adapted CRISPR-based method   for the diagnosis of sleeping sickness.;Projet scientifique;trypanosomes;tsetse fly;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;45;
SHERLOCK4HAT;Guin‚e;Institut Pasteur de Guin‚e;Institut Pasteur De Guin‚e;;Development of a field-adapted CRISPR-based method   for the diagnosis of sleeping sickness.;Projet scientifique;trypanosomes;tsetse fly;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;45;
SHERLOCK4HAT;France;Institut Pasteur;Institut Pasteur;Biologie mol‚culaire des Trypanosomes;Development of a field-adapted CRISPR-based method  for the diagnosis of sleeping sickness.;Projet scientifique;trypanosomes;tsetse fly;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;45;
CAMPYVAC;Canada;Institut Armand Frappier;Institut Armand Frappier;;Development of heptose-containing semi-synthetic glycoconjugate vaccines against campylobacteriosis;Projet scientifique;Campylobacteriosi;vaccine;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;45;
CAMPYVAC;France;Institut Pasteur;Institut Pasteur;Chimie des biomol‚cules;Development of heptose-containing semi-synthetic glycoconjugate vaccines against campylobacteriosis;Projet scientifique;Campylobacteriosi;vaccine;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;45;
DIPs 2;France;Institut Pasteur;Institut Pasteur;Direction internationale P“le des op‚rations;DIPS 2;Sant‚ publique;DIPs;Renforcement;Diagnostic;;;200 000,00 ?;DCI Monaco;11/07/1905;;;;;;;;45;
DIPs 2;France;Institut Pasteur;Institut Pasteur;BIOMICS;DIPS 2;Sant‚ publique;DIPs;Renforcement;Diagnostic;;;200 000,00 ?;DCI Monaco;;;;;;;;;45;
DIPs 2;Tunisie;Institut Pasteur de Tunis;Institut Pasteur De Tunis;;DIPS 2;Sant‚ publique;DIPs;Renforcement;Diagnostic;;;200 000,00 ?;DCI Monaco;11/07/1905;;;;;;;;45;
DIPs 2;Tunisie;Facult‚ de M‚decine de Tunis;Facult‚ De M‚decine De Tunis;;DIPS 2;Sant‚ publique;DIPs;Renforcement;Diagnostic;;;200 000,00 ?;DCI Monaco;;;;;;;;;45;
CoPyMe;France;Institut Pasteur;Institut Pasteur;PathogenŠse de Helicobacter;E. coli and H. pylori as models for the role of DNA methylation in the relation between bacteria and cancer ;Projet scientifique;colorectal cancer;gastric cancer;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;45;
CoPyMe;France;Institut Pasteur;Institut Pasteur;Polarite Cellulaire, Migration et Cancer;E. coli and H. pylori as models for the role of DNA methylation in the relation between bacteria and cancer ;Projet scientifique;colorectal cancer;gastric cancer;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;45;
CoPyMe;France;Institut Pasteur;Institut Pasteur;Chimie Biologique Epig‚n‚tique;E. coli and H. pylori as models for the role of DNA methylation in the relation between bacteria and cancer ;Projet scientifique;colorectal cancer;gastric cancer;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;45;
CoPyMe;GrŠce;Hellenic Institut Pasteur ;Hellenic Institut Pasteur ;;E. coli and H. pylori as models for the role of DNA methylation in the relation between bacteria and cancer ;Projet scientifique;colorectal cancer;gastric cancer;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;45;
EbolaMoDRAD;Allemagne;AJ INNUSCREEN GMBH;Aj Innuscreen Gmbh;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Belgique;CORIS BIOCONCEPT SPRL;Coris Bioconcept Sprl;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Danemark;STATENS SERUM INSTITUT;Statens Serum Institut;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Finlande;TURUN YLIOPISTO;Turun Yliopisto;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;France;Institut Pasteur;Institut Pasteur;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;France;INSERM TRANSFERT SA;Inserm Transfert Sa;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Italie;ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO;Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Italie;CLONIT SRL;Clonit Srl;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Italie;EMERGENCY LIFE SUPPORT FOR CIVILIAN WAR VICTIMS ONG ONLUS;Emergency Life Support For Civilian War Victims Ong Onlus;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Royaume-Uni;Department of Health;Department Of Health;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Royaume-Uni;THE UNIVERSITY OF STIRLING;The University Of Stirling;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;S‚n‚gal;INSTITUT PASTEUR DE DAKAR;Institut Pasteur De Dakar;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;SuŠde;FOLKHALSOMYNDIGHETEN;Folkhalsomyndigheten;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;coordinateur;;;;45;
EbolaMoDRAD;SuŠde;STOCKHOLMS UNIVERSITET;Stockholms Universitet;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 ?;Commission Europ‚enne;01/02/2015;31/01/2018;;;;;;;45;
AMOHI ;Etats-Unis;Wistar Institute;Wistar Institute;;Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patients initiating medication-assisted treatment;Projet scientifique;HIV;cellular immune activation;;;;336 070,00 ?;US National Institute on Drug abuse;01/08/2019;31/12/2024;;;coordinateur;convention d‚marr‚e;;;45;
AMOHI ;Etats-Unis;University of Pennsylvania;University Of Pennsylvania;HIV Prevention Research Division;Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patients initiating medication-assisted treatment;Projet scientifique;HIV;cellular immune activation;;;;336 070,00 ?;US National Institute on Drug abuse;01/08/2019;31/12/2024;;;;convention d‚marr‚e;;;45;
AMOHI ;France;Institut Pasteur;Institut Pasteur;Biologie cellulaire des lymphocytes;Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patients initiating medication-assisted treatment;Projet scientifique;HIV;cellular immune activation;;;;336 070,00 ?;US National Institute on Drug abuse;01/08/2019;31/12/2024;;;;convention d‚marr‚e;;;45;
AMOHI ;France;Institut de M‚decine et d'Epid‚miologie Appliqu‚e;Institut De M‚decine Et D'Epid‚miologie Appliqu‚e;;Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patients initiating medication-assisted treatment;Projet scientifique;HIV;cellular immune activation;;;;336 070,00 ?;US National Institute on Drug abuse;01/08/2019;31/12/2024;;;;convention d‚marr‚e;;;45;
AMOHI ;Vietnam;Institut Pasteur … Ho Chi Minh City;Institut Pasteur · Ho Chi Minh City;;Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patients initiating medication-assisted treatment;Projet scientifique;HIV;cellular immune activation;;;;336 070,00 ?;US National Institute on Drug abuse;01/08/2019;31/12/2024;;;;convention d‚marr‚e;;;45;
ELIXIR-EXCELERATE;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;Coordinateur;;;Research Infrastructures for the control of vector-borne diseases | INFRAVEC2 Project | H2020 | CORDIS | European Commission (europa.eu);23;
ELIXIR-EXCELERATE;Belgique;VlaamsÿInstituut voor Biotechnologie;VlaamsÿInstituut Voor Biotechnologie;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;Research Infrastructures for the control of vector-borne diseases | INFRAVEC2 Project | H2020 | CORDIS | European Commission (europa.eu);23;
ELIXIR-EXCELERATE;Danemark;Technical University of Denmark;Technical University Of Denmark;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Danemark;University of Copenhagen;University Of Copenhagen;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Danemark;Aarhus University;Aarhus University;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Danemark;University ofÿSouthern Denmark;University OfÿSouthern Denmark;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Espagne;AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS;Agencia Estatal Consejo Superior Deinvestigaciones Cientificas;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Espagne;BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION;Barcelona Supercomputing Center - Centro Nacional De Supercomputacion;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Espagne;FUNDACIO CENTRE DE REGULACIO GENOMICA;Fundacio Centre De Regulacio Genomica;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Espagne;FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA);Fundacio Institut De Recerca Biomedica (Irb Barcelona);;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Espagne;FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM;Fundacio Institut Mar D Investigacions Mediques Imim;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Espagne;FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III;Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Espagne;FUNDACION DE LA COMUNIDAD VALENCIANA CENTRO DE INVESTIGACION PRINCIPEFELIPE;Fundacion De La Comunidad Valenciana Centro De Investigacion Principefelipe;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Espagne;FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD;Fundacion Publica Andaluza Progreso Y Salud;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Espagne;UNIVERSIDAD DE MALAGA;Universidad De Malaga;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Espagne;UNIVERSIDAD POMPEU FABRA;Universidad Pompeu Fabra;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Estonie;Tartu University;Tartu University;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Finlande;CSC-IT Center for Science Ltd;Csc-It Center For Science Ltd;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;France;CENTRE DE COOPERATION INTERNATIONALE EN RECHERCHE AGRONOMIQUE POUR LEDEVELOPPEMENT - C.I.R.A.D. EPIC;Centre De Cooperation Internationale En Recherche Agronomique Pour Ledeveloppement - C.I.R.A.D. Epic;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;France;INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT;Institut National De Recherche Pour L'Agriculture, L'Alimentation Et L'Environnement;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;France;INSTITUT PASTEUR;Institut Pasteur;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;GrŠce;ATHINA-EREVNITIKO KENTRO KAINOTOMIAS STIS TECHNOLOGIES TIS PLIROFORIAS, TON EPIKOINONION KAI TIS GNOSIS;Athina-Erevnitiko Kentro Kainotomias Stis Technologies Tis Pliroforias, Ton Epikoinonion Kai Tis Gnosis;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;GrŠce;IDRYMA TECHNOLOGIAS KAI EREVNAS;Idryma Technologias Kai Erevnas;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;GrŠce;BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING;Biomedical Sciences Research Center Alexander Fleming;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Isra‰l;WEIZMANN INSTITUTE OF SCIENCE;Weizmann Institute Of Science;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Isra‰l;THE HEBREW UNIVERSITY OF JERUSALEM;The Hebrew University Of Jerusalem;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;NorvŠge;UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET;Universitetet I Tromsoe - Norges Arktiske Universitet;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;NorvŠge;UNIVERSITETET I OSLO;Universitetet I Oslo;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;NorvŠge;UNIVERSITETET I BERGEN;Universitetet I Bergen;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;NorvŠge;NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNU;Norges Teknisk-Naturvitenskapelige Universitet Ntnu;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Pays-Bas;STICHTING DTL PROJECTS;Stichting Dtl Projects;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Portugal;CENTRO DE CIENCIAS DO MAR DO ALGARVE;Centro De Ciencias Do Mar Do Algarve;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Portugal;FUNDACAO CALOUSTE GULBENKIAN;Fundacao Calouste Gulbenkian;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Portugal;INESC ID - INSTITUTO DE ENGENHARIADE SISTEMAS E COMPUTADORES, INVESTIGACAO E DESENVOLVIMENTO EM LISBOA;Inesc Id - Instituto De Engenhariade Sistemas E Computadores, Investigacao E Desenvolvimento Em Lisboa;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Portugal;INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA;Instituto De Biologia Experimental E Tecnologica;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;R‚publique TchŠque;CESNET ZAJMOVE SDRUZENI PRAVNICKYCH OSOB;Cesnet Zajmove Sdruzeni Pravnickych Osob;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;R‚publique TchŠque;Masarykova univerzita;Masarykova Univerzita;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;R‚publique TchŠque;USTAV ORGANICKE CHEMIE A BIOCHEMIE, AV CR, V.V.I.;Ustav Organicke Chemie A Biochemie, Av Cr, V.V.I.;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Royaume-Uni;EARLHAM INSTITUTE;Earlham Institute;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Royaume-Uni;HERIOT-WATT UNIVERSITY;Heriot-Watt University;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Royaume-Uni;THE UNIVERSITY OF MANCHESTER;The University Of Manchester;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Slov‚nie;UNIVERZA V LJUBLJANI;Univerza V Ljubljani;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Slov‚nie;NACIONALNI INSTITUT ZA BIOLOGIJO;Nacionalni Institut Za Biologijo;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;SuŠde;UPPSALA UNIVERSITET;Uppsala Universitet;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;SuŠde;LINKOPINGS UNIVERSITET;Linkopings Universitet;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Suisse;SIB INSTITUT SUISSE DE BIOINFORMATIQUE;Sib Institut Suisse De Bioinformatique;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 ?;Commission Europ‚enne;01/09/2015;31/08/2019;;;;;;;139;
IAV-m6A;Etats-Unis;DUKE UNIVERSITY;Duke University;;Elucidating the role of m6A RNA methylation on the replication and pathogenesis of influenza A virus;Projet scientifique;virology;RNA virus;;;;264 668,40 ?;Commission Europ‚enne;01/06/2017;31/05/2020;;;;;;;139;
IAV-m6A;France;Institut Pasteur;Institut Pasteur;Virologie structurale;Elucidating the role of m6A RNA methylation on the replication and pathogenesis of influenza A virus;Projet scientifique;virology;RNA virus;;;;264 668,40 ?;Commission Europ‚enne;01/06/2017;31/05/2020;;;coordinateur;;;;139;
Ebola_Tx;Belgique;PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE;Prins Leopold Instituut Voor Tropische Geneeskunde;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 ?;Commission Europ‚enne;01/11/2014;31/10/2016;;;coordinateur;;;;139;
Ebola_Tx;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 ?;Commission Europ‚enne;01/11/2014;31/10/2016;;;;;;;139;
Ebola_Tx;France;ETABLISSEMENT FRANCAIS DU SANG;Etablissement Francais Du Sang;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 ?;Commission Europ‚enne;01/11/2014;31/10/2016;;;;;;;139;
Ebola_Tx;France;INSTITUT PASTEUR;Institut Pasteur;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 ?;Commission Europ‚enne;01/11/2014;31/10/2016;;;;;;;139;
Ebola_Tx;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 ?;Commission Europ‚enne;01/11/2014;31/10/2016;;;;;;;139;
Ebola_Tx;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 ?;Commission Europ‚enne;01/11/2014;31/10/2016;;;;;;;139;
Ebola_Tx;Royaume-Uni;THE UNIVERSITY OF LIVERPOOL;The University Of Liverpool;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 ?;Commission Europ‚enne;01/11/2014;31/10/2016;;;;;;;139;
Ebola_Tx;Royaume-Uni;LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER;London School Of Hygiene And Tropical Medicine Royal Charter;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 ?;Commission Europ‚enne;01/11/2014;31/10/2016;;;;;;;139;
paratransgenesis based on RNAi and Asaia bacterium in Anopheles;France;Institut Pasteur de Guyane;Institut Pasteur De Guyane;;Engineering Asaia to induce RNA interference in larval and adult Anopheles: a tool for vector genetics and paratransgenesis;Projet scientifique;malaria;;;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
paratransgenesis based on RNAi and Asaia bacterium in Anopheles;France;Institut Pasteur;Institut Pasteur;G‚n‚tique et G‚nomique des Insectes Vecteurs;Engineering Asaia to induce RNA interference in larval and adult Anopheles: a tool for vector genetics and paratransgenesis;Projet scientifique;malaria;;;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
paratransgenesis based on RNAi and Asaia bacterium in Anopheles;Iran;Institut Pasteur d'Iran;Institut Pasteur D'Iran;;Engineering Asaia to induce RNA interference in larval and adult Anopheles: a tool for vector genetics and paratransgenesis;Projet scientifique;malaria;;;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;139;
SURVEV68;C“te d'Ivoire;Institut Pasteur de C“te d'Ivoire;Institut Pasteur De C“te D'Ivoire;;Enterovirus 68 investigation in children with acute respiratory infection and acute flaccid myelitis in two Subsaharan african countries.;Projet scientifique;enterovirus;pediatrics;;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
SURVEV68;France;Institut Pasteur;Institut Pasteur;Populations virales et pathogenŠse;Enterovirus 68 investigation in children with acute respiratory infection and acute flaccid myelitis in two Subsaharan african countries.;Projet scientifique;enterovirus;pediatrics;;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
SURVEV68;S‚n‚gal;Institut Pasteur de Dakar;Institut Pasteur De Dakar;;Enterovirus 68 investigation in children with acute respiratory infection and acute flaccid myelitis in two Subsaharan african countries.;Projet scientifique;enterovirus;pediatrics;;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;139;
EVinCA&M;Cameroun;Institut Pasteur du Cameroun;Institut Pasteur Du Cameroun;;Epidemiology and Genetic Diversity of Enteroviruses in Central Africa and in Madagascar: uncovering the hidden parts of the enterovirus ecosystems;Projet scientifique;enterovirus;ecosystems;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
EVinCA&M;Centrafrique;Institut Pasteur de Bangui;Institut Pasteur De Bangui;;Epidemiology and Genetic Diversity of Enteroviruses in Central Africa and in Madagascar: uncovering the hidden parts of the enterovirus ecosystems;Projet scientifique;enterovirus;ecosystems;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
EVinCA&M;France;Institut Pasteur;Institut Pasteur;Populations virales et pathogenŠse;Epidemiology and Genetic Diversity of Enteroviruses in Central Africa and in Madagascar: uncovering the hidden parts of the enterovirus ecosystems;Projet scientifique;enterovirus;ecosystems;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;139;
EVinCA&M;Madagascar;Institut Pasteur in Madagascar;Institut Pasteur In Madagascar;;Epidemiology and Genetic Diversity of Enteroviruses in Central Africa and in Madagascar: uncovering the hidden parts of the enterovirus ecosystems;Projet scientifique;enterovirus;ecosystems;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
ETHOMOS;France;Institut Pasteur de Guyane;Institut Pasteur De Guyane;;Ethomics for mosquitoes;Projet scientifique;mosquito-borne diseases;arbovirus;;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;139;
ETHOMOS;France;Institut Pasteur;Institut Pasteur;D‚cision et processus Bayesiens;Ethomics for mosquitoes;Projet scientifique;mosquito-borne diseases;arbovirus;;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
ETHOMOS;Niger;CERMES;Cermes;;Ethomics for mosquitoes;Projet scientifique;mosquito-borne diseases;arbovirus;;;;50 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
EuroGCT;Allemagne;FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.;Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL;Bundesinstitut Fur Impfstoffe Und Biomedizinische Arzneimittel;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;GERMAN STEMCELL NETWORK (GSCN) - DEUTSCHES STAMMZELLNETZWERK EV;German Stemcell Network (Gscn) - Deutsches Stammzellnetzwerk Ev;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;UNIVERSITAETSKLINIKUM FREIBURG;Universitaetsklinikum Freiburg;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;UNIVERSITATSKLINIKUM BONN;Universitatsklinikum Bonn;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;STAMMZELLNETZWERK.NRW EV;Stammzellnetzwerk.Nrw Ev;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH;Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Autriche;UNIVERSITAET INNSBRUCK;Universitaet Innsbruck;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Autriche;DEBRA AUSTRIA HILFE BEI EPIDERMOLYSIS BULLOSA;Debra Austria Hilfe Bei Epidermolysis Bullosa;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Autriche;INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH;Institut Fuer Molekulare Biotechnologie Gmbh;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Belgique;UNIVERSITE LIBRE DE BRUXELLES;Universite Libre De Bruxelles;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Belgique;VRIJE UNIVERSITEIT BRUSSEL;Vrije Universiteit Brussel;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Espagne;ASOCIACION INSTITUTO BIODONOSTIA;Asociacion Instituto Biodonostia;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Espagne;FUNDACIO CENTRE DE REGULACIO GENOMICA;Fundacio Centre De Regulacio Genomica;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Finlande;ITA-SUOMEN YLIOPISTO;Ita-Suomen Yliopisto;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;France;INSTITUT PASTEUR;Institut Pasteur;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;France;SOCIETE FRANCAISE DE THERAPIE CELLULAIRE ET GENIQUE;Societe Francaise De Therapie Cellulaire Et Genique;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;France;ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK;Ecrin European Clinical Research Infrastructure Network;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Hongrie;BIOTALENTUM TUDASFEJLESZTO KFT;Biotalentum Tudasfejleszto Kft;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Irlande;NATIONAL UNIVERSITY OF IRELAND GALWAY;National University Of Ireland Galway;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Italie;UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA;Universita Degli Studi Di Modena E Reggio Emilia;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Italie;UNIVERSITA DEGLI STUDI DI MILANO;Universita Degli Studi Di Milano;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Pays-Bas;ACADEMISCH ZIEKENHUIS GRONINGEN;Academisch Ziekenhuis Groningen;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Pays-Bas;KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW;Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Pologne;UNIWERSYTET WARSZAWSKI;Uniwersytet Warszawski;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Pologne;UNIWERSYTET JAGIELLONSKI;Uniwersytet Jagiellonski;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;R‚publique TchŠque;Masarykova univerzita;Masarykova Univerzita;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;R‚publique TchŠque;FAKULTNI NEMOCNICE U SV. ANNY V BRNE;Fakultni Nemocnice U Sv. Anny V Brne;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;coordinateur;;;;139;
EuroGCT;Royaume-Uni;CELL THERAPY CATAPULT LIMITED;Cell Therapy Catapult Limited;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE;Imperial College Of Science Technology And Medicine;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;QUEEN MARGARET UNIVERSITY, EDINBURGH;Queen Margaret University, Edinburgh;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;THE UNIVERSITY OF EXETER;The University Of Exeter;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;UNIVERSITY COLLEGE LONDON;University College London;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;CARDIFF UNIVERSITY;Cardiff University;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;THE UNIVERSITY OF MANCHESTER;The University Of Manchester;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;KING'S COLLEGE LONDON;King'S College London;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;SuŠde;KAROLINSKA INSTITUTET;Karolinska Institutet;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;SuŠde;LUNDS UNIVERSITET;Lunds Universitet;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;139;
EuroStemCell;Allemagne;LIFE AND BRAIN GMBH;Life And Brain Gmbh;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Allemagne;GERMAN STEMCELL NETWORK (GSCN) - DEUTSCHES STAMMZELLNETZWERK EV;German Stemcell Network (Gscn) - Deutsches Stammzellnetzwerk Ev;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Autriche;INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH;Institut Fuer Molekulare Biotechnologie Gmbh;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Belgique;VRIJE UNIVERSITEIT BRUSSEL;Vrije Universiteit Brussel;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Belgique;UNIVERSITE LIBRE DE BRUXELLES;Universite Libre De Bruxelles;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Espagne;FUNDACIO CENTRE DE REGULACIO GENOMICA;Fundacio Centre De Regulacio Genomica;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;France;INSTITUT PASTEUR;Institut Pasteur;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;France;ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK;Ecrin European Clinical Research Infrastructure Network;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Hongrie;SZENT ISTVAN UNIVERSITY;Szent Istvan University;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Irlande;NATIONAL UNIVERSITY OF IRELAND GALWAY;National University Of Ireland Galway;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Italie;ISTITUTO EUROPEO DI ONCOLOGIA SRL;Istituto Europeo Di Oncologia Srl;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Italie;UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA;Universita Degli Studi Di Roma La Sapienza;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Italie;UNIVERSITA DEGLI STUDI DI MILANO;Universita Degli Studi Di Milano;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Italie;UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA;Universita Degli Studi Di Modena E Reggio Emilia;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Pays-Bas;KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW;Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;Principles of Polarity ? Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity | PolarNet Project | H2020 | CORDIS | European Commission (europa.eu);;
EuroStemCell;Pays-Bas;ACADEMISCH ZIEKENHUIS GRONINGEN;Academisch Ziekenhuis Groningen;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Pologne;UNIWERSYTET WARSZAWSKI;Uniwersytet Warszawski;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;R‚publique TchŠque;Masarykova univerzita;Masarykova Univerzita;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;coordinateur;;;;;
EuroStemCell;Royaume-Uni;UNIVERSITY OF YORK;University Of York;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Royaume-Uni;THE UNIVERSITY OF MANCHESTER;The University Of Manchester;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Royaume-Uni;KING'S COLLEGE LONDON;King'S College London;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Royaume-Uni;CARDIFF UNIVERSITY;Cardiff University;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Royaume-Uni;THE UNIVERSITY OF BIRMINGHAM;The University Of Birmingham;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;SuŠde;LUNDS UNIVERSITET;Lunds Universitet;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;SuŠde;KAROLINSKA INSTITUTET;Karolinska Institutet;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 ?;Commission Europ‚enne;01/01/2015;31/03/2018;;;;;;Immune profiling to guide host-directed interventions to cure HBV infections | IP-cure-B Project | H2020 | CORDIS | European Commission (europa.eu);;
EMBRIC;Allemagne;FORSCHUNGSVERBUND BERLIN EV;Forschungsverbund Berlin Ev;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Allemagne;TUNATECH GMBH;Tunatech Gmbh;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Allemagne;HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH;Helmholtz-Zentrum Fur Infektionsforschung Gmbh;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Allemagne;LEIBNIZ-INSTITUT DSMZ-DEUTSCHE SAMMLUNG VON MIKROORGANISMEN UND ZELLKULTUREN GMBH;Leibniz-Institut Dsmz-Deutsche Sammlung Von Mikroorganismen Und Zellkulturen Gmbh;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Allemagne;EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM (EU-OPENSCREEN ERIC);European Infrastructure Of Open Screening Platforms For Chemical Biology European Research Infrastucture Consortium (Eu-Openscreen Eric);;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Espagne;UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA;Universidad Del Pais Vasco/ Euskal Herriko Unibertsitatea;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Espagne;UNIVERSIDAD DE VIGO;Universidad De Vigo;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;France;SORBONNE UNIVERSITE;Sorbonne Universite;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;coordinateur;;;;;
EMBRIC;France;Institut Pasteur;Institut Pasteur;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;France;INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT;Institut National De Recherche Pour L'Agriculture, L'Alimentation Et L'Environnement;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer | DECIDER Project | H2020 | CORDIS | European Commission (europa.eu);14;
EMBRIC;France;UNIVERSITE GUSTAVE EIFFEL;Universite Gustave Eiffel;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;France;UNIVERSITE COTE D'AZUR;Universite Cote D'Azur;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;GrŠce;HELLENIC CENTRE FOR MARINE RESEARCH;Hellenic Centre For Marine Research;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Isra‰l;TEL AVIV UNIVERSITY;Tel Aviv University;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Italie;STAZIONE ZOOLOGICA ANTON DOHRN;Stazione Zoologica Anton Dohrn;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;NorvŠge;UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET;Universitetet I Tromsoe - Norges Arktiske Universitet;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;NorvŠge;SCALPRO AS;Scalpro As;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;NorvŠge;UNIVERSITETET I BERGEN;Universitetet I Bergen;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Portugal;CENTRO DE CIENCIAS DO MAR DO ALGARVE;Centro De Ciencias Do Mar Do Algarve;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Royaume-Uni;UNITED KINGDOM RESEARCH AND INNOVATION;United Kingdom Research And Innovation;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Royaume-Uni;THE SCOTTISH ASSOCIATION FOR MARINESCIENCE LBG;The Scottish Association For Marinescience Lbg;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Royaume-Uni;MARINE SCOTLAND;Marine Scotland;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Royaume-Uni;MARINE BIOLOGICAL ASSOCIATION OF THE UNITED KINGDOM;Marine Biological Association Of The United Kingdom;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Royaume-Uni;THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS;The University Court Of The University Of St Andrews;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Royaume-Uni;XELECT LIMITED;Xelect Limited;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Royaume-Uni;CAB INTERNATIONAL;Cab International;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 ?;Commission Europ‚enne;01/06/2015;31/05/2019;;;;;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance | SoNAR-Global Project | H2020 | CORDIS | European Commission (europa.eu);;
EuroBioTox;Allemagne;ROBERT KOCH-INSTITUT;Robert Koch-Institut;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 ?;Commission Europ‚enne;01/06/2017;31/05/2022;;;coordinateur;;;;;
EuroBioTox;Allemagne;TOXOGEN GMBH;Toxogen Gmbh;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 ?;Commission Europ‚enne;01/06/2017;31/05/2022;;;;;;;;
EuroBioTox;Belgique;JRC -JOINT RESEARCH CENTRE- EUROPEAN COMMISSION;Jrc -Joint Research Centre- European Commission;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 ?;Commission Europ‚enne;01/06/2017;31/05/2022;;;;;;;;
EuroBioTox;Belgique;SCIENSANO;Sciensano;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 ?;Commission Europ‚enne;01/06/2017;31/05/2022;;;;;;;;
EuroBioTox;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 ?;Commission Europ‚enne;01/06/2017;31/05/2022;;;;;;;;
EuroBioTox;France;INSTITUT PASTEUR;Institut Pasteur;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 ?;Commission Europ‚enne;01/06/2017;31/05/2022;;;;;;;;
EuroBioTox;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 ?;Commission Europ‚enne;01/06/2017;31/05/2022;;;;;;;;
EuroBioTox;France;AGENCE NATIONALE DE LA SECURITE SANITAIRE DE L ALIMENTATION DE L ENVIRONNEMENT ET DU TRAVAIL;Agence Nationale De La Securite Sanitaire De L Alimentation De L Environnement Et Du Travail;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 ?;Commission Europ‚enne;01/06/2017;31/05/2022;;;;;;;;
EuroBioTox;Royaume-Uni;THE QUEEN'S UNIVERSITY OF BELFAST;The Queen'S University Of Belfast;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 ?;Commission Europ‚enne;01/06/2017;31/05/2022;;;;;;;;
EuroBioTox;SuŠde;TOTALFORSVARETS FORSKNINGSINSTITUT;Totalforsvarets Forskningsinstitut;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 ?;Commission Europ‚enne;01/06/2017;31/05/2022;;;;;;;;
EuroBioTox;Suisse;EIDGENOSSISCHES DEPARTEMENT FUR VERTEIDIGUNG, BEVOLKERUNGSSCHUTZ UND SPORT;Eidgenossisches Departement Fur Verteidigung, Bevolkerungsschutz Und Sport;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 ?;Commission Europ‚enne;01/06/2017;31/05/2022;;;;;;;;
EuroBioTox;Suisse;LUGINBUEHL WERNER;Luginbuehl Werner;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 ?;Commission Europ‚enne;01/06/2017;31/05/2022;;;;;;;;
EuroBioTox;Suisse;ZURCHER HOCHSCHULE FUR ANGEWANDTE WISSENSCHAFTEN;Zurcher Hochschule Fur Angewandte Wissenschaften;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 ?;Commission Europ‚enne;01/06/2017;31/05/2022;;;;;;;;
EPIC-XS;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
EPIC-XS;Allemagne;EBERHARD KARLS UNIVERSITAET TUEBINGEN;Eberhard Karls Universitaet Tuebingen;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;https://cordis.europa.eu/project/id/964568;;
EPIC-XS;Allemagne;TECHNISCHE UNIVERSITAET MUENCHEN;Technische Universitaet Muenchen;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
EPIC-XS;Autriche;FORSCHUNGSINSTITUT FUR MOLEKULARE PATHOLOGIE GESELLSCHAFT MBH;Forschungsinstitut Fur Molekulare Pathologie Gesellschaft Mbh;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
EPIC-XS;Belgique;VIB VZW;Vib Vzw;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
EPIC-XS;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
EPIC-XS;Espagne;FUNDACIO CENTRE DE REGULACIO GENOMICA;Fundacio Centre De Regulacio Genomica;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
EPIC-XS;Espagne;FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III;Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos Iii;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;European programme for the establishment of validated procedures for the detection and identification of biological toxins | EuroBioTox Project | H2020 | CORDIS | European Commission (europa.eu);;
EPIC-XS;Estonie;TARTU ULIKOOL;Tartu Ulikool;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
EPIC-XS;France;Institut Pasteur;Institut Pasteur;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
EPIC-XS;GrŠce;IDRYMA TECHNOLOGIAS KAI EREVNAS;Idryma Technologias Kai Erevnas;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
EPIC-XS;Italie;ISTITUTO EUROPEO DI ONCOLOGIA SRL;Istituto Europeo Di Oncologia Srl;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
EPIC-XS;NorvŠge;UNIVERSITETET I BERGEN;Universitetet I Bergen;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
EPIC-XS;Pays-Bas;UNIVERSITEIT UTRECHT;Universiteit Utrecht;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;coordinateur;;;;;
EPIC-XS;R‚publique TchŠque;MIKROBIOLOGICKY USTAV AV CR V.V.I;Mikrobiologicky Ustav Av Cr V.V.I;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
EPIC-XS;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
EPIC-XS;SuŠde;KUNGLIGA TEKNISKA HOEGSKOLAN;Kungliga Tekniska Hoegskolan;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
EPIC-XS;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 ?;Commission Europ‚enne;01/01/2019;31/12/2022;;;;;;;;
ERA4TB;Allemagne;FORSCHUNGSZENTRUM BORSTEL;Forschungszentrum Borstel;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Allemagne;KLINIKUM DER UNIVERSITAET ZU KOELN;Klinikum Der Universitaet Zu Koeln;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Allemagne;EVOTEC INTERNATIONAL GMBH;Evotec International Gmbh;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;Towards an instrument-free future of molecular diagnostics at the point-of-care | FreeATPOC Project | H2020 | CORDIS | European Commission (europa.eu);;
ERA4TB;Belgique;SCIENSANO;Sciensano;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Belgique;JANSSEN PHARMACEUTICA NV;Janssen Pharmaceutica Nv;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Danemark;GRITSYSTEMS AS;Gritsystems As;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Espagne;UNIVERSIDAD CARLOS III DE MADRID;Universidad Carlos Iii De Madrid;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;coordinateur;;;;;
ERA4TB;Espagne;UNIVERSIDAD DE ZARAGOZA;Universidad De Zaragoza;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses | Rafts4Biotech Project | H2020 | CORDIS | European Commission (europa.eu);;
ERA4TB;Espagne;SYNAPSE RESEARCH MANAGEMENT PARTNERS SL;Synapse Research Management Partners Sl;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Espagne;SERVICIO MADRILENO DE SALUD;Servicio Madrileno De Salud;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Espagne;GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL;Glaxosmithkline Investigacion Y Desarrollo Sl;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Etats-Unis;BILL & MELINDA GATES FOUNDATION;Bill & Melinda Gates Foundation;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Etats-Unis;GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION;Global Alliance For Tb Drug Development Non Profit Organisation;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;France;Institut Pasteur;Institut Pasteur;Pathogenomique mycobacterienne integree;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;France;INSTITUT PASTEUR DE LILLE FONDATION;Institut Pasteur De Lille Fondation;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;France;IMABIOTECH SAS;Imabiotech Sas;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;France;BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE;Bioaster Fondation De Cooperation Scientifique;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Ireland;CRITICAL PATH INSTITUTE, LIMITED;Critical Path Institute, Limited;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis | LeiSHield-MATI Project | H2020 | CORDIS | European Commission (europa.eu);;
ERA4TB;Italie;UNIVERSITA DEGLI STUDI DI PADOVA;Universita Degli Studi Di Padova;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Italie;UNIVERSITA DEGLI STUDI DI PAVIA;Universita Degli Studi Di Pavia;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Lettonie;LATVIJAS ORGANISKAS SINTEZES INSTITUTS;Latvijas Organiskas Sintezes Instituts;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Pays-Bas;QPS NETHERLANDS BV;Qps Netherlands Bv;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Royaume-Uni;Department of Health;Department Of Health;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Royaume-Uni;NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE;National Institute For Health And Care Excellence;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Royaume-Uni;UNIVERSITY OF DUNDEE;University Of Dundee;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;SuŠde;UPPSALA UNIVERSITET;Uppsala Universitet;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;SuŠde;LUNDS UNIVERSITETÿ;Lunds Universitetÿ;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Suisse;FONDATION INNOVATIVE MEDICINES FOR TUBERCULOSIS;Fondation Innovative Medicines For Tuberculosis;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;;;
ERA4TB;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 ?;Commission Europ‚enne;01/01/2020;31/12/2025;;;;;;"TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development | TBVAC2020 Project | H2020 | CORDIS | European Commission (europa.eu)";;
EVAg;Afrique du Sud;AGRICULTURAL RESEARCH COUNCIL INSTITUTE FOR SOIL CLIMATE AND WATER;Agricultural Research Council Institute For Soil Climate And Water;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Afrique du Sud;NATIONAL HEALTH LABORATORY SERVICES;National Health Laboratory Services;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Allemagne;BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN;Bernhard-Nocht-Institut Fuer Tropenmedizin;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Allemagne;ROBERT KOCH-INSTITUT;Robert Koch-Institut;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Allemagne;FRIEDRICH LOEFFLER INSTITUT - BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT;Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer Tiergesundheit;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Allemagne;CHARITE - UNIVERSITAETSMEDIZIN BERLIN;Charite - Universitaetsmedizin Berlin;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Australie;COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION;Commonwealth Scientific And Industrial Research Organisation;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Chine;WUHAN INSTITUTE OF VIROLOGY, CHINESE ACADEMY OF SCIENCES;Wuhan Institute Of Virology, Chinese Academy Of Sciences;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;coordinateur;;;;;
EVAg;France;Institut Pasteur;Institut Pasteur;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;France;FONDATION MERIEUX;Fondation Merieux;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Italie;ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO;Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Pays-Bas;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Erasmus Universitair Medisch Centrum Rotterdam;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Royaume-Uni;THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;The Secretary Of State For Environment, Food And Rural Affairs;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Royaume-Uni;Department of Health;Department Of Health;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Royaume-Uni;THE PIRBRIGHT INSTITUTE LBG;The Pirbright Institute Lbg;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Russie;FEDERAL STATE BUDGETARY SCIENTIFIC INSTITUTION CHUMAKOV INSTITUTE OF POLIOMYELITIS AND VIRAL ENCEPHALITIDES;Federal State Budgetary Scientific Institution Chumakov Institute Of Poliomyelitis And Viral Encephalitides;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Russie;SMORODINTSEV RESEARCH INSTITUTE OF INFLUENZA OF THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION;Smorodintsev Research Institute Of Influenza Of The Ministry Of Health Of The Russian Federation;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Russie;RESEARCH INSTITUTE OF VACCINES AND SERA II MECHNIKOV;Research Institute Of Vaccines And Sera Ii Mechnikov;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Slovaquie;BIOMEDICINSKE CENTRUM SLOVENSKEJ AKADEMIE VIED;Biomedicinske Centrum Slovenskej Akademie Vied;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Slov‚nie;UNIVERZA V LJUBLJANI;Univerza V Ljubljani;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;SuŠde;FOLKHALSOMYNDIGHETEN;Folkhalsomyndigheten;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Suisse;UNIVERSITAT BASEL;Universitat Basel;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 ?;Commission Europ‚enne;01/04/2015;31/07/2020;;;;;;;;
EVA-GLOBAL;Allemagne;Bernhard-Nocht-Institut fr Tropenmedizin;Bernhard-Nocht-Institut Fr Tropenmedizin;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Allemagne;Charit‚ ? Universit„tsmedizin Berlin;Charit‚ ? Universit„tsmedizin Berlin;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Allemagne;Robert Koch-Institut;Robert Koch-Institut;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Allemagne;PHILIPPS UNIVERSITAET MARBURG;Philipps Universitaet Marburg;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Allemagne;FRIEDRICH LOEFFLER INSTITUT;Friedrich Loeffler Institut;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Allemagne;LEIBNIZ-INSTITUT DSMZ-DEUTSCHE SAMMLUNG VON MIKROORGANISMEN UND ZELLKULTUREN GMBH;Leibniz-Institut Dsmz-Deutsche Sammlung Von Mikroorganismen Und Zellkulturen Gmbh;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Allemagne;JULIUS KUHN-INSTITUTBUNDESFORSCHUNGSINSTITUT FURKULTURPFLANZEN;Julius Kuhn-Institutbundesforschungsinstitut Furkulturpflanzen;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Australie;COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION;Commonwealth Scientific And Industrial Research Organisation;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Belgique;EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS;European Research Infrastructure On Highly Pathogenic Agents;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Chine;WUHAN INSTITUTE OF VIROLOGY, CHINESE ACADEMY OF SCIENCES;Wuhan Institute Of Virology, Chinese Academy Of Sciences;Chinese Academy of Science wuhang;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Chine;WUHAN INSTITUTE OF VIROLOGY, CHINESE ACADEMY OF SCIENCES;Wuhan Institute Of Virology, Chinese Academy Of Sciences;National Biosafety Laboratory;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Etats-Unis;University of Florida;University Of Florida;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;France;Institut Pasteur;Institut Pasteur;Lyssavirus, ‚pid‚miologie et neuropathologie;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus ;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;France;Institut Pasteur;Institut Pasteur;Epid‚mio.& Physiopatho.Virus OncogŠnes;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus ;Virus collection;Network;;11 602 750,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;France;Institut Pasteur;Institut Pasteur;G‚n‚tique mol‚culaire des virus ARN;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus ;Virus collection;Network;;11 602 751,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;France;Institut Pasteur;Institut Pasteur;Populations virales et pathogenŠse;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus ;Virus collection;Network;;11 602 752,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;France;Institut Pasteur;Institut Pasteur;Arbovirus et Insectes Vecteurs;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus ;Virus collection;Network;;11 602 753,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century | IS_MIRRI21 Project | H2020 | CORDIS | European Commission (europa.eu);;
EVA-GLOBAL;France;Institut Pasteur;Institut Pasteur;Environnement et risques infectieux;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus ;Virus collection;Network;;11 602 755,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;France;Universit‚ d'Aix Marseille*;Universit‚ D'Aix Marseille*;Coordination Team;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;Coordinateur;Avenant sign‚;;;;
EVA-GLOBAL;France;Universit‚ d'Aix Marseille*;Universit‚ D'Aix Marseille*;Unit‚ des Virus Emergents;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;France;Institut national de la sant‚ et de la recherche m‚dicale;Institut National De La Sant‚ Et De La Recherche M‚dicale;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;France;INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE;Institut National De La Recherche Agronomique;INRA Bordeaux-Aquitaine -UMR 1332 Biologie du Fruit et Pathologie;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;France;INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE;Institut National De La Recherche Agronomique;INRA PACA AVIGNON ?UR407 Unit‚ de Pathologie V‚g‚tale;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;France;CENTRE DE COOPERATION INTERNATIONALE EN RECHERCHE AGRONOMIQUE POUR LEDEVELOPPEMENT;Centre De Cooperation Internationale En Recherche Agronomique Pour Ledeveloppement;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;France;AGENCE NATIONALE DE LA SECURITE SANITAIRE DE L?ALIMENTATIONDE L?ENVIRONNEMENTET DU TRAVAIL;Agence Nationale De La Securite Sanitaire De L?Alimentationde L?Environnementet Du Travail;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;France;FONDATION MERIEUX;Fondation Merieux;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;GrŠce;Institut Pasteur Hellenique;Institut Pasteur Hellenique;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Hongrie;Nemzeti N‚peg‚szs‚ggyi K”zpont;Nemzeti N‚peg‚szs‚ggyi K”zpont;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Italie;Istituto di Ricovero e Cura a Carattere Scientifico;Istituto Di Ricovero E Cura A Carattere Scientifico;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Italie;Istituto nazionale per le malattie infettive Lazzaro Spallanzani;Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Italie;ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE;Istituto Zooprofilattico Sperimentale Delle Venezie;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Italie;ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA LOMBARDIA E DELL'EMILIA ROMAGNA BRUNO UBERTINI;Istituto Zooprofilattico Sperimentale Della Lombardia E Dell'Emilia Romagna Bruno Ubertini;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Italie;CONSIGLIO NAZIONALE DELLERICERCHE;Consiglio Nazionale Dellericerche;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;Accelerated Early staGe drug diScovery | AEGIS Project | H2020 | CORDIS | European Commission (europa.eu);;
EVA-GLOBAL;Pays-Bas;Erasmus University Medical Center;Erasmus University Medical Center;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Pays-Bas;RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU;Rijksinstituut Voor Volksgezondheid En Milieu;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Royaume-Uni;Department of Health;Department Of Health;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Royaume-Uni;THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;The Secretary Of State For Environment, Food And Rural Affairs;Animal Health and Veterinaries Agency;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Royaume-Uni;THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;The Secretary Of State For Environment, Food And Rural Affairs;Centre for Environment, Fisheries and AquacultureScience;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Royaume-Uni;THE PIRBRIGHT INSTITUTE LBG;The Pirbright Institute Lbg;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Russie;SMORODINTSEV RESEARCH INSTITUTE OF INFLUENZA OF THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION;Smorodintsev Research Institute Of Influenza Of The Ministry Of Health Of The Russian Federation;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;S‚n‚gal;INSTITUT PASTEUR DE DAKAR;Institut Pasteur De Dakar;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Slovaquie;Biomedicinske Centrum Slovenskej Akademie Vied;Biomedicinske Centrum Slovenskej Akademie Vied;Institute of Virology;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Slovaquie;Biomedicinske Centrum Slovenskej Akademie Vied;Biomedicinske Centrum Slovenskej Akademie Vied;Department of Plant Virology;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Slov‚nie;Univerza v Ljubljani;Univerza V Ljubljani;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
EVA-GLOBAL;Suisse;Universit„t Basel;Universit„t Basel;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 ?;Commission Europ‚enne;01/01/2020;01/01/2024;;;;Avenant sign‚;;;;
REACTION;Allemagne;BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN;Bernhard-Nocht-Institut Fuer Tropenmedizin;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;;
REACTION;Allemagne;RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG;Ruprecht-Karls-Universitaet Heidelberg;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;;
REACTION;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;coordinateur;;;;;
REACTION;France;ASSOCIATION POUR LE DEVELOPPEMENT DE L'ENSEIGNEMENT ET DES RECHERCHES AUPRES DES UNIVERSITES, DES CENTRES DE RECHERCHE ET DES ENTREPRISES D'AQUITAINE;Association Pour Le Developpement De L'Enseignement Et Des Recherches Aupres Des Universites, Des Centres De Recherche Et Des Entreprises D'Aquitaine;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;;
REACTION;France;INSTITUT PASTEUR;Institut Pasteur;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;;
REACTION;France;ECOLE NORMALE SUPERIEURE DE LYON;Ecole Normale Superieure De Lyon;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;;
REACTION;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;;
REACTION;Pays-Bas;DRUG DISCOVERY FACTORY BV;Drug Discovery Factory Bv;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;;
REACTION;Pays-Bas;UNIVERSITEIT UTRECHT;Universiteit Utrecht;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;;
REACTION;Royaume-Uni;Department of Health;Department Of Health;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;;
REACTION;S‚n‚gal;UNIVERSITE CHEIKH ANTA DIOP DE DAKAR;Universite Cheikh Anta Diop De Dakar;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;;
REACTION;Suisse;FONDATION POUR L INSTITUT DE HAUTES ETUDES INTERNATIONALES ET DU DEVELOPPEMENT;Fondation Pour L Institut De Hautes Etudes Internationales Et Du Developpement;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 ?;Commission Europ‚enne;01/11/2014;31/10/2017;;;;;;;;
EVoSP;Br‚sil;FIOCRUZ;Fiocruz;;Evolution of regulatory interactions through the lens of antibiotic selective pressure;Projet scientifique;Polymyxins;antibiotics;antibioresistance;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;coordinateur;;;;;
EVoSP;France;Institut Pasteur;Institut Pasteur;Plate-Forme Cristallographie;Evolution of regulatory interactions through the lens of antibiotic selective pressure;Projet scientifique;Polymyxins;antibiotics;antibioresistance;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
EVoSP;France;Institut Pasteur;Institut Pasteur;Plate-forme Technologique de RMN Biologique;Evolution of regulatory interactions through the lens of antibiotic selective pressure;Projet scientifique;Polymyxins;antibiotics;antibioresistance;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
EVoSP;Uruguay;Institut Pasteur in Montevideo;Institut Pasteur In Montevideo;;Evolution of regulatory interactions through the lens of antibiotic selective pressure;Projet scientifique;Polymyxins;antibiotics;antibioresistance;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
RI-VIS;Allemagne;INFRAFRONTIER GMBH;Infrafrontier Gmbh;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Allemagne;EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM (EU-OPENSCREEN ERIC);European Infrastructure Of Open Screening Platforms For Chemical Biology European Research Infrastucture Consortium (Eu-Openscreen Eric);;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Allemagne;FORSCHUNGSZENTRUM JULICH GMBH;Forschungszentrum Julich Gmbh;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Autriche;BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC);Biobanks And Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric);;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Belgique;EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS;European Research Infrastructure On Highly Pathogenic Agents;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Belgique;Service Public F‚d‚ral de Programmation Politique Scientifique (Belspo);Service Public F‚d‚ral De Programmation Politique Scientifique (Belspo);;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;France;ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK;Ecrin European Clinical Research Infrastructure Network;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;France;EUROPEAN MARINE BIOLOGICAL RESOURCE CENTRE EUROPEAN RESEARCH INFRASTRUCTURE CONSORTIUM;European Marine Biological Resource Centre European Research Infrastructure Consortium;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;France;INSTITUT PASTEUR;Institut Pasteur;Collection Nle Cultures Micro-organismes;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Pays-Bas;EATRIS ERIC;Eatris Eric;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Royaume-Uni;INSTRUCT-ERIC;Instruct-Eric;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2019;31/07/2021;;;coordinateur;;;;;
RI-VIS;Royaume-Uni;EUROPEAN SOCIAL SURVEY EUROPEAN RESEARCH INFRASTRUCTURE CONSORTIUM;European Social Survey European Research Infrastructure Consortium;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2019;31/07/2021;;;;;;;;
ZIKAVAX;Allemagne;EUROPEAN VACCINE INITIATIVE EWIV;European Vaccine Initiative Ewiv;;Fast track development of a Zika vaccine based on measles vector;Projet scientifique;Zika;vaccine;epidemics;;;4 918 137,50 ?;Commission Europ‚enne;01/10/2016;31/12/2020;;;coordinateur;;;;;
ZIKAVAX;Autriche;THEMIS BIOSCIENCE GMBH;Themis Bioscience Gmbh;;Fast track development of a Zika vaccine based on measles vector;Projet scientifique;Zika;vaccine;epidemics;;;4 918 137,50 ?;Commission Europ‚enne;01/10/2016;31/12/2020;;;;;;European Proteomics Infrastructure Consortium providing Access | EPIC-XS Project | H2020 | CORDIS | European Commission (europa.eu);;
ZIKAVAX;France;INSTITUT PASTEUR;Institut Pasteur;;Fast track development of a Zika vaccine based on measles vector;Projet scientifique;Zika;vaccine;epidemics;;;4 918 137,50 ?;Commission Europ‚enne;01/10/2016;31/12/2020;;;;;;;;
ZIKAVAX;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;Fast track development of a Zika vaccine based on measles vector;Projet scientifique;Zika;vaccine;epidemics;;;4 918 137,50 ?;Commission Europ‚enne;01/10/2016;31/12/2020;;;;;;;;
FiTeRaD;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;Field Tests for Rabies Diagnostic;Projet scientifique;rabies;first point of care tests;detection;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
FiTeRaD;France;Institut Pasteur;Institut Pasteur;Lyssavirus, ‚pid‚miologie et neuropathologie;Field Tests for Rabies Diagnostic;Projet scientifique;rabies;first point of care tests;detection;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;;
FiTeRaD;France;Institut Pasteur;Institut Pasteur;Chimie bioorganique des acides nucl‚iques;Field Tests for Rabies Diagnostic;Projet scientifique;rabies;first point of care tests;detection;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
FiTeRaD;Madagascar;Institut Pasteur in Madagascar;Institut Pasteur In Madagascar;;Field Tests for Rabies Diagnostic;Projet scientifique;rabies;first point of care tests;detection;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
MusVir;France;Institut Pasteur;Institut Pasteur;Cellules Souches et D‚veloppement - Stem Cells and Development;Functional consequences of pathogen infection in tissue specific stem cells;Projet scientifique;stem cells;flu;influenza;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;;
MusVir;France;Institut Pasteur;Institut Pasteur;Neuropathologie exp‚rimentale;Functional consequences of pathogen infection in tissue specific stem cells;Projet scientifique;stem cells;flu;influenza;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
MusVir;Hong-Kong;Hong-Kong University-Pasteur Research Centre;Hong-Kong University-Pasteur Research Centre;;Functional consequences of pathogen infection in tissue specific stem cells;Projet scientifique;stem cells;flu;influenza;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
HDM-FUN;Allemagne;JOHANN WOLFGANG GOETHE UNIVERSITAT FRANKFURT AM MAIN;Johann Wolfgang Goethe Universitat Frankfurt Am Main;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
HDM-FUN;Allemagne;JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG;Julius-Maximilians-Universitat Wurzburg;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
HDM-FUN;Allemagne;LEIBNIZ-INSTITUT FUER NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS-KNOELL-INSTITUT;Leibniz-Institut Fuer Naturstoff-Forschung Und Infektionsbiologie Ev Hans-Knoell-Institut;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
HDM-FUN;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
HDM-FUN;Etats-Unis;DUKE UNIVERSITY;Duke University;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
HDM-FUN;France;Institut Pasteur;Institut Pasteur;Biologie et pathogenicite fongiques;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
HDM-FUN;France;Institut Pasteur;Institut Pasteur;Immunologie des infections fongiques;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
HDM-FUN;France;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOI;Centre Hospitalier Universitaire Vaudoi;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
HDM-FUN;France;Institut Imagine;Institut Imagine;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;Fast track development of a Zika vaccine based on measles vector | ZIKAVAX Project | H2020 | CORDIS | European Commission (europa.eu);;
HDM-FUN;GrŠce;FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLA;Foundation For Research And Technology Hella;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
HDM-FUN;Italie;UNIVERSITA DEGLI STUDI DI PERUGIA;Universita Degli Studi Di Perugia;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
HDM-FUN;Italie;INNOVATION ACTA S.R.L;Innovation Acta S.R.L;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
HDM-FUN;Pays-Bas;Stichting Katholieke Universiteit;Stichting Katholieke Universiteit;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;Coordinateur;Avenant sign‚;;Rapid European SARS-CoV-2 Emergency research Response | RECoVER Project | H2020 | CORDIS | European Commission (europa.eu);;
HDM-FUN;Pays-Bas;HYCULT BIOTECHNOLOGY BV;Hycult Biotechnology Bv;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
HDM-FUN;Portugal;UNIVERSIDADEDO MINHO;Universidadedo Minho;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
HDM-FUN;Roumanie;UNIVERSITATEADE MEDICINA SIFARMACIE IULIUHATIEGANUCLUJ-NAPOCA;Universitateade Medicina Sifarmacie Iuliuhatieganucluj-Napoca;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
HDM-FUN;Royaume-Uni;THE UNIVERSITYCOURT OF THEUNIVERSITY OFABERDEEN;The Universitycourt Of Theuniversity Ofaberdeen;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 ?;Commission Europ‚enne;01/01/2020;01/01/2025;;;;Avenant sign‚;;;;
ZOOFOAMENV;Cameroun;Centre Pasteur du Cameroun;Centre Pasteur Du Cameroun;;Host pathogens interactions in humans infected with zoonotic foamy viruses;Projet scientifique;retroviruses;foamy viruses;zoonoses ;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
ZOOFOAMENV;Chine;Institut Pasteur of Shanghai-Chinese Academy of Sciences;Institut Pasteur Of Shanghai-Chinese Academy Of Sciences;;Host pathogens interactions in humans infected with zoonotic foamy viruses;Projet scientifique;retroviruses;foamy viruses;zoonoses ;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
ZOOFOAMENV;France;Institut Pasteur;Institut Pasteur;Epid‚miologie et Physiopathologie des Virus OncogŠnes;Host pathogens interactions in humans infected with zoonotic foamy viruses;Projet scientifique;retroviruses;foamy viruses;zoonoses ;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;;
ZOOFOAMENV;France;Institut Pasteur;Institut Pasteur;Virologie structurale;Host pathogens interactions in humans infected with zoonotic foamy viruses;Projet scientifique;retroviruses;foamy viruses;zoonoses ;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
IP-cure-B;Allemagne;UNIVERSITAETSKLINIKUM FREIBURG;Universitaetsklinikum Freiburg;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
IP-cure-B;Belgique;EUROPEAN LIVER PATIENTS ASSOCIATION;European Liver Patients Association;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
IP-cure-B;Espagne;FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA;Fundacio Hospital Universitari Vall D'Hebron - Institut De Recerca;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
IP-cure-B;Etats-Unis;GILEAD SCIENCES INC;Gilead Sciences Inc;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
IP-cure-B;France;Institut Pasteur;Institut Pasteur;Immunit‚ inn‚e;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
IP-cure-B;France;Institut national de la sant‚ et de la recherche m‚dicale;Institut National De La Sant‚ Et De La Recherche M‚dicale;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;coordinateur;;;European Virus Archive goes global | EVAg Project | H2020 | CORDIS | European Commission (europa.eu);;
IP-cure-B;France;INSERM TRANSFERT SA;Inserm Transfert Sa;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
IP-cure-B;France;HOSPICES CIVILS DE LYON;Hospices Civils De Lyon;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
IP-cure-B;GrŠce;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;Ethniko Kai Kapodistriako Panepistimio Athinon;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
IP-cure-B;Italie;UNIVERSITA DEGLI STUDI DI PARMA;Universita Degli Studi Di Parma;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
IP-cure-B;Italie;FONDAZIONE IRCCS CA' GRANDA - OSPEDALE MAGGIORE POLICLINICO;Fondazione Irccs Ca' Granda - Ospedale Maggiore Policlinico;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
IP-cure-B;SuŠde;KAROLINSKA INSTITUTET;Karolinska Institutet;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
IP-cure-B;Suisse;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS;Centre Hospitalier Universitaire Vaudois;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
HBP SGA1;Allemagne;BAUHAUS-UNIVERSITAET WEIMAR;Bauhaus-Universitaet Weimar;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;BERGISCHE UNIVERSITAET WUPPERTAL;Bergische Universitaet Wuppertal;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;FORSCHUNGSZENTRUM JULICH GMBH;Forschungszentrum Julich Gmbh;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;FORTISS GMBH;Fortiss Gmbh;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.;Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;HEINRICH-HEINE-UNIVERSITAET DUESSELDORF;Heinrich-Heine-Universitaet Duesseldorf;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;HITS GGMBH;Hits Ggmbh;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN;Johann Wolfgang Goethe-Universitaet Frankfurt Am Main;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;KARLSRUHER INSTITUT FUER TECHNOLOGIE;Karlsruher Institut Fuer Technologie;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN;Rheinisch-Westfaelische Technische Hochschule Aachen;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG;Ruprecht-Karls-Universitaet Heidelberg;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;FZI FORSCHUNGSZENTRUM INFORMATIK;Fzi Forschungszentrum Informatik;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;TECHNISCHE UNIVERSITAET DRESDEN;Technische Universitaet Dresden;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;TECHNISCHE UNIVERSITAET MUENCHEN;Technische Universitaet Muenchen;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;UNIVERSITAET BIELEFELD;Universitaet Bielefeld;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;UNIVERSITAETSKLINIKUM AACHEN;Universitaetsklinikum Aachen;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF;Universitaetsklinikum Hamburg-Eppendorf;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;TECHNISCHE UNIVERSITAT DARMSTADT;Technische Universitat Darmstadt;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation | INCENTIVE Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA1;Allemagne;UNIVERSITAET HAMBURG;Universitaet Hamburg;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;HUMBOLDT-UNIVERSITAET ZU BERLIN;Humboldt-Universitaet Zu Berlin;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV;Deutsches Zentrum Fur Neurodegenerative Erkrankungen Ev;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Autriche;INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA;Institute Of Science And Technology Austria;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Autriche;MEDIZINISCHE UNIVERSITAT INNSBRUCK;Medizinische Universitat Innsbruck;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Autriche;OSTERREICHISCHE STUDIENGESELLSCHAFTFUR KYBERNETIK VEREIN;Osterreichische Studiengesellschaftfur Kybernetik Verein;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Autriche;TECHNISCHE UNIVERSITAET GRAZ;Technische Universitaet Graz;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Belgique;UNIVERSITEIT ANTWERPEN;Universiteit Antwerpen;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Belgique;UNIVERSITE DE LIEGE;Universite De Liege;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Danemark;DANMARKS TEKNISKE UNIVERSITET;Danmarks Tekniske Universitet;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Danemark;FONDEN TEKNOLOGIRADET;Fonden Teknologiradet;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;BARCELONA SUPERCOMPUTING CENTER-CENTRO NACIONAL DE SUPERCOMPUTACION;Barcelona Supercomputing Center-Centro Nacional De Supercomputacion;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;UNIVERSIDAD AUTONOMA DE MADRID;Universidad Autonoma De Madrid;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;UNIVERSIDAD DE CASTILLA - LA MANCHA;Universidad De Castilla - La Mancha;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;UNIVERSIDAD DE GRANADA;Universidad De Granada;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;UNIVERSIDAD POLITECNICA DE MADRID;Universidad Politecnica De Madrid;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;UNIVERSIDAD REY JUAN CARLOS;Universidad Rey Juan Carlos;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy | CANDY Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA1;Espagne;UNIVERSITAT DE BARCELONA;Universitat De Barcelona;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;UNIVERSIDAD POMPEU FABRA;Universidad Pompeu Fabra;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER;Consorci Institut D'Investigacions Biomediques August Pi I Sunyer;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA;Fundacio Institut De Bioenginyeria De Catalunya;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Finlande;AALTO KORKEAKOULUSAATIO SR;Aalto Korkeakoulusaatio Sr;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Finlande;TTY-SAATIO;Tty-Saatio;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;ECOLE NORMALE SUPERIEURE;Ecole Normale Superieure;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE;Institut Du Cerveau Et De La Moelle Epiniere;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE;Institut National De Recherche En Informatique Et Automatique;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;UNIVERSITE DE BORDEAUX;Universite De Bordeaux;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;UNIVERSITE PIERRE ET MARIE CURIE - PARIS 6;Universite Pierre Et Marie Curie - Paris 6;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;UNIVERSITE LYON 1 CLAUDE BERNARD;Universite Lyon 1 Claude Bernard;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;Institut Pasteur;Institut Pasteur;Lyssavirus ???;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;SustainAble Farming for Effective Aquaculture | SAFE-Aqua Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA1;GrŠce;ATHENS UNIVERSITY OF ECONOMICS AND BUSINESS - RESEARCH CENTER;Athens University Of Economics And Business - Research Center;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;GrŠce;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;Ethniko Kai Kapodistriako Panepistimio Athinon;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;GrŠce;POLYTECHNEIO KRITIS;Polytechneio Kritis;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Hongrie;DEBRECENI EGYETEM;Debreceni Egyetem;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Hongrie;KIRSERLETI ORVOSTUDOMANYI KUTATOINTEZET;Kirserleti Orvostudomanyi Kutatointezet;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;Human Brain Project Specific Grant Agreement 1 | HBP SGA1 Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA1;Isra‰l;Bloomfield Science Museum Jerusalem (BSMJ);Bloomfield Science Museum Jerusalem (Bsmj);;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Isra‰l;TEL AVIV UNIVERSITY;Tel Aviv University;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Isra‰l;THE HEBREW UNIVERSITY OF JERUSALEM;The Hebrew University Of Jerusalem;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Isra‰l;WEIZMANN INSTITUTE OF SCIENCE;Weizmann Institute Of Science;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;CINECA CONSORZIO INTERUNIVERSITARIO;Cineca Consorzio Interuniversitario;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;LABORATORIO EUROPEO DI SPETTROSCOPIE NON LINEARI;Laboratorio Europeo Di Spettroscopie Non Lineari;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA;Scuola Superiore Di Studi Universitari E Di Perfezionamento S Anna;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;UNIVERSITA DEGLI STUDI DI PAVIA;Universita Degli Studi Di Pavia;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;ISTITUTO NAZIONALE DI FISICA NUCLEARE;Istituto Nazionale Di Fisica Nucleare;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;UNIVERSITA DEGLI STUDI DI MILANO;Universita Degli Studi Di Milano;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;ISTITUTO SUPERIORE DI SANITA;Istituto Superiore Di Sanita;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;POLITECNICO DI TORINO;Politecnico Di Torino;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;FONDAZIONE EUROPEAN BRAIN RESEARCHINSTITUTE RITA LEVI;Fondazione European Brain Researchinstitute Rita Levi;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;SCUOLA NORMALE SUPERIORE;Scuola Normale Superiore;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;NorvŠge;NORGES MILJO-OG BIOVITENSKAPLIGE UNIVERSITET;Norges Miljo-Og Biovitenskaplige Universitet;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;NorvŠge;UNIVERSITETET I OSLO;Universitetet I Oslo;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Pays-Bas;STICHTING CENTRUM VOOR WISKUNDE EN INFORMATICA;Stichting Centrum Voor Wiskunde En Informatica;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Pays-Bas;STICHTING RADBOUD UNIVERSITEIT;Stichting Radboud Universiteit;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Pays-Bas;KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW;Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Pays-Bas;UNIVERSITEIT VAN AMSTERDAM;Universiteit Van Amsterdam;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Pays-Bas;STICHTING VU;Stichting Vu;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Pays-Bas;UNIVERSITEIT MAASTRICHT;Universiteit Maastricht;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Portugal;FUNDACAO D. ANNA SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD;Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Portugal;UNIVERSIDADE DO MINHO;Universidade Do Minho;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;CARDIFF UNIVERSITY;Cardiff University;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;DE MONTFORT UNIVERSITY;De Montfort University;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE;Imperial College Of Science Technology And Medicine;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;KING'S COLLEGE LONDON;King'S College London;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN;The University Court Of The University Of Aberdeen;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;THE UNIVERSITY OF MANCHESTER;The University Of Manchester;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;UCL Elizabeth Garrett Anderson Institute for Women?s Health;Ucl Elizabeth Garrett Anderson Institute For Women?S Health;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;MEDICAL RESEARCH COUNCIL;Medical Research Council;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;UNIVERSITY OF THE WEST OF ENGLAND, BRISTOL;University Of The West Of England, Bristol;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;UNIVERSITY OF SURREY;University Of Surrey;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;UNIVERSITY OF LEEDS;University Of Leeds;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;THE UNIVERSITY OF SUSSEX;The University Of Sussex;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;MIDDLESEX UNIVERSITY HIGHER EDUCATION CORPORATION;Middlesex University Higher Education Corporation;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;THE UNIVERSITY OF HERTFORDSHIRE HIGHER EDUCATION CORPORATION;The University Of Hertfordshire Higher Education Corporation;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Slov‚nie;INSTITUT JOZEF STEFAN;Institut Jozef Stefan;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;SuŠde;KAROLINSKA INSTITUTET;Karolinska Institutet;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;SuŠde;KUNGLIGA TEKNISKA HOEGSKOLAN;Kungliga Tekniska Hoegskolan;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;SuŠde;LINNEUNIVERSITETET;Linneuniversitetet;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;SuŠde;UPPSALA UNIVERSITET;Uppsala Universitet;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;coordinateur;;;;;
HBP SGA1;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS;Centre Hospitalier Universitaire Vaudois;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;UNIVERSITAET BERN;Universitaet Bern;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;University of Zurich;University Of Zurich;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;UNIVERSITE DE GENEVE;Universite De Geneve;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;UNIVERSITAT BASEL;Universitat Basel;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;SIB INSTITUT SUISSE DE BIOINFORMATIQUE;Sib Institut Suisse De Bioinformatique;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Turquie;SABANCI UNIVERSITESI;Sabanci Universitesi;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 ?;Commission Europ‚enne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA2;Allemagne;BAUHAUS-UNIVERSITAET WEIMAR;Bauhaus-Universitaet Weimar;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;BERGISCHE UNIVERSITAET WUPPERTAL;Bergische Universitaet Wuppertal;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;FORSCHUNGSZENTRUM JULICH GMBH;Forschungszentrum Julich Gmbh;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;FORTISS GMBH;Fortiss Gmbh;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.;Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;HEINRICH-HEINE-UNIVERSITAET DUESSELDORF;Heinrich-Heine-Universitaet Duesseldorf;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;HITS GGMBH;Hits Ggmbh;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN;Johann Wolfgang Goethe-Universitaet Frankfurt Am Main;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;KARLSRUHER INSTITUT FUER TECHNOLOGIE;Karlsruher Institut Fuer Technologie;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN;Rheinisch-Westfaelische Technische Hochschule Aachen;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG;Ruprecht-Karls-Universitaet Heidelberg;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;FZI FORSCHUNGSZENTRUM INFORMATIK;Fzi Forschungszentrum Informatik;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;TECHNISCHE UNIVERSITAET DRESDEN;Technische Universitaet Dresden;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;TECHNISCHE UNIVERSITAET MUENCHEN;Technische Universitaet Muenchen;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;UNIVERSITAET BIELEFELD;Universitaet Bielefeld;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;UNIVERSITAETSKLINIKUM AACHEN;Universitaetsklinikum Aachen;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF;Universitaetsklinikum Hamburg-Eppendorf;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;TECHNISCHE UNIVERSITAT DARMSTADT;Technische Universitat Darmstadt;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;UNIVERSITAET HAMBURG;Universitaet Hamburg;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;HUMBOLDT-UNIVERSITAET ZU BERLIN;Humboldt-Universitaet Zu Berlin;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV;Deutsches Zentrum Fur Neurodegenerative Erkrankungen Ev;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Autriche;INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA;Institute Of Science And Technology Austria;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Autriche;MEDIZINISCHE UNIVERSITAT INNSBRUCK;Medizinische Universitat Innsbruck;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Autriche;OSTERREICHISCHE STUDIENGESELLSCHAFTFUR KYBERNETIK VEREIN;Osterreichische Studiengesellschaftfur Kybernetik Verein;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Autriche;TECHNISCHE UNIVERSITAET GRAZ;Technische Universitaet Graz;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Belgique;UNIVERSITEIT ANTWERPEN;Universiteit Antwerpen;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Belgique;UNIVERSITE DE LIEGE;Universite De Liege;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Danemark;DANMARKS TEKNISKE UNIVERSITET;Danmarks Tekniske Universitet;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Danemark;FONDEN TEKNOLOGIRADET;Fonden Teknologiradet;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;BARCELONA SUPERCOMPUTING CENTER-CENTRO NACIONAL DE SUPERCOMPUTACION;Barcelona Supercomputing Center-Centro Nacional De Supercomputacion;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;UNIVERSIDAD AUTONOMA DE MADRID;Universidad Autonoma De Madrid;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;UNIVERSIDAD DE CASTILLA - LA MANCHA;Universidad De Castilla - La Mancha;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;UNIVERSIDAD DE GRANADA;Universidad De Granada;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;UNIVERSIDAD POLITECNICA DE MADRID;Universidad Politecnica De Madrid;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;UNIVERSIDAD REY JUAN CARLOS;Universidad Rey Juan Carlos;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;UNIVERSITAT DE BARCELONA;Universitat De Barcelona;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;UNIVERSIDAD POMPEU FABRA;Universidad Pompeu Fabra;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER;Consorci Institut D'Investigacions Biomediques August Pi I Sunyer;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA;Fundacio Institut De Bioenginyeria De Catalunya;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Finlande;AALTO KORKEAKOULUSAATIO SR;Aalto Korkeakoulusaatio Sr;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Finlande;TAMPEREEN KORKEAKOULUSAATIO SR;Tampereen Korkeakoulusaatio Sr;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;Institut Pasteur;Institut Pasteur;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;ECOLE NORMALE SUPERIEURE;Ecole Normale Superieure;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE;Institut Du Cerveau Et De La Moelle Epiniere;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE;Institut National De Recherche En Informatique Et Automatique;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;UNIVERSITE DE BORDEAUX;Universite De Bordeaux;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;SORBONNE UNIVERSITE;Sorbonne Universite;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;UNIVERSITE LYON 1 CLAUDE BERNARD;Universite Lyon 1 Claude Bernard;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;GrŠce;ATHENS UNIVERSITY OF ECONOMICS AND BUSINESS - RESEARCH CENTER;Athens University Of Economics And Business - Research Center;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;GrŠce;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;Ethniko Kai Kapodistriako Panepistimio Athinon;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;GrŠce;POLYTECHNEIO KRITIS;Polytechneio Kritis;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Hongrie;DEBRECENI EGYETEM;Debreceni Egyetem;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Hongrie;KIRSERLETI ORVOSTUDOMANYI KUTATOINTEZET;Kirserleti Orvostudomanyi Kutatointezet;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;Central Repository for Digital Pathology | BIGPICTURE Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA2;Isra‰l;Bloomfield Science Museum Jerusalem (BSMJ);Bloomfield Science Museum Jerusalem (Bsmj);;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Isra‰l;TEL AVIV UNIVERSITY;Tel Aviv University;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Isra‰l;THE HEBREW UNIVERSITY OF JERUSALEM;The Hebrew University Of Jerusalem;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Isra‰l;WEIZMANN INSTITUTE OF SCIENCE;Weizmann Institute Of Science;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;CINECA CONSORZIO INTERUNIVERSITARIO;Cineca Consorzio Interuniversitario;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;LABORATORIO EUROPEO DI SPETTROSCOPIE NON LINEARI;Laboratorio Europeo Di Spettroscopie Non Lineari;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA;Scuola Superiore Di Studi Universitari E Di Perfezionamento S Anna;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;UNIVERSITA DEGLI STUDI DI PAVIA;Universita Degli Studi Di Pavia;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;ISTITUTO NAZIONALE DI FISICA NUCLEARE;Istituto Nazionale Di Fisica Nucleare;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;UNIVERSITA DEGLI STUDI DI MILANO;Universita Degli Studi Di Milano;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;ISTITUTO SUPERIORE DI SANITA;Istituto Superiore Di Sanita;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;POLITECNICO DI TORINO;Politecnico Di Torino;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;FONDAZIONE EUROPEAN BRAIN RESEARCHINSTITUTE RITA LEVI;Fondazione European Brain Researchinstitute Rita Levi;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;SCUOLA NORMALE SUPERIORE;Scuola Normale Superiore;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;NorvŠge;NORGES MILJO-OG BIOVITENSKAPLIGE UNIVERSITET;Norges Miljo-Og Biovitenskaplige Universitet;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;NorvŠge;UNIVERSITETET I OSLO;Universitetet I Oslo;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Pays-Bas;STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTEN;Stichting Nederlandse Wetenschappelijk Onderzoek Instituten;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Pays-Bas;STICHTING RADBOUD UNIVERSITEIT;Stichting Radboud Universiteit;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Pays-Bas;KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW;Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Pays-Bas;UNIVERSITEIT VAN AMSTERDAM;Universiteit Van Amsterdam;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Pays-Bas;STICHTING VU;Stichting Vu;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Pays-Bas;UNIVERSITEIT MAASTRICHT;Universiteit Maastricht;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Portugal;FUNDACAO D. ANNA SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD;Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Portugal;UNIVERSIDADE DO MINHO;Universidade Do Minho;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;CARDIFF UNIVERSITY;Cardiff University;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;DE MONTFORT UNIVERSITY;De Montfort University;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE;Imperial College Of Science Technology And Medicine;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;KING'S COLLEGE LONDON;King'S College London;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN;The University Court Of The University Of Aberdeen;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;THE UNIVERSITY OF MANCHESTER;The University Of Manchester;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;UNIVERSITY COLLEGE LONDON;University College London;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;UNIVERSITY OF THE WEST OF ENGLAND, BRISTOL;University Of The West Of England, Bristol;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;UNIVERSITY OF SURREY;University Of Surrey;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;UNIVERSITY OF LEEDS;University Of Leeds;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;THE UNIVERSITY OF SUSSEX;The University Of Sussex;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;MIDDLESEX UNIVERSITY HIGHER EDUCATION CORPORATION;Middlesex University Higher Education Corporation;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;THE UNIVERSITY OF HERTFORDSHIRE HIGHER EDUCATION CORPORATION;The University Of Hertfordshire Higher Education Corporation;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Slov‚nie;INSTITUT JOZEF STEFAN;Institut Jozef Stefan;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;SuŠde;KAROLINSKA INSTITUTET;Karolinska Institutet;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis | HERCULES Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA2;SuŠde;KUNGLIGA TEKNISKA HOEGSKOLAN;Kungliga Tekniska Hoegskolan;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;SuŠde;LINNEUNIVERSITETET;Linneuniversitetet;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;SuŠde;UPPSALA UNIVERSITET;Uppsala Universitet;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;coordinateur;;;;;
HBP SGA2;Suisse;ZUERICH;Zuerich;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suisse;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS;Centre Hospitalier Universitaire Vaudois;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suisse;UNIVERSITAET BERN;Universitaet Bern;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suisse;UNIVERSITAT ZURICH;Universitat Zurich;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suisse;UNIVERSITE DE GENEVE;Universite De Geneve;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;http://cordis.europa.eu/project/id/687681;;
HBP SGA2;Suisse;UNIVERSITAT BASEL;Universitat Basel;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suisse;SIB INSTITUT SUISSE DE BIOINFORMATIQUE;Sib Institut Suisse De Bioinformatique;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Turquie;SABANCI UNIVERSITESI;Sabanci Universitesi;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 ?;Commission Europ‚enne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA3;Allemagne;BERGISCHE UNIVERSITAET WUPPERTAL;Bergische Universitaet Wuppertal;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;FORSCHUNGSZENTRUM JULICH GMBH;Forschungszentrum Julich Gmbh;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;FORTISS GMBH;Fortiss Gmbh;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.;Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;Virus-X: Viral Metagenomics for Innovation Value | Virus-X Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Allemagne;HEINRICH-HEINE-UNIVERSITAET DUESSELDORF;Heinrich-Heine-Universitaet Duesseldorf;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;HITS GGMBH;Hits Ggmbh;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN;Rheinisch-Westfaelische Technische Hochschule Aachen;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG;Ruprecht-Karls-Universitaet Heidelberg;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;FZI FORSCHUNGSZENTRUM INFORMATIK;Fzi Forschungszentrum Informatik;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;TECHNISCHE UNIVERSITAET DRESDEN;Technische Universitaet Dresden;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;TECHNISCHE UNIVERSITAET MUENCHEN;Technische Universitaet Muenchen;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;UNIVERSITAETSKLINIKUM AACHEN;Universitaetsklinikum Aachen;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF;Universitaetsklinikum Hamburg-Eppendorf;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;TECHNISCHE UNIVERSITAT DARMSTADT;Technische Universitat Darmstadt;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;UNIVERSITAET HAMBURG;Universitaet Hamburg;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;HUMBOLDT-UNIVERSITAET ZU BERLIN;Humboldt-Universitaet Zu Berlin;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV;Deutsches Zentrum Fur Neurodegenerative Erkrankungen Ev;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;CHARITE - UNIVERSITAETSMEDIZIN BERLIN;Charite - Universitaetsmedizin Berlin;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;Next generation precision antibody profiling - from science fiction to reality | TopSpec Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Allemagne;UNIVERSITAETSKLINIKUM FREIBURG;Universitaetsklinikum Freiburg;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;UNIVERSITAT TRIER;Universitat Trier;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;HOCHSCHULE STRALSUND;Hochschule Stralsund;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;GEORG-AUGUST-UNIVERSITAT GOTTINGEN STIFTUNG OFFENTLICHEN RECHTS;Georg-August-Universitat Gottingen Stiftung Offentlichen Rechts;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Autriche;MEDIZINISCHE UNIVERSITAT INNSBRUCK;Medizinische Universitat Innsbruck;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Autriche;TECHNISCHE UNIVERSITAET GRAZ;Technische Universitaet Graz;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Autriche;CONVELOP - COOPERATIVE KNOWLEDGE DESIGN GMBH;Convelop - Cooperative Knowledge Design Gmbh;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;ALgorithms for PAngenome Computational Analysis | ALPACA Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Belgique;UNIVERSITEIT ANTWERPEN;Universiteit Antwerpen;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Belgique;UNIVERSITE DE LIEGE;Universite De Liege;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Danemark;DANMARKS TEKNISKE UNIVERSITET;Danmarks Tekniske Universitet;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Danemark;FONDEN TEKNOLOGIRADET;Fonden Teknologiradet;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Espagne;BARCELONA SUPERCOMPUTING CENTER-CENTRO NACIONAL DE SUPERCOMPUTACION;Barcelona Supercomputing Center-Centro Nacional De Supercomputacion;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Espagne;UNIVERSIDAD AUTONOMA DE MADRID;Universidad Autonoma De Madrid;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Espagne;UNIVERSIDAD DE CASTILLA - LA MANCHA;Universidad De Castilla - La Mancha;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Espagne;UNIVERSIDAD DE GRANADA;Universidad De Granada;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Espagne;UNIVERSIDAD POLITECNICA DE MADRID;Universidad Politecnica De Madrid;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Espagne;UNIVERSIDAD REY JUAN CARLOS;Universidad Rey Juan Carlos;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Espagne;UNIVERSITAT DE BARCELONA;Universitat De Barcelona;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside | INFLANET Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Espagne;UNIVERSIDAD POMPEU FABRA;Universidad Pompeu Fabra;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Espagne;CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER;Consorci Institut D'Investigacions Biomediques August Pi I Sunyer;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Espagne;FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA;Fundacio Institut De Bioenginyeria De Catalunya;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Finlande;TAMPEREEN KORKEAKOULUSAATIO SR;Tampereen Korkeakoulusaatio Sr;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;France;Institut Pasteur;Institut Pasteur;Lyssavirus, ‚pid‚miologie et neuropathologie;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;France;ECOLE NORMALE SUPERIEURE;Ecole Normale Superieure;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;France;INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE;Institut Du Cerveau Et De La Moelle Epiniere;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;France;INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE;Institut National De Recherche En Informatique Et Automatique;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;France;UNIVERSITE DE BORDEAUX;Universite De Bordeaux;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine | TranSYS Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;France;UNIVERSITE LYON 1 CLAUDE BERNARD;Universite Lyon 1 Claude Bernard;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;France;UNIVERSITE GRENOBLE ALPES;Universite Grenoble Alpes;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;France;CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE;Centre Hospitalier Universitaire De Grenoble;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;France;CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE;Centre Hospitalier Regional Et Universitaire De Lille;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;France;CENTRE HOSPITALIER REGIONAL DE MARSEILLE ASSISTANCE PUBLIQUE-HOPITAUX MARSEILLE;Centre Hospitalier Regional De Marseille Assistance Publique-Hopitaux Marseille;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;GrŠce;ATHENS UNIVERSITY OF ECONOMICS AND BUSINESS - RESEARCH CENTER;Athens University Of Economics And Business - Research Center;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;GrŠce;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;Ethniko Kai Kapodistriako Panepistimio Athinon;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;GrŠce;IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON;Idryma Iatroviologikon Ereunon Akademias Athinon;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;GrŠce;ATHINA-EREVNITIKO KENTRO KAINOTOMIAS STIS TECHNOLOGIES TIS PLIROFORIAS, TON EPIKOINONION KAI TIS GNOSIS;Athina-Erevnitiko Kentro Kainotomias Stis Technologies Tis Pliroforias, Ton Epikoinonion Kai Tis Gnosis;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Hongrie;KIRSERLETI ORVOSTUDOMANYI KUTATOINTEZET;Kirserleti Orvostudomanyi Kutatointezet;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Isra‰l;TEL AVIV UNIVERSITY;Tel Aviv University;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Isra‰l;THE HEBREW UNIVERSITY OF JERUSALEM;The Hebrew University Of Jerusalem;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Isra‰l;WEIZMANN INSTITUTE OF SCIENCE;Weizmann Institute Of Science;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;Elucidating the role of m6A RNA methylation on the replication and pathogenesis of influenza A virus. | IAV-m6A Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Italie;CINECA CONSORZIO INTERUNIVERSITARIO;Cineca Consorzio Interuniversitario;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;MAnufacturing of TUmour-REactive Natural Killer cells | MATURE-NK Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Italie;LABORATORIO EUROPEO DI SPETTROSCOPIE NON LINEARI;Laboratorio Europeo Di Spettroscopie Non Lineari;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Italie;SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA;Scuola Superiore Di Studi Universitari E Di Perfezionamento S Anna;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Italie;UNIVERSITA DEGLI STUDI DI PAVIA;Universita Degli Studi Di Pavia;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Italie;ISTITUTO NAZIONALE DI FISICA NUCLEARE;Istituto Nazionale Di Fisica Nucleare;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Italie;UNIVERSITA DEGLI STUDI DI MILANO;Universita Degli Studi Di Milano;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Italie;ISTITUTO SUPERIORE DI SANITA;Istituto Superiore Di Sanita;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Italie;POLITECNICO DI TORINO;Politecnico Di Torino;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Italie;FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA;Fondazione Istituto Italiano Di Tecnologia;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Italie;POLITECNICO DI MILANO;Politecnico Di Milano;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Italie;UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II;Universita Degli Studi Di Napoli Federico Ii;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Italie;UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA;Universita Degli Studi Di Roma La Sapienza;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Italie;SCUOLA INTERNAZIONALE SUPERIORE DI STUDI AVANZATI DI TRIESTE;Scuola Internazionale Superiore Di Studi Avanzati Di Trieste;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;NorvŠge;NORGES MILJO-OG BIOVITENSKAPLIGE UNIVERSITET;Norges Miljo-Og Biovitenskaplige Universitet;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;NorvŠge;UNIVERSITETET I OSLO;Universitetet I Oslo;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease | ImageInLife Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Pays-Bas;STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTEN;Stichting Nederlandse Wetenschappelijk Onderzoek Instituten;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Pays-Bas;KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW;Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Pays-Bas;UNIVERSITEIT VAN AMSTERDAM;Universiteit Van Amsterdam;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Pays-Bas;STICHTING VU;Stichting Vu;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Pays-Bas;UNIVERSITEIT MAASTRICHT;Universiteit Maastricht;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Pays-Bas;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Erasmus Universitair Medisch Centrum Rotterdam;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Portugal;UNIVERSIDADE DO MINHO;Universidade Do Minho;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Royaume-Uni;DE MONTFORT UNIVERSITY;De Montfort University;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Royaume-Uni;IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE;Imperial College Of Science Technology And Medicine;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Royaume-Uni;THE UNIVERSITY OF MANCHESTER;The University Of Manchester;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Royaume-Uni;UNIVERSITY COLLEGE LONDON;University College London;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Royaume-Uni;UNIVERSITY OF THE WEST OF ENGLAND, BRISTOL;University Of The West Of England, Bristol;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;Unraveling Principles of PDZ-mediated Cell Signaling | PDZnet Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Royaume-Uni;THE UNIVERSITY OF SUSSEX;The University Of Sussex;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Royaume-Uni;THE UNIVERSITY OF HERTFORDSHIRE HIGHER EDUCATION CORPORATION;The University Of Hertfordshire Higher Education Corporation;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;SuŠde;KAROLINSKA INSTITUTET;Karolinska Institutet;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;SuŠde;KUNGLIGA TEKNISKA HOEGSKOLAN;Kungliga Tekniska Hoegskolan;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;SuŠde;LINNEUNIVERSITETET;Linneuniversitetet;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;SuŠde;UPPSALA UNIVERSITET;Uppsala Universitet;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Suisse;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS;Centre Hospitalier Universitaire Vaudois;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Suisse;UNIVERSITAET BERN;Universitaet Bern;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Suisse;UNIVERSITAT BASEL;Universitat Basel;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;VIral and BacteRial Adhesin Network Training | ViBrANT Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Suisse;SICHH SWISS INTEGRATIVE CENTER FOR HUMAN HEALTH SA;Sichh Swiss Integrative Center For Human Health Sa;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;;;;;;
HBP SGA3;Belgique;EBRAINS;Ebrains;;Human Brain Project Specific Grant Agreement 4;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 ?;Commission Europ‚enne;01/04/2020;31/03/2023;;;coordinateur;;;;;
IS_MIRRI21;Belgique;Service Public F‚d‚ral de Programmation Politique Scientifique (Belspo);Service Public F‚d‚ral De Programmation Politique Scientifique (Belspo);;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Espagne;UNIVERSITAT DE VALENCIA;Universitat De Valencia;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Espagne;UNIVERSIDAD DE LAS PALMAS DE GRAN CANARIA;Universidad De Las Palmas De Gran Canaria;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;France;INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT;Institut National De Recherche Pour L'Agriculture, L'Alimentation Et L'Environnement;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;France;INSTITUT PASTEUR;Institut Pasteur;Collection de l'Institut Pasteur;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;France;INSTITUT PASTEUR;Institut Pasteur;Centre de Ressources Biologiques de l'Institut Pasteur;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;France;INSTITUT PASTEUR;Institut Pasteur;Collection Nle Cultures Micro-organismes;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;GrŠce;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;Ethniko Kai Kapodistriako Panepistimio Athinon;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Italie;UNIVERSITA DEGLI STUDI DI TORINO;Universita Degli Studi Di Torino;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Lettonie;LATVIJAS UNIVERSITATE;Latvijas Universitate;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Pays-Bas;"KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW
";"Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw
";;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Pologne;INSTYTUT BIOTECHNOLOGII PRZEMYSLU ROLNO-SPOZYWCZEGO IM PROF WACLAWA DABROWSKIEGO - PANSTWOWY INSTYTUT BADAWCZY;Instytut Biotechnologii Przemyslu Rolno-Spozywczego Im Prof Waclawa Dabrowskiego - Panstwowy Instytut Badawczy;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;Versatile Emerging infectious disease Observatory | VEO Project | H2020 | CORDIS | European Commission (europa.eu);;
IS_MIRRI21;Portugal;UNIVERSIDADE DO MINHO;Universidade Do Minho;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;coordinateur;;;;;
IS_MIRRI21;Portugal;SOCIEDADE PORTUGUESA DE INOVACAO CONSULTADORIA EMPRESARIAL E FOMENTO DA INOVACAO SA;Sociedade Portuguesa De Inovacao Consultadoria Empresarial E Fomento Da Inovacao Sa;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Portugal;Associa‡Æo CCG/ZGDV - Centro de Computa‡Æo Gr fica;Associa‡Æo Ccg/Zgdv - Centro De Computa‡Æo Gr fica;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Russie;INSTITUT OF THE RUSSIAN ACADEMY OF SCIENCES SKRYABIN INSTITUTE OF BIOCHEMISTRY AND PHYSIOLOGY OF MICROORGANISMS RAS;Institut Of The Russian Academy Of Sciences Skryabin Institute Of Biochemistry And Physiology Of Microorganisms Ras;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 ?;Commission Europ‚enne;01/02/2020;31/01/2023;;;;;;;;
DECIDER;Allemagne;UNIVERSITATSKLINIKUM HEIDELBERG;Universitatsklinikum Heidelberg;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;;
DECIDER;Danemark;KRAEFTENS BEKAEMPELSE;Kraeftens Bekaempelse;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;;
DECIDER;Danemark;2CUREX A/S;2Curex A/S;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;;
DECIDER;Espagne;FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA);Fundacio Institut De Recerca Biomedica (Irb Barcelona);;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;;
DECIDER;Espagne;BARCELONA SUPERCOMPUTING CENTER-CENTRO NACIONAL DE SUPERCOMPUTACION;Barcelona Supercomputing Center-Centro Nacional De Supercomputacion;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;;
DECIDER;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;coordinateur;;;;;
DECIDER;Finlande;VARSINAIS-SUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA;Varsinais-Suomen Sairaanhoitopiirin Kuntayhtyma;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;;
DECIDER;Finlande;HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMŽ;Helsingin Ja Uudenmaan Sairaanhoitopiirin Kuntayhtym„;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;;
DECIDER;Finlande;AIFORIA TECHNOLOGIES OY;Aiforia Technologies Oy;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;;
DECIDER;Finlande;VEIL.AI OY;Veil.Ai Oy;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;;
DECIDER;France;Institut Pasteur;Institut Pasteur;Biologie computationnelle;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;;
DECIDER;Italie;UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA;Universita Degli Studi Di Modena E Reggio Emilia;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;;
DECIDER;Italie;AB ANALITICA SRL;Ab Analitica Srl;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;;
DECIDER;SuŠde;KAROLINSKA INSTITUTET;Karolinska Institutet;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 ?;Commission Europ‚enne;01/02/2021;31/01/2026;;;;;;;;
ARBOsurv;Espagne;INMUNOLOGIA Y GENETICA APLICADA SA;Inmunologia Y Genetica Aplicada Sa;;Improving surveillance and control of arboviral diseases of animals in the Euro-African interface;Projet scientifique;Infectious diseases;animal diagnostics;animal health;;;5 964 650,00 ?;Commission Europ‚enne;08/09/2020;08/09/2020;;;Coordinateur;Financement rejet‚;1217;;;
INCENTIVE;Allemagne;HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH;Helmholtz-Zentrum Fur Infektionsforschung Gmbh;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;coordinateur;;;;;
INCENTIVE;Allemagne;ASA SPEZIALENZYME GMBH;Asa Spezialenzyme Gmbh;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;Belgique;UNIVERSITE LIBRE DE BRUXELLES;Universite Libre De Bruxelles;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;Belgique;UNIVERSITEIT ANTWERPEN;Universiteit Antwerpen;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;Espagne;FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA;Fundacion Privada Instituto De Salud Global Barcelona;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;Etats-Unis;UGA RESEARCH FOUNDATION INC NON PROFIT CORP;Uga Research Foundation Inc Non Profit Corp;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;Etats-Unis;HUMAN VACCINES PROJECT, INC;Human Vaccines Project, Inc;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;France;Institut Pasteur;Institut Pasteur;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;France;BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE;Bioaster Fondation De Cooperation Scientifique;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;Inde;PUBLIC HEALTH FOUNDATION OF INDIA;Public Health Foundation Of India;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;Inde;TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE;Translational Health Science And Technology Institute;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;Inde;INDIAN INSTITUTE OF TECHNOLOGY MADRAS (IITM);Indian Institute Of Technology Madras (Iitm);;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;Inde;SETH G S M COLLEGE AND K E M HOSPITAL DIAMOND JUBILEE SOCIETY;Seth G S M College And K E M Hospital Diamond Jubilee Society;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;Inde;NATIONAL INSTITUTE OF IMMUNOLOGY SOCIETY;National Institute Of Immunology Society;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;NorvŠge;UNIVERSITETET I BERGEN;Universitetet I Bergen;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;NorvŠge;UNIVERSITETET I OSLO;Universitetet I Oslo;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;Pays-Bas;STICHTING HUMAN VACCINES PROJECT EUROPE;Stichting Human Vaccines Project Europe;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;;;
INCENTIVE;Suisse;EUROVACC FOUNDATION;Eurovacc Foundation;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 ?;Commission Europ‚enne;01/08/2020;31/07/2025;;;;;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries. | Ebola_Tx Project | H2020 | CORDIS | European Commission (europa.eu);;
InSCEMiX;Cor‚e du Sud;Institut Pasteur Korea;Institut Pasteur Korea;;Inhibitor Screening, Cryo-Electron Microscopy, X-ray studies of CyaA;Projet scientifique;Whooping cough;biophysics;bio informatic;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
InSCEMiX;France;Institut Pasteur;Institut Pasteur;Biochimie des Interactions Macromol‚culaires;Inhibitor Screening, Cryo-Electron Microscopy, X-ray studies of CyaA;Projet scientifique;Whooping cough;biophysics;bio informatic;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;;
InSCEMiX;France;Institut Pasteur;Institut Pasteur;Technologie et service Biolmagerie Ultrastructurale ( UTechS UBI);Inhibitor Screening, Cryo-Electron Microscopy, X-ray studies of CyaA;Projet scientifique;Whooping cough;biophysics;bio informatic;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
InSCEMiX;France;Institut Pasteur;Institut Pasteur;Plateforme Cristallographie;Inhibitor Screening, Cryo-Electron Microscopy, X-ray studies of CyaA;Projet scientifique;Whooping cough;biophysics;bio informatic;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
InSCEMiX;France;Institut Pasteur;Institut Pasteur;Plateforme de Biophysique Mol‚culaire  ;Inhibitor Screening, Cryo-Electron Microscopy, X-ray studies of CyaA;Projet scientifique;Whooping cough;biophysics;bio informatic;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
InSCEMiX;France;Institut Pasteur;Institut Pasteur;Plateforme Technologique de RMN Biologique  ;Inhibitor Screening, Cryo-Electron Microscopy, X-ray studies of CyaA;Projet scientifique;Whooping cough;biophysics;bio informatic;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
InSCEMiX;France;Institut Pasteur;Institut Pasteur;Bio-Informatique Structurale  ;Inhibitor Screening, Cryo-Electron Microscopy, X-ray studies of CyaA;Projet scientifique;Whooping cough;biophysics;bio informatic;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
ICEI;Allemagne;BAUHAUS-UNIVERSITAET WEIMAR;Bauhaus-Universitaet Weimar;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders | COSYN Project | H2020 | CORDIS | European Commission (europa.eu);;
ICEI;Allemagne;BERGISCHE UNIVERSITAET WUPPERTAL;Bergische Universitaet Wuppertal;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;FORSCHUNGSZENTRUM JULICH GMBH;Forschungszentrum Julich Gmbh;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;FORTISS GMBH;Fortiss Gmbh;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.;Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;HEINRICH-HEINE-UNIVERSITAET DUESSELDORF;Heinrich-Heine-Universitaet Duesseldorf;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;HITS GGMBH;Hits Ggmbh;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN;Johann Wolfgang Goethe-Universitaet Frankfurt Am Main;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;KARLSRUHER INSTITUT FUER TECHNOLOGIE;Karlsruher Institut Fuer Technologie;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN;Rheinisch-Westfaelische Technische Hochschule Aachen;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG;Ruprecht-Karls-Universitaet Heidelberg;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;FZI FORSCHUNGSZENTRUM INFORMATIK;Fzi Forschungszentrum Informatik;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;TECHNISCHE UNIVERSITAET DRESDEN;Technische Universitaet Dresden;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;TECHNISCHE UNIVERSITAET MUENCHEN;Technische Universitaet Muenchen;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;UNIVERSITAET BIELEFELD;Universitaet Bielefeld;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;Population genomics of co-evolution between non-retroviral RNA viruses and their hosts | NIRV_HOST_INT Project | H2020 | CORDIS | European Commission (europa.eu);;
ICEI;Allemagne;UNIVERSITAETSKLINIKUM AACHEN;Universitaetsklinikum Aachen;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF;Universitaetsklinikum Hamburg-Eppendorf;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;Zika Preparedness Latin American Network | ZikaPLAN Project | H2020 | CORDIS | European Commission (europa.eu);;
ICEI;Allemagne;TECHNISCHE UNIVERSITAT DARMSTADT;Technische Universitat Darmstadt;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;UNIVERSITAET HAMBURG;Universitaet Hamburg;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;HUMBOLDT-UNIVERSITAET ZU BERLIN;Humboldt-Universitaet Zu Berlin;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV;Deutsches Zentrum Fur Neurodegenerative Erkrankungen Ev;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Autriche;INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA;Institute Of Science And Technology Austria;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Autriche;MEDIZINISCHE UNIVERSITAT INNSBRUCK;Medizinische Universitat Innsbruck;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Autriche;OSTERREICHISCHE STUDIENGESELLSCHAFTFUR KYBERNETIK VEREIN;Osterreichische Studiengesellschaftfur Kybernetik Verein;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Autriche;TECHNISCHE UNIVERSITAET GRAZ;Technische Universitaet Graz;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Belgique;UNIVERSITEIT ANTWERPEN;Universiteit Antwerpen;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Belgique;UNIVERSITE DE LIEGE;Universite De Liege;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Danemark;DANMARKS TEKNISKE UNIVERSITET;Danmarks Tekniske Universitet;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Danemark;FONDEN TEKNOLOGIRADET;Fonden Teknologiradet;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;BARCELONA SUPERCOMPUTING CENTER-CENTRO NACIONAL DE SUPERCOMPUTACION;Barcelona Supercomputing Center-Centro Nacional De Supercomputacion;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;UNIVERSIDAD AUTONOMA DE MADRID;Universidad Autonoma De Madrid;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;UNIVERSIDAD DE CASTILLA - LA MANCHA;Universidad De Castilla - La Mancha;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;UNIVERSIDAD DE GRANADA;Universidad De Granada;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;UNIVERSIDAD POLITECNICA DE MADRID;Universidad Politecnica De Madrid;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;UNIVERSIDAD REY JUAN CARLOS;Universidad Rey Juan Carlos;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;UNIVERSITAT DE BARCELONA;Universitat De Barcelona;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;UNIVERSIDAD POMPEU FABRA;Universidad Pompeu Fabra;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER;Consorci Institut D'Investigacions Biomediques August Pi I Sunyer;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA;Fundacio Institut De Bioenginyeria De Catalunya;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;Expanding research infrastructure visibility to strengthen strategic partnerships | RI-VIS Project | H2020 | CORDIS | European Commission (europa.eu);;RI-VIS will increase the visibility of European RIs to broader scientific communities, industry and strategic partners in third countries
ICEI;Finlande;AALTO KORKEAKOULUSAATIO SR;Aalto Korkeakoulusaatio Sr;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Finlande;TAMPEREEN KORKEAKOULUSAATIO SR;Tampereen Korkeakoulusaatio Sr;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;ECOLE NORMALE SUPERIEURE;Ecole Normale Superieure;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE;Institut Du Cerveau Et De La Moelle Epiniere;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE;Institut National De Recherche En Informatique Et Automatique;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;INSTITUT PASTEUR;Institut Pasteur;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;UNIVERSITE DE BORDEAUX;Universite De Bordeaux;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;SORBONNE UNIVERSITE;Sorbonne Universite;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;UNIVERSITE LYON 1 CLAUDE BERNARD;Universite Lyon 1 Claude Bernard;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics ? Sofia ref.: 115843 | EbolaMoDRAD Project | H2020 | CORDIS | European Commission (europa.eu);;The overall aim of EbolaMoDRAD was to develop and deliver rapid and bedside diagnostic tool(s) that will significantly increase our capacity to handle the Ebola Virus Disease (EVD) in West Africa and also future outbreaks. 
ICEI;GrŠce;ATHENS UNIVERSITY OF ECONOMICS AND BUSINESS - RESEARCH CENTER;Athens University Of Economics And Business - Research Center;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;GrŠce;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;Ethniko Kai Kapodistriako Panepistimio Athinon;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;GrŠce;POLYTECHNEIO KRITIS;Polytechneio Kritis;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Hongrie;DEBRECENI EGYETEM;Debreceni Egyetem;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Hongrie;KIRSERLETI ORVOSTUDOMANYI KUTATOINTEZET;Kirserleti Orvostudomanyi Kutatointezet;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Isra‰l;Bloomfield Science Museum Jerusalem (BSMJ);Bloomfield Science Museum Jerusalem (Bsmj);;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Isra‰l;TEL AVIV UNIVERSITY;Tel Aviv University;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Isra‰l;THE HEBREW UNIVERSITY OF JERUSALEM;The Hebrew University Of Jerusalem;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Isra‰l;WEIZMANN INSTITUTE OF SCIENCE;Weizmann Institute Of Science;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;CINECA CONSORZIO INTERUNIVERSITARIO;Cineca Consorzio Interuniversitario;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;LABORATORIO EUROPEO DI SPETTROSCOPIE NON LINEARI;Laboratorio Europeo Di Spettroscopie Non Lineari;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA;Scuola Superiore Di Studi Universitari E Di Perfezionamento S Anna;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;UNIVERSITA DEGLI STUDI DI PAVIA;Universita Degli Studi Di Pavia;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;ISTITUTO NAZIONALE DI FISICA NUCLEARE;Istituto Nazionale Di Fisica Nucleare;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;UNIVERSITA DEGLI STUDI DI MILANO;Universita Degli Studi Di Milano;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;ISTITUTO SUPERIORE DI SANITA;Istituto Superiore Di Sanita;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;POLITECNICO DI TORINO;Politecnico Di Torino;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy | EMBRIC Project | H2020 | CORDIS | European Commission (europa.eu);;"The objectives of EMBRIC are to: (1) develop integrated workflows of high quality services for access to biological, analytical and data resources, and deploy common underpinning technologies and practices; (2) strengthen the connection of science with industry by engaging companies and by federating technology transfer (TT) services; (3) defragment RDI policies and involve maritime regions with the construction of EMBRIC"
ICEI;Italie;FONDAZIONE EUROPEAN BRAIN RESEARCHINSTITUTE RITA LEVI;Fondazione European Brain Researchinstitute Rita Levi;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;SCUOLA NORMALE SUPERIORE;Scuola Normale Superiore;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;NorvŠge;NORGES MILJO-OG BIOVITENSKAPLIGE UNIVERSITET;Norges Miljo-Og Biovitenskaplige Universitet;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;NorvŠge;UNIVERSITETET I OSLO;Universitetet I Oslo;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Pays-Bas;STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTEN;Stichting Nederlandse Wetenschappelijk Onderzoek Instituten;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Pays-Bas;STICHTING RADBOUD UNIVERSITEIT;Stichting Radboud Universiteit;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Pays-Bas;KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW;Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Pays-Bas;UNIVERSITEIT VAN AMSTERDAM;Universiteit Van Amsterdam;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Pays-Bas;STICHTING VU;Stichting Vu;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Pays-Bas;UNIVERSITEIT MAASTRICHT;Universiteit Maastricht;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Portugal;FUNDACAO D. ANNA SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD;Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Portugal;UNIVERSIDADE DO MINHO;Universidade Do Minho;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;CARDIFF UNIVERSITY;Cardiff University;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;DE MONTFORT UNIVERSITY;De Montfort University;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE;Imperial College Of Science Technology And Medicine;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;KING'S COLLEGE LONDON;King'S College London;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN;The University Court Of The University Of Aberdeen;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;THE UNIVERSITY OF MANCHESTER;The University Of Manchester;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;UNIVERSITY COLLEGE LONDON;University College London;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;UNIVERSITY OF THE WEST OF ENGLAND, BRISTOL;University Of The West Of England, Bristol;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;UNIVERSITY OF SURREY;University Of Surrey;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;UNIVERSITY OF LEEDS;University Of Leeds;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;THE UNIVERSITY OF SUSSEX;The University Of Sussex;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;MIDDLESEX UNIVERSITY HIGHER EDUCATION CORPORATION;Middlesex University Higher Education Corporation;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;THE UNIVERSITY OF HERTFORDSHIRE HIGHER EDUCATION CORPORATION;The University Of Hertfordshire Higher Education Corporation;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;Human Brain Project Specific Grant Agreement 2 | HBP SGA2 Project | H2020 | CORDIS | European Commission (europa.eu);;In the upcoming SGA2 funding period (2018-20), the HBP will continue to strengthen global brain research efforts by extending coordination with other brain initiatives and projects. Internally, it will continue its unique inter-disciplinary co-design approach, developing research infrastructure capabilities via use cases built around specific research needs.
ICEI;Slov‚nie;INSTITUT JOZEF STEFAN;Institut Jozef Stefan;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;SuŠde;KAROLINSKA INSTITUTET;Karolinska Institutet;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;SuŠde;KUNGLIGA TEKNISKA HOEGSKOLAN;Kungliga Tekniska Hoegskolan;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;SuŠde;LINNEUNIVERSITETET;Linneuniversitetet;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;SuŠde;UPPSALA UNIVERSITET;Uppsala Universitet;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;coordinateur;;;;;
ICEI;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suisse;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS;Centre Hospitalier Universitaire Vaudois;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suisse;UNIVERSITAET BERN;Universitaet Bern;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suisse;UNIVERSITAT ZURICH;Universitat Zurich;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suisse;UNIVERSITE DE GENEVE;Universite De Geneve;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suisse;UNIVERSITAT BASEL;Universitat Basel;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suisse;SIB INSTITUT SUISSE DE BIOINFORMATIQUE;Sib Institut Suisse De Bioinformatique;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Turquie;SABANCI UNIVERSITESI;Sabanci Universitesi;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 ?;Commission Europ‚enne;01/01/2018;31/03/2023;;;;;;;;
ObWein;Etats-Unis;Georgia State University;Georgia State University;;Intestinal homeostasis in the prevention of pediatric obesity and its consequences on health;Projet scientifique;Immune disorders;Inflammatory diseases;microbiota;;;50 000,00 ?;Biostime Institute for Nutrition and Care;30/12/2019;29/12/2021;;;;Convention sign‚e;;;;
ObWein;France;Institut Pasteur;Institut Pasteur;Microenvironnement et Immunit‚ ;Intestinal homeostasis in the prevention of pediatric obesity and its consequences on health;Projet scientifique;Immune disorders;Inflammatory diseases;microbiota;;;50 000,00 ?;Biostime Institute for Nutrition and Care;30/12/2019;29/12/2021;;;Coordinateur;Convention sign‚e;;;;
ObWein;France;Institut Pasteur;Institut Pasteur;Pathog‚nie Microbienne Mol‚culaire;Intestinal homeostasis in the prevention of pediatric obesity and its consequences on health;Projet scientifique;Immune disorders;Inflammatory diseases;microbiota;;;50 000,00 ?;Biostime Institute for Nutrition and Care;30/12/2019;29/12/2021;;;;Convention sign‚e;;;;
ObWein;France;Universit‚ d?Auvergne;Universit‚ D?Auvergne;;Intestinal homeostasis in the prevention of pediatric obesity and its consequences on health;Projet scientifique;Immune disorders;Inflammatory diseases;microbiota;;;50 000,00 ?;Biostime Institute for Nutrition and Care;30/12/2019;29/12/2021;;;;Convention sign‚e;;;;
ObWein;France;Universit‚ Pierre et Marie Curie;Universit‚ Pierre Et Marie Curie;;Intestinal homeostasis in the prevention of pediatric obesity and its consequences on health;Projet scientifique;Immune disorders;Inflammatory diseases;microbiota;;;50 000,00 ?;Biostime Institute for Nutrition and Care;30/12/2019;29/12/2021;;;;Convention sign‚e;;;;
ObWein;France;Institut Imagine;Institut Imagine;;Intestinal homeostasis in the prevention of pediatric obesity and its consequences on health;Projet scientifique;Immune disorders;Inflammatory diseases;microbiota;;;50 000,00 ?;Biostime Institute for Nutrition and Care;30/12/2019;29/12/2021;;;;Convention sign‚e;;;;
FleaVec;France;Institut Pasteur;Institut Pasteur;Unit‚ de Recherche Yersinia;Investigating flea vectors towards understanding human bubonic plague persistence in Madagascar;Projet scientifique;plague;zoonoses;flea;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
FleaVec;France;Institut Pasteur de Lille;Institut Pasteur De Lille;;Investigating flea vectors towards understanding human bubonic plague persistence in Madagascar;Projet scientifique;plague;zoonoses;flea;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
FleaVec;Madagascar;Institut Pasteur in Madagascar;Institut Pasteur In Madagascar;;Investigating flea vectors towards understanding human bubonic plague persistence in Madagascar;Projet scientifique;plague;zoonoses;flea;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;coordinateur;;;;;
IP Guin‚e;France;Institut Pasteur;Institut Pasteur;Direction internationale P“le des op‚rations;IP Guin‚e;Institutionnelle;Cr‚ation;Renforcement;;;;4 000 000,00 ?;AFD;06/07/1905;;;;;;;;;
IP Guin‚e;Guin‚e;Institut Pasteur de Guin‚e;Institut Pasteur De Guin‚e;;IP Guin‚e;Institutionnelle;Cr‚ation;Renforcement;;;;4 000 000,00 ?;AFD;06/07/1905;;;;;;;;;
MATURE-NK;Allemagne;MEDIZINISCHE HOCHSCHULE HANNOVER;Medizinische Hochschule Hannover;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 ?;Commission Europ‚enne;01/06/2018;31/05/2022;;;coordinateur;;;;;
MATURE-NK;Allemagne;RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG;Ruprecht-Karls-Universitaet Heidelberg;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 ?;Commission Europ‚enne;01/06/2018;31/05/2022;;;;;;;;
MATURE-NK;Allemagne;MILTENYI BIOTEC GMBHÿ;Miltenyi Biotec Gmbhÿ;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 ?;Commission Europ‚enne;01/06/2018;31/05/2022;;;;;;;;
MATURE-NK;Allemagne;FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.;Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 ?;Commission Europ‚enne;01/06/2018;31/05/2022;;;;;;;;
MATURE-NK;Allemagne;MILTENYI BIOTEC BV & CO KG;Miltenyi Biotec Bv & Co Kg;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 ?;Commission Europ‚enne;01/06/2018;31/05/2022;;;;;;;;
MATURE-NK;Autriche;MEDIZINISCHE UNIVERSITAET WIEN;Medizinische Universitaet Wien;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 ?;Commission Europ‚enne;01/06/2018;31/05/2022;;;;;;;;
MATURE-NK;Espagne;UNIVERSIDAD POMPEU FABRA;Universidad Pompeu Fabra;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 ?;Commission Europ‚enne;01/06/2018;31/05/2022;;;;;;;;
MATURE-NK;France;INSTITUT PASTEUR;Institut Pasteur;Immunit‚ inn‚e;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 ?;Commission Europ‚enne;01/06/2018;31/05/2022;;;;;;;;
MATURE-NK;France;INNATE PHARMA;Innate Pharma;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 ?;Commission Europ‚enne;01/06/2018;31/05/2022;;;;;;;;
MATURE-NK;Isra‰l;THE HEBREW UNIVERSITY OF JERUSALEM;The Hebrew University Of Jerusalem;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 ?;Commission Europ‚enne;01/06/2018;31/05/2022;;;;;;;;
MATURE-NK;Italie;IRCCS OSPEDALE POLICLINICO SAN MARTINO;Irccs Ospedale Policlinico San Martino;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 ?;Commission Europ‚enne;01/06/2018;31/05/2022;;;;;;;;
MATURE-NK;NorvŠge;OSLO UNIVERSITETSSYKEHUS HF;Oslo Universitetssykehus Hf;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 ?;Commission Europ‚enne;01/06/2018;31/05/2022;;;;;;;;
MATURE-NK;Pays-Bas;GLYCOSTEM-THERAPEUTICS B.V.;Glycostem-Therapeutics B.V.;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 ?;Commission Europ‚enne;01/06/2018;31/05/2022;;;;;;;;
MATURE-NK;Suisse;UNIVERSITAT BASEL;Universitat Basel;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 ?;Commission Europ‚enne;01/06/2018;31/05/2022;;;;;;;;
MIAD;France;Institut Pasteur de Lille;Institut Pasteur De Lille;Molecular determinants of neurodegenerative diseases Laboratory;Microglia imaging in Alzheimer's disease;Projet scientifique;alzheimer;neurobiology;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;;
MIAD;France;Institut Pasteur;Institut Pasteur;Hub d'analyse d'images;Microglia imaging in Alzheimer's disease;Projet scientifique;alzheimer;neurobiology;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
MIAD;GrŠce;Institut Pasteur Hellenique;Institut Pasteur Hellenique;;Microglia imaging in Alzheimer's disease;Projet scientifique;alzheimer;neurobiology;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
CaptoTryp;Br‚sil;FIOCRUZ;Fiocruz;;Molecular and structural tools for deciphering trypanosomatid-specific features of EIF4E in the translational machinery  ;Projet scientifique;trypanosomatid;;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;;
CaptoTryp;France;Institut Pasteur;Institut Pasteur;Chimie Biologique Epig‚n‚tique;Molecular and structural tools for deciphering trypanosomatid-specific features of EIF4E in the translational machinery  ;Projet scientifique;trypanosomatid;;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
CaptoTryp;France;Institut Pasteur;Institut Pasteur;Bio-Informatique Structurale;Molecular and structural tools for deciphering trypanosomatid-specific features of EIF4E in the translational machinery  ;Projet scientifique;trypanosomatid;;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
I-MOVE-COVID-19;Albanie;INSTITUTE OF PUBLIC HEALTH;Institute Of Public Health;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;Allemagne;VIENNA VACCINE SAFETY INITIATIVE EV;Vienna Vaccine Safety Initiative Ev;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;Belgique;VRIJE UNIVERSITEIT BRUSSEL;Vrije Universiteit Brussel;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;Espagne;INSTITUTO DE SALUD CARLOS III;Instituto De Salud Carlos Iii;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;Espagne;ORGANISMO AUTONOMO INSTITUTO DE SALUD PUBLICA Y LABORAL DE NAVARRA;Organismo Autonomo Instituto De Salud Publica Y Laboral De Navarra;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;France;EPICONCEPT;Epiconcept;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;coordinateur;;;;;
I-MOVE-COVID-19;France;UNIVERSITE DE CORSE PASCAL PAOLI;Universite De Corse Pascal Paoli;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;France;SORBONNE UNIVERSITE;Sorbonne Universite;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;France;AGENCE NATIONALE DE SANTE PUBLIQUE;Agence Nationale De Sante Publique;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;France;INSTITUT PASTEUR;Institut Pasteur;CNR Virus des infections respiratoires;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;France;ASSISTANCE PUBLIQUE HOPITAUX DE PARIS;Assistance Publique Hopitaux De Paris;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;France;CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER;Centre Hospitalier Universitaire Montpellier;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;France;CENTRE HOSPITALIER UNIVERSITAIRE DE RENNES;Centre Hospitalier Universitaire De Rennes;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;France;HOSPICES CIVILS DE LYON;Hospices Civils De Lyon;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;Irlande;HEALTH SERVICE EXECUTIVE HSE;Health Service Executive Hse;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;Lituanie;LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS;Lietuvos Sveikatos Mokslu Universitetas;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;Pays-Bas;STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG;Stichting Nederlands Instituut Voor Onderzoek Van De Gezondheidszorg;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;Pays-Bas;RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU;Rijksinstituut Voor Volksgezondheid En Milieu;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;Portugal;INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE;Instituto Nacional De Saude Dr. Ricardo Jorge;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;Portugal;MINISTERIO DA SAUDE - REPUBLICA PORTUGUESA;Ministerio Da Saude - Republica Portuguesa;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;Roumanie;INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE MEDICO-MILITARA CANTACUZINO;Institutul National De Cercetare-Dezvoltare Medico-Militara Cantacuzino;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;Royaume-Uni;NHS NATIONAL SERVICES SCOTLAND;Nhs National Services Scotland;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;Royaume-Uni;Department of Health;Department Of Health;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
I-MOVE-COVID-19;SuŠde;FOLKHALSOMYNDIGHETEN;Folkhalsomyndigheten;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 ?;Commission Europ‚enne;16/03/2020;15/06/2022;;;;;;;;
Neo-LIC;France;Institut Pasteur;Institut Pasteur;Epid‚miologie & mod‚lisation de la r‚sistance aux antimicrobiens;Neonatal acquisition of ESBL-PE in the community  of a low-income country  ;Projet scientifique;enterobacteriaceae;epidemiology;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;;
Neo-LIC;France;Institut Pasteur;Institut Pasteur;Hub Bioinformatique et Biostatistique;Neonatal acquisition of ESBL-PE in the community  of a low-income country  ;Projet scientifique;enterobacteriaceae;epidemiology;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
Neo-LIC;Madagascar;Institut Pasteur in Madagascar;Institut Pasteur In Madagascar;;Neonatal acquisition of ESBL-PE in the community  of a low-income country  ;Projet scientifique;enterobacteriaceae;epidemiology;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
Neovac;Burkina Faso;LAMIVAC;Lamivac;;NEOVAC;Sant‚ publique;H‚patite;Vaccination;essai vaccinal;;;1 573 824,00 ?;Fondation Total;07/07/1905;;;;;;;;;
Neovac;France;Institut Pasteur;Institut Pasteur;Direction Scientifique Unit‚ de Recherche et d'Expertise Epid‚miologie des Maladies Emergentes;NEOVAC;Sant‚ publique;H‚patite;Vaccination;;;;1 573 824,00 ?;Fondation Total;07/07/1905;;;;;;;;;
Neovac;Madagascar;Institut Pasteur de Madagascar;Institut Pasteur De Madagascar;;NEOVAC;Sant‚ publique;H‚patite;Vaccination;essai vaccinal;;;1 573 824,00 ?;Fondation Total;07/07/1905;;;;;;;;;
Neovac;S‚n‚gal;Institut Pasteur de Dakar;Institut Pasteur De Dakar;;NEOVAC;Sant‚ publique;H‚patite;Vaccination;essai vaccinal;;;1 573 824,00 ?;Fondation Total;07/07/1905;;;;;;;;;
NECESSITY;Espagne;FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD;Fundacion Publica Andaluza Progreso Y Salud;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;Espagne;FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA;Fundacio Clinic Per A La Recerca Biomedica;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;Etats-Unis;BRISTOL-MYERS SQUIBB COMPANY CORP;Bristol-Myers Squibb Company Corp;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;coordinateur;;;;;
NECESSITY;France;HOPITAUX UNIVERSITAIRES DE STRASBOURG;Hopitaux Universitaires De Strasbourg;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;France;UNIVERSITE DE BRETAGNE OCCIDENTALE;Universite De Bretagne Occidentale;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;France;UNIVERSITE DE PARIS;Universite De Paris;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;France;ASSISTANCE PUBLIQUE HOPITAUX DE PARIS;Assistance Publique Hopitaux De Paris;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;France;ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK;Ecrin European Clinical Research Infrastructure Network;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;France;ASSOCIATION FRANCAISE GOUGEROT-SJOGREN;Association Francaise Gougerot-Sjogren;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;France;Institut Pasteur;Institut Pasteur;Biologie Computationnelle;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;France;INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS;Institut De Recherches Internationales Servier Iris;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;GrŠce;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;Ethniko Kai Kapodistriako Panepistimio Athinon;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;Italie;INNOVATION ACTA S.R.L.;Innovation Acta S.R.L.;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;Italie;UNIVERSITA DEGLI STUDI DI UDINE;Universita Degli Studi Di Udine;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;NorvŠge;HELSE STAVANGER HF;Helse Stavanger Hf;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;Pays-Bas;UNIVERSITAIR MEDISCH CENTRUM UTRECHT;Universitair Medisch Centrum Utrecht;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;Pays-Bas;ACADEMISCH ZIEKENHUIS GRONINGEN;Academisch Ziekenhuis Groningen;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;Royaume-Uni;THE UNIVERSITY OF BIRMINGHAM;The University Of Birmingham;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;Royaume-Uni;UNIVERSITY OF NEWCASTLE UPON TYNE;University Of Newcastle Upon Tyne;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;Royaume-Uni;QUEEN MARY UNIVERSITY OF LONDON;Queen Mary University Of London;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;Royaume-Uni;GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.;Glaxosmithkline Research And Development Ltd.;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;SuŠde;KAROLINSKA INSTITUTET;Karolinska Institutet;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
NECESSITY;Suisse;NOVARTIS PHARMA AG;Novartis Pharma Ag;;NEw Clinical Endpoints in primary Sj”gren?s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sj”gren?s syndrome;;;;8 200 000,00 ?;Commission Europ‚enne;01/01/2019;31/12/2024;;;;;;;;
TopSpec;Allemagne;THERMO FISHER SCIENTIFIC (BREMEN) GMBH;Thermo Fisher Scientific (Bremen) Gmbh;;Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 ?;Commission Europ‚enne;01/01/2019;30/06/2022;;;;;;;;
TopSpec;France;INSTITUT PASTEUR;Institut Pasteur;Technologie et service Spectrom‚trie de masse pour la biologie (UtechS MSBio);Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 ?;Commission Europ‚enne;01/01/2019;30/06/2022;;;;;;;;
TopSpec;GrŠce;FASMATECH EPISTIMONIKI KAI TECHNOLOGIKI ANONYMI ETAIREIA;Fasmatech Epistimoniki Kai Technologiki Anonymi Etaireia;;Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 ?;Commission Europ‚enne;01/01/2019;30/06/2022;;;;;;;;
TopSpec;Pays-Bas;SPECTROMETRY VISION BV;Spectrometry Vision Bv;;Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 ?;Commission Europ‚enne;01/01/2019;30/06/2022;;;;;;;;
TopSpec;Royaume-Uni;THE NOTTINGHAM TRENT UNIVERSITY;The Nottingham Trent University;;Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 ?;Commission Europ‚enne;01/01/2019;30/06/2022;;;;;;;;
TopSpec;SuŠde;KAROLINSKA INSTITUTET;Karolinska Institutet;;Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 ?;Commission Europ‚enne;01/01/2019;30/06/2022;;;coordinateur;;;;;
TopSpec;SuŠde;BIOMOTIF AB;Biomotif Ab;;Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 ?;Commission Europ‚enne;01/01/2019;30/06/2022;;;;;;;;
TopSpec;Suisse;SPECTROSWISS SARL;Spectroswiss Sarl;;Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 ?;Commission Europ‚enne;01/01/2019;30/06/2022;;;;;;;;
MultiSeroSurv;France;Institut Pasteur;Institut Pasteur;Malaria : Parasites et h“tes;Novel integrated serological surveillance of malaria and neglected tropical diseases;Projet scientifique;malaria;tropical diseases;Infectious diseases;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2020;31/01/2025;;;coordinateur;;;;;
MultiSeroSurv;S‚n‚gal;INSTITUT PASTEUR DE DAKAR;Institut Pasteur De Dakar;;Novel integrated serological surveillance of malaria and neglected tropical diseases;Projet scientifique;malaria;tropical diseases;Infectious diseases;;;1 500 000,00 ?;Commission Europ‚enne;01/02/2020;31/01/2025;;;;;;;;
ACRAS-R;Allemagne;Technische Universit„t Dresden;Technische Universit„t Dresden;;One Health: AMR in environmental reservoirs and Colonizing antibiotic resistant bacteria;Projet scientifique;;;;;;130 680,00 ?;Agence Nationale de la Recherche;01/01/2021;31/12/2023;;;coordinateur;;;;;
ACRAS-R;Allemagne;Dresden University Bio-technology Centre;Dresden University Bio-Technology Centre;;One Health: AMR in environmental reservoirs and Colonizing antibiotic resistant bacteria;Projet scientifique;;;;;;130 680,00 ?;Agence Nationale de la Recherche;01/01/2021;31/12/2023;;;;;;;;
ACRAS-R;France;Universit‚ de Limoges;Universit‚ De Limoges;;One Health: AMR in environmental reservoirs and Colonizing antibiotic resistant bacteria;Projet scientifique;AMR transmission;one health;;;;130 680,00 ?;Agence Nationale de la Recherche;01/01/2021;31/12/2023;;;coordinateur;;;;;
ACRAS-R;France;Institut Pasteur de Guadeloupe;Institut Pasteur De Guadeloupe;;One Health: AMR in environmental reservoirs and Colonizing antibiotic resistant bacteria;Projet scientifique;;;;;;130 680,00 ?;Agence Nationale de la Recherche;01/01/2021;31/12/2023;;;;;;Pan-genome Graph Algorithms and Data Integration | PANGAIA Project | H2020 | CORDIS | European Commission (europa.eu);;This EU-funded project is going to explore graph-based representation of large genome datasets and determine their advantages over traditional sequence-based presentation of pan-genomic data
ACRAS-R;France;Institut Pasteur;Institut Pasteur;Epid‚miologie & mod‚lisation de la r‚sistance aux antimicrobie;One Health: AMR in environmental reservoirs and Colonizing antibiotic resistant bacteria;Projet scientifique;;;;;;130 680,00 ?;Agence Nationale de la Recherche;01/01/2021;31/12/2023;;;;;;;;
OrganoEar;Cor‚e du Sud;Institut Pasteur Korea;Institut Pasteur Korea;;Organoids-on-chip: role of Sonic-Hedgehog signaling on the development of inner ear organoids;Projet scientifique;cochlea;;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
OrganoEar;France;Institut Pasteur;Institut Pasteur;Equipe Ida Plasticit‚ des Circuits Auditifs Centrauxÿÿ- Plasticity of Central Auditory Circuit;Organoids-on-chip: role of Sonic-Hedgehog signaling on the development of inner ear organoids;Projet scientifique;cochlea;;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;;
OrganoEar;France;Institut Pasteur;Institut Pasteur;Plate-forme Technologique Biomat‚riaux et Microfluidique;Organoids-on-chip: role of Sonic-Hedgehog signaling on the development of inner ear organoids;Projet scientifique;cochlea;;;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
PANGAIA;Allemagne;UNIVERSITAET BIELEFELD;Universitaet Bielefeld;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;;;;;;
PANGAIA;Canada;Simon Fraser University;Simon Fraser University;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;;;;;;
PANGAIA;Etats-Unis;CORNELL UNIVERSITY;Cornell University;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;;;;;;
PANGAIA;Etats-Unis;The Pennsylvania State University;The Pennsylvania State University;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;;;;;;
PANGAIA;France;INSTITUT PASTEUR;Institut Pasteur;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;;;;;;
PANGAIA;Italie;UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA;Universita' Degli Studi Di Milano-Bicocca;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;coordinateur;;;;;
PANGAIA;Japon;NATIONAL UNIVERSITY CORPORATION THEUNIVERSITY OF TOKYO;National University Corporation Theuniversity Of Tokyo;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;;;;;;This project constitutes a pioneering work that aim to characterize EVs that circulate among domestic and wild animals in central Africa, a geographical region that harbours a highly diverse wild fauna, where close contact between humans and herd animals are still common and where poor sanitation systems provide a conducive environment for EV transmissio
PANGAIA;Pays-Bas;STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTEN;Stichting Nederlandse Wetenschappelijk Onderzoek Instituten;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;;;;;;
PANGAIA;Royaume-Uni;ILLUMINA CAMBRIDGE LTD;Illumina Cambridge Ltd;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;;;;;;
PANGAIA;Slovaquie;UNIVERZITA KOMENSKEHO V BRATISLAVE;Univerzita Komenskeho V Bratislave;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;;;;;;The scientists from four institutes of Institut Pasteur International Network (Rome, Paris, Cambodia and Ivory Coast) will combine their expertise in virology, immunology and entomology to perform a comprehensive characterization of mechanisms underlying the interaction between DENV infection, mosquito vectors, and the early host antiviral immunit
PANGAIA;Slovaquie;GENETON S.R.O.;Geneton S.R.O.;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;;;;;;
NIRV_HOST_INT;France;INSTITUT PASTEUR;Institut Pasteur;;Population genomics of co-evolution between non-retroviral RNA viruses and their hosts;Projet scientifique;biology;RNA virus;virology;;;1 686 875,00 ?;Commission Europ‚enne;01/05/2016;30/04/2022;;;;;;;;
NIRV_HOST_INT;Italie;UNIVERSITA DEGLI STUDI DI PAVIA;Universita Degli Studi Di Pavia;;Population genomics of co-evolution between non-retroviral RNA viruses and their hosts;Projet scientifique;biology;RNA virus;virology;;;1 686 875,00 ?;Commission Europ‚enne;01/05/2016;30/04/2022;;;coordinateur;;;;;
SADaniel;Br‚sil;Oswaldo Cruz Institute FIOCRUZ;Oswaldo Cruz Institute Fiocruz;Laboratory of AIDS and Molecular Immunology;Primary Yellow Fever immunization of HIV-infected individuals: impact of immune activation and inflammation in the innate and adaptive immune response to vaccine;Projet scientifique;HIV;yellow fever;vaccination;innate immunity;antibody response;176 800,00 ?;ANSR;01/04/2019;31/03/2021;;;;;;;;Scientists from Institut Pasteur in Iran, French Guiana and Paris will combine their complementary expertise to develop the tools using Asaia spp. in order to produce and delivery double stranded RNA against two specific genes into the Anopheles mosquito vectors to reduce their vectorial capaci
SADaniel;France;Institut Pasteur;Institut Pasteur;Biologie cellulaire des lymphocytes;Primary Yellow Fever immunization of HIV-infected individuals: impact of immune activation and inflammation in the innate and adaptive immune response to vaccine;Projet scientifique;HIV;yellow fever;vaccination;innate immunity;antibody response;176 800,00 ?;ANSR;01/04/2019;31/03/2021;;;Coordinateur;Projet financ‚;;;;
PolarNet;Allemagne;TECHNISCHE UNIVERSITAET DRESDEN;Technische Universitaet Dresden;;Principles of Polarity ? Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 ?;Commission Europ‚enne;01/10/2015;30/09/2021;;;;;;;;
PolarNet;Belgique;Union Biometrica BVBA;Union Biometrica Bvba;;Principles of Polarity ? Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 ?;Commission Europ‚enne;01/10/2015;30/09/2021;;;;;;;3;The present project aims to demonstrate that the statistical signature of behavioural changes in mosquitoes after YFV infection can be leveraged to detect the virus circulation in transmission are
PolarNet;France;Institut Pasteur;Institut Pasteur;;Principles of Polarity ? Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 ?;Commission Europ‚enne;01/10/2015;30/09/2021;;;;;;;3;
PolarNet;France;INSTITUT CURIE;Institut Curie;;Principles of Polarity ? Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 ?;Commission Europ‚enne;01/10/2015;30/09/2021;;;;;;;3;
PolarNet;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Principles of Polarity ? Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 ?;Commission Europ‚enne;01/10/2015;30/09/2021;;;;;;;3;Three Institutes of Institut Pasteur International Network (Dakar, Ivory Coast and Paris) involved in this project will combine their complementary expertise to investigate the burden and clinical presentations of EV-68 infections in pediatrics facilities in Senegal and Ivory Coast and to provide insights to the epidemiologic and genetic characteristics of EV-D68 in both countrie
PolarNet;Pays-Bas;UNIVERSITEIT UTRECHT;Universiteit Utrecht;;Principles of Polarity ? Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 ?;Commission Europ‚enne;01/10/2015;30/09/2021;;;coordinateur;;;;3;
PolarNet;Pays-Bas;ELEVATE BV;Elevate Bv;;Principles of Polarity ? Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 ?;Commission Europ‚enne;01/10/2015;30/09/2021;;;;;;;3;
PolarNet;Pays-Bas;Scientific Volume Imaging BV;Scientific Volume Imaging Bv;;Principles of Polarity ? Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 ?;Commission Europ‚enne;01/10/2015;30/09/2021;;;;;;;3;The present project, which associates scientists from Institut Pasteur of New Caledonia, Paris and Cambodia, aims to identify the determinants of the emergence of minority serotypes during dengue outbreaks. The respective roles of viral and human factors in the emergence of a new serotype will be explored
PolarNet;Royaume-Uni;THE FRANCIS CRICK INSTITUTE LIMITED;The Francis Crick Institute Limited;;Principles of Polarity ? Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 ?;Commission Europ‚enne;01/10/2015;30/09/2021;;;;;;;3;
PolarNet;Royaume-Uni;CARDIFF UNIVERSITY;Cardiff University;;Principles of Polarity ? Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 ?;Commission Europ‚enne;01/10/2015;30/09/2021;;;;;;;3;
PolarNet;Royaume-Uni;UNIVERSITY COLLEGE LONDON;University College London;;Principles of Polarity ? Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 ?;Commission Europ‚enne;01/10/2015;30/09/2021;;;;;;;3;The scientists from three institutes of Institut Pasteur International Network (Paris, Shanghai and Laos) will combine their expertise to understand how hypoxic environment and host cellular restriction factors work hand in hand to annihilate HBV infection
PolarNet;Royaume-Uni;NDS Ltd.;Nds Ltd.;;Principles of Polarity ? Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 ?;Commission Europ‚enne;01/10/2015;30/09/2021;;;;;;;3;
PolarNet;Suisse;UNIVERSITAT BASEL;Universitat Basel;;Principles of Polarity ? Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 ?;Commission Europ‚enne;01/10/2015;30/09/2021;;;;;;;3;
One Health EJP;Allemagne;BUNDESINSTITUT FUER RISIKOBEWERTUNG;Bundesinstitut Fuer Risikobewertung;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;Scientists from 3 institutes of Institut Pasteur International Network (Sofia, Paris and Brussels) will combine their expertise, spread across the fields of immunology, epigenetics, and infection biology to assess whether the epigenetic code of transcripts and the genomic organization of lung epithelial cells is modified by rheumatoid arthritis (RA) and influenza infection, and whether RA thereby increases the susceptibility to infection
One Health EJP;Allemagne;FRIEDRICH LOEFFLER INSTITUT - BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT;Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer Tiergesundheit;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Allemagne;ROBERT KOCH-INSTITUT;Robert Koch-Institut;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Autriche;AGES - OSTERREICHISCHE AGENTUR FUR GESUNDHEIT UND ERNAHRUNGSSICHERHEIT GMBH;Ages - Osterreichische Agentur Fur Gesundheit Und Ernahrungssicherheit Gmbh;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;The consortium will gather scientists from 3 institutes of Institut Pasteur International Network, with expertise on structural biology, biochemistry and antibiotic resistance, to discover how mutations in PhoPQ and PmrAB cause PM resistance
One Health EJP;Belgique;SCIENSANO;Sciensano;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Bulgarie;BULGARIAN FOOD SAFETY AGENCY;Bulgarian Food Safety Agency;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Danemark;DANMARKS TEKNISKE UNIVERSITET;Danmarks Tekniske Universitet;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Danemark;STATENS SERUM INSTITUT;Statens Serum Institut;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;Scientists from three institutes from the Institut Pasteur International Network (Madagascar, Paris and Lille) with expertise in the field of plague, and collaborating within the framework of an Institut Pasteur International Unit, plan to investigate the involvement and the role of fleas in sylvatic plague maintenance and in human plague reappearance/re-emergence in Madagascar.
One Health EJP;Espagne;INSTITUTO NACIONAL DE INVESTIGACION Y TECNOLOGIA AGRARIA Y ALIMENTARIA OA MP;Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria Oa Mp;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Espagne;UNIVERSIDAD COMPLUTENSE DE MADRID;Universidad Complutense De Madrid;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Espagne;INSTITUTO DE SALUD CARLOS III;Instituto De Salud Carlos Iii;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;Scientists from three institutes from Institut Pasteur International Network (Paris, French Guiana and Bangui) will combine their expertise to analyze the impact of Vit.C seric levels on susceptibility to enteric infections and diarrhea in children in countries with a high diarrheal burden
One Health EJP;Estonie;TARTU ULIKOOL;Tartu Ulikool;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Estonie;VETERINAAR JA TOIDULABORATOORIUM;Veterinaar Ja Toidulaboratoorium;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Finlande;RUOKAVIRASTO;Ruokavirasto;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;Scientists from instituts Pasteur in Paris, in Cambodia and in Madagascar will associate their expertise to determine in real-world conditions whether the long-term antibody response measured and cellular / humoral immunity parameters are comparable after three intradermal dose-sparing PEP sessions using Vero cell vaccine, compared to that after four sessions, before and after rabies vaccine boosting
One Health EJP;Finlande;TERVEYDEN JA HYVINVOINNIN LAITOS;Terveyden Ja Hyvinvoinnin Laitos;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;France;Institut Pasteur;Institut Pasteur;Arbovirus et Insectes Vecteurs;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;France;Agence nationale de la s‚curit‚ sanitaire de l'alimentation de l'environnement et du travail;Agence Nationale De La S‚curit‚ Sanitaire De L'Alimentation De L'Environnement Et Du Travail;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;coordinateur;;;;4;Scientists from 4 institutes of Institut Pasteur International Network (Paris, Bangui, Cameroon and Madagascar) will combine their expertise to identify the mechanisms that generate genetic diversity in EV ecosystems and to understand how this diversity promotes the emergence of new virus lineages with modified phenotypic properties.
One Health EJP;France;ASSOCIATION MED-VET-NET DE RECHERCHE SUR LES ZOONOSES;Association Med-Vet-Net De Recherche Sur Les Zoonoses;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;4;
One Health EJP;France;INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT;Institut National De Recherche Pour L'Agriculture, L'Alimentation Et L'Environnement;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;4;
One Health EJP;Hongrie;NEMZETI NEPEGESZSEGUGYI KOZPONT;Nemzeti Nepegeszsegugyi Kozpont;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;4;
One Health EJP;Hongrie;NEMZETI ELELMISZERLANC-BIZTONSAGI HIVATAL;Nemzeti Elelmiszerlanc-Biztonsagi Hivatal;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;This project is an integrative structural biology project bringing together scientists of the Institut Pasteur in Paris and in Korea with complementary expertise (biochemistry, biophysics, crystallography, ultra-structural bioimaging, HDX-MS, bio informatic)
One Health EJP;Irlande;NATIONAL UNIVERSITY OF IRELAND GALWAY;National University Of Ireland Galway;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Irlande;TEAGASC - AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY;Teagasc - Agriculture And Food Development Authority;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Italie;ISTITUTO SUPERIORE DI SANITA;Istituto Superiore Di Sanita;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Italie;ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELL'ABRUZZO E DEL MOLISE G CAPORALE;Istituto Zooprofilattico Sperimentale Dell'Abruzzo E Del Molise G Caporale;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Italie;ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA LOMBARDIA E DELL'EMILIA ROMAGNA BRUNO UBERTINI;Istituto Zooprofilattico Sperimentale Della Lombardia E Dell'Emilia Romagna Bruno Ubertini;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Lettonie;PARTIKAS DROSIBAS, DZIVNIEKU VESELIBAS UN VIDES ZINATNISKAIS INSTITUTSBIOR;Partikas Drosibas, Dzivnieku Veselibas Un Vides Zinatniskais Institutsbior;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Lituanie;NACIONALINIS MAISTO IR VETERINARIJOS RIZIKOS VERTINIMO INSTITUTAS;Nacionalinis Maisto Ir Veterinarijos Rizikos Vertinimo Institutas;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;Scientists from Institut Pasteur in Paris and in Guinea will combine their expertise to adapt the recently developed Specific High-sensitivity Enzymatic Reporter unLOCKing (SHERLOCK) technology that combines a CRISPR-Cas system and lateral flow test to the detection of trypanosomes.
One Health EJP;NorvŠge;FOLKEHELSEINSTITUTTET;Folkehelseinstituttet;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;NorvŠge;VETERINAERINSTITUTTET - NORWEGIAN VETERINARY INSTITUTE;Veterinaerinstituttet - Norwegian Veterinary Institute;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Pays-Bas;RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU;Rijksinstituut Voor Volksgezondheid En Milieu;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Pays-Bas;STICHTING WAGENINGEN RESEARCH;Stichting Wageningen Research;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;4;For this project, scientists from Institut Pasteur in Belgium and France (Lille, Paris) will join their experiences with those of their colleagues from St Petersburg to fully unlock the potential of their diagnostic platform
One Health EJP;Pologne;PANSTWOWY INSTYTUT WETERYNARYJNY - PANSTWOWY INSTYTUT BADAWCZY;Panstwowy Instytut Weterynaryjny - Panstwowy Instytut Badawczy;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;4;
One Health EJP;Portugal;INSTITUTO NACIONAL DE INVESTIGA€AO AGRARIA E VETERINARIA;Instituto Nacional De Investiga‡ao Agraria E Veterinaria;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;4;
One Health EJP;Portugal;INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE;Instituto Nacional De Saude Dr. Ricardo Jorge;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;4;
One Health EJP;R‚publique TchŠque;STATNI ZDRAVOTNI USTAV;Statni Zdravotni Ustav;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;Three teams of two institutes of the IPIN (Fiocruz and Institut Pasteur Paris) will combine their complementary expertise to study the structure and molecular interactions of T. cruzi EIF4E factors with their different partners (protein/RNA) in the protein synthesis machinery
One Health EJP;R‚publique TchŠque;VYZKUMNY USTAV VETERINARNIHO LEKARSTVI;Vyzkumny Ustav Veterinarniho Lekarstvi;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Roumanie;INSTITUTUL DE IGIENA SI SANATATE PUBLICA VETERINARIA;Institutul De Igiena Si Sanatate Publica Veterinaria;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Royaume-Uni;THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;The Secretary Of State For Environment, Food And Rural Affairs;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;The current project brings together several scientists from Institut Pasteur International Network in the field of immunology and virology to study the immune responses initiated after dengue infection that provides protection from disease, but clears the virus efficientl
One Health EJP;Royaume-Uni;Department of Health;Department Of Health;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Royaume-Uni;UNIVERSITY OF SURREY;University Of Surrey;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;SuŠde;LIVSMEDELS VERKET;Livsmedels Verket;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;SuŠde;FOLKHALSOMYNDIGHETEN;Folkhalsomyndigheten;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;Teams from Institut Pasteur of Bangui and of Paris as well as external partners will combine their complementary expertise (epidemiology, virology, anthropology, zoology and environmental ecology) to develop a One health comprehensive approach for studing monkeypox in Central African Republic.
One Health EJP;SuŠde;STATENS VETERINAERMEDICINSKA ANSTALT;Statens Veterinaermedicinska Anstalt;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 ?;Commission Europ‚enne;01/01/2018;31/12/2022;;;;;;;2;
RECoVER;Allemagne;CHARITE - UNIVERSITAETSMEDIZIN BERLIN;Charite - Universitaetsmedizin Berlin;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 ?;Commission Europ‚enne;14/02/2020;13/02/2022;;;;;;;2;
RECoVER;Belgique;UNIVERSITEIT ANTWERPEN;Universiteit Antwerpen;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 ?;Commission Europ‚enne;14/02/2020;13/02/2022;;;coordinateur;;;;2;
RECoVER;Chine;INSTITUT PASTEUR OF SHANGHAI, CHINESE ACADEMY OF SCIENCES;Institut Pasteur Of Shanghai, Chinese Academy Of Sciences;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 ?;Commission Europ‚enne;14/02/2020;13/02/2022;;;;;;;2;Mathematicians, biophysicians and biologists from 2 instituts of IPIN (Institut Pasteur Paris and Pasteur Research Pole Hong Kong) will combine their expertise to provide an integrated framework to analyze cell mechanics by combining imaging, and biophysical and computational approaches and to investigate the relation ship between host tissue mechanical forces and microbe
RECoVER;France;INSTITUT PASTEUR;Institut Pasteur;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 ?;Commission Europ‚enne;14/02/2020;13/02/2022;;;;;;;2;
RECoVER;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 ?;Commission Europ‚enne;14/02/2020;13/02/2022;;;;;;;2;
RECoVER;France;ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK;Ecrin European Clinical Research Infrastructure Network;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 ?;Commission Europ‚enne;14/02/2020;13/02/2022;;;;;;;2;Four teams from two institutes of Institut Pasteur International Network (Paris and Cambodia) will combine their highly complementary skills (chemistry of epigenetic drugs, biology and epigenetics of the malaria parasite, Plasmodiumtransmission and Plasmodium drug resistance in the field) to develop alternative therapies by targeting epigenetics mechanism
RECoVER;Italie;FONDAZIONE PENTA - FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES - ONLUS;Fondazione Penta - For The Treatment And Care Of Children With Hiv Andrelated Diseases - Onlus;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 ?;Commission Europ‚enne;14/02/2020;13/02/2022;;;;;;;2;
RECoVER;NorvŠge;FOLKEHELSEINSTITUTTET;Folkehelseinstituttet;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 ?;Commission Europ‚enne;14/02/2020;13/02/2022;;;;;;;2;
RECoVER;Pays-Bas;UNIVERSITAIR MEDISCH CENTRUM UTRECHT;Universitair Medisch Centrum Utrecht;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 ?;Commission Europ‚enne;14/02/2020;13/02/2022;;;;;;;2;
RECoVER;Pays-Bas;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Erasmus Universitair Medisch Centrum Rotterdam;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 ?;Commission Europ‚enne;14/02/2020;13/02/2022;;;;;;;2;This interdisciplinary project, which involves the concerted effort of four teams from the Institut Pasteur of Paris, the Institut Pasteur of Korea and external partners, represents the first step toward the generation of cochlear organoid
RECoVER;Pays-Bas;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM;Academisch Medisch Centrum Bij De Universiteit Van Amsterdam;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 ?;Commission Europ‚enne;14/02/2020;13/02/2022;;;;;;;2;
RECoVER;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 ?;Commission Europ‚enne;14/02/2020;13/02/2022;;;;;;;2;
RECoVER;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 ?;Commission Europ‚enne;14/02/2020;13/02/2022;;;;;;;3;Scientists from 3 institutes of Institut Pasteur International network (Paris, Cambodia and Madagscar) with complementary expertise will bring together in order to to develop and to validate, both in laboratory conditions and in field settings, the first point of care tests (POCTs) for the rapid detection of the etiological agent of rabies (with rabies virus - RABV) in human
RECoVER;Royaume-Uni;INTENSIVE CARE NATIONAL AUDIT AND RESEARCH CENTRE;Intensive Care National Audit And Research Centre;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 ?;Commission Europ‚enne;14/02/2020;13/02/2022;;;;;;;3;
Autophagy in vitro;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Reconstituting Autophagosome Biogenesis in vitro;Projet scientifique;autoimmune diseases;electron microscopy;cancer;;;1 499 726,00 ?;Commission Europ‚enne;01/04/2015;31/01/2021;;;;;;;3;
Autophagy in vitro;France;Institut Pasteur;Institut Pasteur;;Reconstituting Autophagosome Biogenesis in vitro;Projet scientifique;autoimmune diseases;electron microscopy;cancer;;;1 499 726,00 ?;Commission Europ‚enne;01/04/2015;31/01/2021;;;;;;;3;
INFRAVEC2;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;This project is the result of synergistic expertise within the Pasteur network (skeletal muscle research and stem cell biology, infectious diseases and sepsis). It aims to investigate in detail the mechanisms and the consequences of how muscle stem cells sense and respond to acute systemic pathogen-driven inflammation. 
INFRAVEC2;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;
INFRAVEC2;Burkina Faso;MINISTERE DE LA SANTE;Ministere De La Sante;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;
INFRAVEC2;Espagne;INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES;Institut De Recerca I Tecnologia Agroalimentaries;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;The objectives of this project are to identify the different routes of ESBL-PE transmissions to newborns in the community and to suggest new strategies to control ESBL-PE acquisition in newbor
INFRAVEC2;France;Institut Pasteur;Institut Pasteur;Arbovirus et Insectes Vecteurs;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;
INFRAVEC2;France;Institut Pasteur;Institut Pasteur;G‚nomique des Insectes Vecteurs;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;coordinateur;;;;2;
INFRAVEC2;France;INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT;Institut De Recherche Pour Le Developpement;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;The Four teams from two institutes of Institut Pasteur International Network (Paris and Greece) will combine their highly complementary skills (genotoxicity and epigenetic changes, oncogenic cellular signaling, chemical drug design, mechanism of pathogenicity, host signaling pathways) to study the mechanisms responsible for infection-driven carcinogenesis
INFRAVEC2;France;INSTITUT PASTEUR DE NOUVELLE-CALEDONIE;Institut Pasteur De Nouvelle-Caledonie;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;
INFRAVEC2;France;CENTRE DE COOPERATION INTERNATIONALE EN RECHERCHE AGRONOMIQUE POUR LEDEVELOPPEMENT - C.I.R.A.D. EPIC;Centre De Cooperation Internationale En Recherche Agronomique Pour Ledeveloppement - C.I.R.A.D. Epic;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;
INFRAVEC2;GrŠce;IDRYMA TECHNOLOGIAS KAI EREVNAS;Idryma Technologias Kai Erevnas;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;
INFRAVEC2;Italie;POLO D'INNOVAZIONE DI GENOMICA, GENETICA E BIOLOGIA SCARL;Polo D'Innovazione Di Genomica, Genetica E Biologia Scarl;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;Four teams from two institutes of Institut Pasteur International Network (Paris and UPS- Sao Paulo) will combine their scientific expertise (on plasmodial pre-erythrocytic stages, lentiviral vectorology, on humanized mouse models and on system vaccinology) to develop a novel method to map epitopes and validate protective antigens presented on the surface of infected human cells.
INFRAVEC2;Italie;CENTRO AGRICOLTURA E AMBIENTE GIORGIO NICOLI SRL;Centro Agricoltura E Ambiente Giorgio Nicoli Srl;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;
INFRAVEC2;Mali;UNIVERSITE DES SCIENCES DES TECHNIQUES ET DES TECHNOLOGIES DE BAMAKO;Universite Des Sciences Des Techniques Et Des Technologies De Bamako;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;
INFRAVEC2;Pays-Bas;TROPIQ HEALTH SCIENCES;Tropiq Health Sciences;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;
INFRAVEC2;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;3;The four teams belong to three institutions of the Institut Pasteur International Network (Paris, Yaound‚ and Shanghai) and have internationally recognized expertise in epidemiology and SFV immunology, in structural studies of viral glycoproteins, in medical virology and in the identification of pathogens. They will examine the consequences of SFV infection on human health and investigate the Env structure
INFRAVEC2;Pays-Bas;WAGENINGEN UNIVERSITY;Wageningen University;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;3;
INFRAVEC2;R‚publique TchŠque;UNIVERZITA KARLOVA;Univerzita Karlova;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;3;
INFRAVEC2;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;3;
INFRAVEC2;Royaume-Uni;IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE;Imperial College Of Science Technology And Medicine;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;3;The project consortium is composed of 3 groups with distinct and complementary expertise in neural stem cell biology, neurobiology, induced pluripotent stem cells technology, animal models of neurodegeneration, in vivo imaging and digital image processing, all aiming to decode the contribution of BIN1 in microglia activation during AD progressio
INFRAVEC2;Royaume-Uni;THE PIRBRIGHT INSTITUTE LBG;The Pirbright Institute Lbg;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;3;
INFRAVEC2;Royaume-Uni;LIVERPOOL SCHOOL OF TROPICAL MEDICINE;Liverpool School Of Tropical Medicine;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;3;
INFRAVEC2;S‚n‚gal;INSTITUT PASTEUR DE DAKAR;Institut Pasteur De Dakar;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;Capitalizing on their strong background in the field of synthetic carbohydrate-based antibacterial vaccines (Shigella and Burkholderia), scientists from the Centre Armand-Frappier (Canada) and Institut Pasteur (Paris) aim to develop a safe and effective vaccine against campylobacteriosis through chemical synthesi
INFRAVEC2;Serbie;UNIVERZITET U NOVOM SADU, POLJOPRIVREDNI FAKULTET NOVI SAD;Univerzitet U Novom Sadu, Poljoprivredni Fakultet Novi Sad;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;
INFRAVEC2;Suisse;UNIVERSITAT ZURICH;Universitat Zurich;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;Three teams from two institutes of Institut Pasteur International Network (Paris and Montevideo) with complementary expertise (Legionella infection models, protein crystallization and structure analyses and chemical approaches to decipher epigenetic modifications) propose to combine their different strengths to characterize one of those newly discovered nucleomodulins of L. pneumophila at the functional and structural levels in order to understand its role during infectio
INFRAVEC2;Suisse;Fondation Health Sciences e-Training;Fondation Health Sciences E-Training;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 ?;Commission Europ‚enne;01/02/2017;31/12/2021;;;;;;;2;
NHL;France;Institut Pasteur … Paris;Institut Pasteur · Paris;Direction internationale P“le des op‚rations;Soutien au laboratoire NHL;Institutionnelle;Renforcement;;;;;5 000 000,00 ?;"Union Europ‚enne; AFD";11/07/1905;;;;;;;;2;
NHL;Myanmar;NHL Myanmar;Nhl Myanmar;Direction internationale P“le des op‚rations;Soutien au laboratoire NHL;Institutionnelle;Renforcement;;;;;5 000 000,00 ?;"Union Europ‚enne; AFD";11/07/1905;;;;;;;;2;The scientists from the Institut Pasteur in Paris and Montevideo with complementary expertise allowing the use of multidisciplinary approaches (transcriptomics, proteomics, infectiology, cell biology and microbiology) will investigate the regulation of the adaptive response to oxidative stress by PerR1 and PerR2 in Leptospira
SPARK;Australie;Peter Doherty Institute for Infection and Immunity;Peter Doherty Institute For Infection And Immunity;" ; ";SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;2;
SPARK;Australie;Walter & Eliza Hall Institute of Medical Research ;Walter & Eliza Hall Institute Of Medical Research ;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;2;
SPARK;Australie;Nossal Institute for Global Health, University of Melbourne;Nossal Institute For Global Health, University Of Melbourne;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;8;
SPARK;Australie;Australian National University;Australian National University;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;8;
SPARK;Australie;Commonwealth Scientific and Industrial Research Organisations ;Commonwealth Scientific And Industrial Research Organisations ;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;8;
SPARK;France;Institut Pasteur;Institut Pasteur;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;8;
SPARK;Indon‚sie;Eijkman-Oxford Clinical Research Unit ;Eijkman-Oxford Clinical Research Unit ;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;8;
SPARK;Tha‹lande;Mahidol University;Mahidol University;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;8;
SPARK;Vietnam;Institut Pasteur de H“-Chi-Minh Ville;Institut Pasteur De H“-Chi-Minh Ville;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;8;
SPECTRUM;Australie;Murdoch Children's Research Institute (MCRI);Murdoch Children'S Research Institute (Mcri);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;8;
SPECTRUM;Australie;Kirby Institute;Kirby Institute;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Menzies School of Health Research;Menzies School Of Health Research;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;TB Modelling and Analysis Consortium (TB-MAC);Tb Modelling And Analysis Consortium (Tb-Mac);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Australian Centre of Research Excellence in Malaria Elimination (ACREME);Australian Centre Of Research Excellence In Malaria Elimination (Acreme);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Queensland University of Technology (QUT);Queensland University Of Technology (Qut);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Tupaia;Tupaia;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Public Health Laboratory Network (PHLN);Public Health Laboratory Network (Phln);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Victoria State Government - Health and Human Services;Victoria State Government - Health And Human Services;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;CSIRO;Csiro;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Australian National University (ANU);Australian National University (Anu);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;The University of Adelaide;The University Of Adelaide;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Burnet Institute;Burnet Institute;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;La Trobe University;La Trobe University;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Monash University;Monash University;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;James Cook University;James Cook University;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;University of New South Wales;University Of New South Wales;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Australian Tuberculosis Modelling Network (AuTuMN);Australian Tuberculosis Modelling Network (Autumn);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;NHMRC Centre of Research Excellence in Tuberculosis Control (TB-CRE);Nhmrc Centre Of Research Excellence In Tuberculosis Control (Tb-Cre);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Australian Government - Department of Foreign Affairs and Trade;Australian Government - Department Of Foreign Affairs And Trade;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Australian Partnership for Preparedness Research on Infectious Disease Emergencies (APPRISE);Australian Partnership For Preparedness Research On Infectious Disease Emergencies (Apprise);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Walter & Eliza Hall Institute of Medical Research (WEHI);Walter & Eliza Hall Institute Of Medical Research (Wehi);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;The University of Melbourne - The Nossal Institute for Global Health;The University Of Melbourne - The Nossal Institute For Global Health;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Cambodge;ICEMR Project;Icemr Project;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Cambodge;National Center for Parasitology, Entomology, and Malaria Control ;National Center For Parasitology, Entomology, And Malaria Control ;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Indon‚sie;Eijkman-Oxford Clinical Research Unit ;Eijkman-Oxford Clinical Research Unit ;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;International;OMS;Oms;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Papouasie Nouvelle-Guin‚e;STRIVE-PNG;Strive-Png;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Papouasie Nouvelle-Guin‚e;PNG IMR;Png Imr;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Papouasie Nouvelle-Guin‚e;Trilateral Project (Australia-China-PNG);Trilateral Project (Australia-China-Png);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Papouasie Nouvelle-Guin‚e;Asia Pacific Leaders Malaria Initiative (APLMA);Asia Pacific Leaders Malaria Initiative (Aplma);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Papouasie Nouvelle-Guin‚e;Asia Pacific Malaria Elimination Network (APMEN);Asia Pacific Malaria Elimination Network (Apmen);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Papouasie Nouvelle-Guin‚e;PNG NMCP;Png Nmcp;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Papouasie Nouvelle-Guin‚e;PNG ICPMR;Png Icpmr;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Royaume-Uni;Imperial College London;Imperial College London;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Royaume-Uni;London School of Hygiene & Tropical Medicine ;London School Of Hygiene & Tropical Medicine ;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Tha‹lande;Mahidol University;Mahidol University;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;26;
SPECTRUM;Vietnam;Institut Pasteur de H“-Chi-Minh Ville;Institut Pasteur De H“-Chi-Minh Ville;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;26;
SPECTRUM;;TEPHINET;Tephinet;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;26;
SPECTRUM;;South Asia Field Epidemiology and Technology Network Inc. ;South Asia Field Epidemiology And Technology Network Inc. ;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;26;
PHINDacces;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV ;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev ;;Strengthening Omics data analysis capacities in pathogen-host interaction;Projet scientifique;Infectious diseases;Pathogen-Host interaction;Bioinformatics;network;omics;989 468,70 ?;Commission Europ‚enne;01/10/2018;30/09/2021;;;;;;;26;
PHINDacces;Allemagne;ROBERT KOCH-INSTITUT;Robert Koch-Institut;;Strengthening Omics data analysis capacities in pathogen-host interaction;Projet scientifique;Infectious diseases;Pathogen-Host interaction;Bioinformatics;network;omics;989 468,70 ?;Commission Europ‚enne;01/10/2018;30/09/2021;;;;;;;26;
PHINDacces;Espagne;FUNDACIO CENTRE DE REGULACIO GENOMICA ;Fundacio Centre De Regulacio Genomica ;;Strengthening Omics data analysis capacities in pathogen-host interaction;Projet scientifique;Infectious diseases;Pathogen-Host interaction;Bioinformatics;network;omics;989 468,70 ?;Commission Europ‚enne;01/10/2018;30/09/2021;;;;;;;26;
PHINDacces;France;INSTITUT PASTEUR ;Institut Pasteur ;Biologie et Pathogenicite Fongiques;Strengthening Omics data analysis capacities in pathogen-host interaction;Projet scientifique;Infectious diseases;Pathogen-Host interaction;Bioinformatics;network;omics;989 468,70 ?;Commission Europ‚enne;01/10/2018;30/09/2021;;;;;;;26;
PHINDacces;Tunisie;INSTITUT PASTEUR DE TUNIS;Institut Pasteur De Tunis;;Strengthening Omics data analysis capacities in pathogen-host interaction;Projet scientifique;Infectious diseases;Pathogen-Host interaction;Bioinformatics;network;omics;989 468,70 ?;Commission Europ‚enne;01/10/2018;30/09/2021;;;coordinateur;;;;26;
LegiDOT;France;Institut Pasteur;Institut Pasteur;Biologie des bacteries intracellulaires;Structural and functional characterization of a Dot1-like methyltransferase encoded by Legionella pneumophila: bacteria-induced epigenetics?;Projet scientifique;legionellosis;;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;26;
LegiDOT;France;Institut Pasteur;Institut Pasteur;Chimie Biologique Epig‚n‚tique;Structural and functional characterization of a Dot1-like methyltransferase encoded by Legionella pneumophila: bacteria-induced epigenetics?;Projet scientifique;legionellosis;;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;26;
LegiDOT;Uruguay;Institut Pasteur de Montevideo;Institut Pasteur De Montevideo;;Structural and functional characterization of a Dot1-like methyltransferase encoded by Legionella pneumophila: bacteria-induced epigenetics?;Projet scientifique;legionellosis;;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;26;
VIRAGE;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Structural and functional outcomes of epitranscriptomic methylation of RNA virus genomes;Projet scientifique;coronaviruses;flaviviruses;;;;154 000,00 ?;Agence Nationale de la Recherche;01/10/2020;30/04/2024;;;coordinateur;;;;26;
VIRAGE;France;Institut Pasteur;Institut Pasteur;Virologie (Dpt);Structural and functional outcomes of epitranscriptomic methylation of RNA virus genomes;Projet scientifique;coronaviruses;flaviviruses;;;;154 000,00 ?;Agence Nationale de la Recherche;01/10/2020;30/04/2024;;;;;;;26;
VIRAGE;France;Ecole Nationale Sup‚rieure de Chimie de Montpellier;Ecole Nationale Sup‚rieure De Chimie De Montpellier;;Structural and functional outcomes of epitranscriptomic methylation of RNA virus genomes;Projet scientifique;coronaviruses;flaviviruses;;;;154 000,00 ?;Agence Nationale de la Recherche;01/10/2020;30/04/2024;;;;;;;26;
VIRAGE;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;Structural and functional outcomes of epitranscriptomic methylation of RNA virus genomes;Projet scientifique;coronaviruses;flaviviruses;;;;154 000,00 ?;Agence Nationale de la Recherche;01/10/2020;30/04/2024;;;;;;;26;
SAFE-Aqua;Espagne;BACMINE SL;Bacmine Sl;;SustainAble Farming for Effective Aquaculture;Projet scientifique;aquaculture;;;;;900 000,00 ?;Commission Europ‚enne;01/01/2017;31/12/2020;;;;;;;26;
SAFE-Aqua;France;INSTITUT PASTEUR;Institut Pasteur;;SustainAble Farming for Effective Aquaculture;Projet scientifique;aquaculture;;;;;900 000,00 ?;Commission Europ‚enne;01/01/2017;31/12/2020;;;coordinateur;;;;26;
SAFE-Aqua;Pays-Bas;WAGENINGEN UNIVERSITY;Wageningen University;;SustainAble Farming for Effective Aquaculture;Projet scientifique;aquaculture;;;;;900 000,00 ?;Commission Europ‚enne;01/01/2017;31/12/2020;;;;;;;26;
SAFE-Aqua;Royaume-Uni;SWANSEA UNIVERSITY;Swansea University;;SustainAble Farming for Effective Aquaculture;Projet scientifique;aquaculture;;;;;900 000,00 ?;Commission Europ‚enne;01/01/2017;31/12/2020;;;;;;;26;
SAFE-Aqua;Thailande;NATIONAL SCIENCE & TECHNOLOGY DEVELOPMENT AGENCY;National Science & Technology Development Agency;;SustainAble Farming for Effective Aquaculture;Projet scientifique;aquaculture;;;;;900 000,00 ?;Commission Europ‚enne;01/01/2017;31/12/2020;;;;;;;26;
Rafts4Biotech;Allemagne;GEORG-AUGUST-UNIVERSITAT GOTTINGEN STIFTUNG OFFENTLICHEN RECHTS;Georg-August-Universitat Gottingen Stiftung Offentlichen Rechts;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 ?;Commission Europ‚enne;01/01/2017;31/06/2021;;;;;;;26;
Rafts4Biotech;Allemagne;UNIVERSITATSMEDIZIN GREIFSWALD KORPERSCHAFT DES OFFENTLICHEN RECHTS;Universitatsmedizin Greifswald Korperschaft Des Offentlichen Rechts;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 ?;Commission Europ‚enne;01/01/2017;31/06/2021;;;;;;;26;
Rafts4Biotech;Autriche;ENGENES BIOTECH GMBH;Engenes Biotech Gmbh;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 ?;Commission Europ‚enne;01/01/2017;31/06/2021;;;;;;;26;
Rafts4Biotech;Danemark;BIOSYNTIA APS;Biosyntia Aps;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 ?;Commission Europ‚enne;01/01/2017;31/06/2021;;;;;;;26;
Rafts4Biotech;Espagne;AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS;Agencia Estatal Consejo Superior Deinvestigaciones Cientificas;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 ?;Commission Europ‚enne;01/01/2017;31/06/2021;;;coordinateur;;;;26;
Rafts4Biotech;Espagne;SCIENSEED SL;Scienseed Sl;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 ?;Commission Europ‚enne;01/01/2017;31/06/2021;;;;;;;3;
Rafts4Biotech;France;INSTITUT PASTEUR;Institut Pasteur;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 ?;Commission Europ‚enne;01/01/2017;31/06/2021;;;;;;;3;
Rafts4Biotech;Italie;NAICONS SRL;Naicons Srl;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 ?;Commission Europ‚enne;01/01/2017;31/06/2021;;;;;;;3;
Rafts4Biotech;Pays-Bas;RIJKSUNIVERSITEIT GRONINGEN;Rijksuniversiteit Groningen;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 ?;Commission Europ‚enne;01/01/2017;31/06/2021;;;;;;;47;
Rafts4Biotech;R‚publique TchŠque;FAKULTNI NEMOCNICE U SV. ANNY V BRNE;Fakultni Nemocnice U Sv. Anny V Brne;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 ?;Commission Europ‚enne;01/01/2017;31/06/2021;;;;;;;47;
Rafts4Biotech;R‚publique TchŠque;ENANTIS SRO;Enantis Sro;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 ?;Commission Europ‚enne;01/01/2017;31/06/2021;;;;;;;47;
Rafts4Biotech;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 ?;Commission Europ‚enne;01/01/2017;31/06/2021;;;;;;;47;
DEHBV;Chine;Institut Pasteur of Shanghai - Chinese Academy of Sciences;Institut Pasteur Of Shanghai - Chinese Academy Of Sciences;;Targeting hepatitis B virus cccDNA by cellular nucleases: towards viral elimination of chronic hepatitis B;Projet scientifique;hepatitis B;;;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;47;
DEHBV;France;Institut Pasteur;Institut Pasteur;R‚trovirologie Mol‚culaire;Targeting hepatitis B virus cccDNA by cellular nucleases: towards viral elimination of chronic hepatitis B;Projet scientifique;hepatitis B;;;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;coordinateur;;;;47;
DEHBV;Laos;Institut Pasteur in Laos;Institut Pasteur In Laos;;Targeting hepatitis B virus cccDNA by cellular nucleases: towards viral elimination of chronic hepatitis B;Projet scientifique;hepatitis B;;;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;47;
TaME;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;Targeting Malaria Epigenetics;Projet scientifique;malaria;epigenetics;therapy;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;47;
TaME;France;Institut Pasteur;Institut Pasteur;Chimie Biologique Epig‚n‚tique;Targeting Malaria Epigenetics;Projet scientifique;malaria;epigenetics;therapy;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;47;
TaME;France;Institut Pasteur;Institut Pasteur;Biologie des Interactions H“te-Parasite;Targeting Malaria Epigenetics;Projet scientifique;malaria;epigenetics;therapy;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;47;
TaME;France;Institut Pasteur;Institut Pasteur;Plate-Forme Centre de Production et Infection des AnophŠles;Targeting Malaria Epigenetics;Projet scientifique;malaria;epigenetics;therapy;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;47;
m6A_RAIAV;Belgique;Sciensano;Sciensano;;The lung epitranscriptome and chromatin accessibility landscape in rheumatoid arthritis complicated by the flu;Projet scientifique;Rheumatoid arthritis;immunology;epigenetics;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;47;
m6A_RAIAV;Bulgarie;Stephan Angeloff Institute;Stephan Angeloff Institute;;The lung epitranscriptome and chromatin accessibility landscape in rheumatoid arthritis complicated by the flu;Projet scientifique;Rheumatoid arthritis;immunology;epigenetics;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;coordinateur;;;;47;
m6A_RAIAV;France;Institut Pasteur;Institut Pasteur;UTECHS CB Technologie et Service Cytometrie et Biomarqueurs;The lung epitranscriptome and chromatin accessibility landscape in rheumatoid arthritis complicated by the flu;Projet scientifique;Rheumatoid arthritis;immunology;epigenetics;;;50 000,00 ?;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;47;
FED-AMR;Allemagne;German Federal Institute for Risk Assessment;German Federal Institute For Risk Assessment;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;47;
FED-AMR;Allemagne;Friedrich-Loeffler-Institut ;Friedrich-Loeffler-Institut ;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;47;
FED-AMR;Autriche;Austrian Agency for Health and Food Safety;Austrian Agency For Health And Food Safety;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;coordinateur;;;;47;
FED-AMR;Danemark;Statens Serum Institut;Statens Serum Institut;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;47;
FED-AMR;Estonie;University of Tartu;University Of Tartu;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;47;
FED-AMR;France;Institut Pasteur;Institut Pasteur;CNR Bact‚ries ana‚robies et botulisme;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;47;
FED-AMR;Irlande;National University of Ireland, Galway;National University Of Ireland, Galway;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;47;
FED-AMR;NorvŠge;Norwegian Veterinary Institute;Norwegian Veterinary Institute;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;47;
FED-AMR;Pologne;National Veterinary Research Institute;National Veterinary Research Institute;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;47;
FED-AMR;Portugal;National Institute of Health;National Institute Of Health;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;47;
FED-AMR;R‚publique TchŠque;National Institute of Public Health;National Institute Of Public Health;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;47;
FED-AMR;Royaume-Uni;University of Surrey;University Of Surrey;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 ?;Commission Europ‚enne;01/01/2020;30/06/2022;;;;;;;47;
FreeATPOC;France;INSTITUT PASTEUR;Institut Pasteur;;Towards an instrument-free future of molecular diagnostics at the point-of-care;Projet scientifique;nucleic acid;molecular diagnostics;;;;3 052 500,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;;;;;47;
FreeATPOC;GrŠce;IDRYMA TECHNOLOGIAS KAI EREVNAS;Idryma Technologias Kai Erevnas;;Towards an instrument-free future of molecular diagnostics at the point-of-care;Projet scientifique;nucleic acid;molecular diagnostics;;;;3 052 500,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;coordinateur;;;;47;
FreeATPOC;GrŠce;GNOSIS DATA ANALYSIS IDIOTIKI KEFALAIOUCHIKI ETAIREIA;Gnosis Data Analysis Idiotiki Kefalaiouchiki Etaireia;;Towards an instrument-free future of molecular diagnostics at the point-of-care;Projet scientifique;nucleic acid;molecular diagnostics;;;;3 052 500,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;;;;;47;
FreeATPOC;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;Towards an instrument-free future of molecular diagnostics at the point-of-care;Projet scientifique;nucleic acid;molecular diagnostics;;;;3 052 500,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;;;;;47;
FreeATPOC;Royaume-Uni;UNIVERSITY COLLEGE LONDON HOSPITALSNHS FOUNDATION TRUST;University College London Hospitalsnhs Foundation Trust;;Towards an instrument-free future of molecular diagnostics at the point-of-care;Projet scientifique;nucleic acid;molecular diagnostics;;;;3 052 500,00 ?;Commission Europ‚enne;01/01/2020;31/12/2023;;;;;;;47;
INFRAFRONTIER2020;Allemagne;HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH;Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;coordinateur;;;;47;
INFRAFRONTIER2020;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Allemagne;HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH;Helmholtz-Zentrum Fur Infektionsforschung Gmbh;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Allemagne;MEDIZINISCHE HOCHSCHULE HANNOVER;Medizinische Hochschule Hannover;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Allemagne;TSE SYSTEMS GMBH;Tse Systems Gmbh;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Allemagne;AYOXXA BIOSYSTEMS GMBH;Ayoxxa Biosystems Gmbh;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Autriche;VETERINAERMEDIZINISCHE UNIVERSITAET WIEN;Veterinaermedizinische Universitaet Wien;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Canada;Toronto Centre for Phenogenomics Inc;Toronto Centre For Phenogenomics Inc;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Espagne;AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS;Agencia Estatal Consejo Superior Deinvestigaciones Cientificas;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Espagne;UNIVERSIDAD AUTONOMA DE BARCELONA;Universidad Autonoma De Barcelona;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Finalnde;OULUN YLIOPISTO;Oulun Yliopisto;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;France;CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE;Centre Europeen De Recherche En Biologie Et Medecine;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;France;INSTITUT PASTEUR;Institut Pasteur;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;GrŠce;BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING;Biomedical Sciences Research Center Alexander Fleming;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;GrŠce;BIOMEDCODE ELLAS ANONIMI ETERIA EPISTIMONIKIS KAI TEXNOLOGIKIS EREVNAS KAI EMBORIKIS EKMETALLEFSIS EPHARMOGON IATRIKIS;Biomedcode Ellas Anonimi Eteria Epistimonikis Kai Texnologikis Erevnas Kai Emborikis Ekmetallefsis Epharmogon Iatrikis;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Isra‰l;TEL AVIV UNIVERSITY;Tel Aviv University;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Pays-Bas;STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS;Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Pays-Bas;ACADEMISCH ZIEKENHUIS GRONINGEN;Academisch Ziekenhuis Groningen;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Portugal;FUNDACAO CALOUSTE GULBENKIAN;Fundacao Calouste Gulbenkian;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;R‚publique TchŠque;USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE;Ustav Molekularni Genetiky Akademie Ved Ceske Republiky Verejna Vyzkumna Instituce;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Royaume-Uni;UNITED KINGDOM RESEARCH AND INNOVATION;United Kingdom Research And Innovation;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Royaume-Uni;GENOME RESEARCH LIMITED;Genome Research Limited;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;SuŠde;KAROLINSKA INSTITUTET;Karolinska Institutet;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 ?;Commission Europ‚enne;01/01/2017;31/12/2021;;;;;;;31;
ASDENV;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;Towards new vaccine strategies for dengue virus infection: identification of protective humoral immune responses in asymptomatic dengue-infected individuals  ;Projet scientifique;dengue;immunology;Infectious diseases;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;31;
ASDENV;France;Institut Pasteur;Institut Pasteur;Virologie structurale;Towards new vaccine strategies for dengue virus infection: identification of protective humoral immune responses in asymptomatic dengue-infected individuals  ;Projet scientifique;dengue;immunology;Infectious diseases;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;31;
ASDENV;France;Institut Pasteur;Institut Pasteur;Anticorps en Th‚rapie et Pathologie;Towards new vaccine strategies for dengue virus infection: identification of protective humoral immune responses in asymptomatic dengue-infected individuals  ;Projet scientifique;dengue;immunology;Infectious diseases;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;31;
ASDENV;France;Institut Pasteur;Institut Pasteur;Technologie et Service Cytometrie et Biomarqueurs (UTechS CB);Towards new vaccine strategies for dengue virus infection: identification of protective humoral immune responses in asymptomatic dengue-infected individuals  ;Projet scientifique;dengue;immunology;Infectious diseases;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;31;
HearLight;France;Institut Pasteur;Institut Pasteur;;Towards optogenetic cortical implants for hearing impaired;Projet scientifique;acoustics;physiotherapy;implants;artificial intelligence;phonetics;2 999 971,25 ?;Commission Europ‚enne;01/04/2021;31/03/2025;;;coordinateur;;;;31;
HearLight;France;INSTITUT MINES-TELECOM;Institut Mines-Telecom;;Towards optogenetic cortical implants for hearing impaired;Projet scientifique;acoustics;physiotherapy;implants;artificial intelligence;phonetics;2 999 971,25 ?;Commission Europ‚enne;01/04/2021;31/03/2025;;;;;;;31;
HearLight;NorvŠge;NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNU;Norges Teknisk-Naturvitenskapelige Universitet Ntnu;;Towards optogenetic cortical implants for hearing impaired;Projet scientifique;acoustics;physiotherapy;implants;artificial intelligence;phonetics;2 999 971,25 ?;Commission Europ‚enne;01/04/2021;31/03/2025;;;;;;;31;
HearLight;Royaume-Uni;UNIVERSITY OF STRATHCLYDE;University Of Strathclyde;;Towards optogenetic cortical implants for hearing impaired;Projet scientifique;acoustics;physiotherapy;implants;artificial intelligence;phonetics;2 999 971,25 ?;Commission Europ‚enne;01/04/2021;31/03/2025;;;;;;;31;
HearLight;Suisse;UNIVERSITAT BASEL;Universitat Basel;;Towards optogenetic cortical implants for hearing impaired;Projet scientifique;acoustics;physiotherapy;implants;artificial intelligence;phonetics;2 999 971,25 ?;Commission Europ‚enne;01/04/2021;31/03/2025;;;;;;;31;
HearLight;Suisse;NOVAGAN SARL;Novagan Sarl;;Towards optogenetic cortical implants for hearing impaired;Projet scientifique;acoustics;physiotherapy;implants;artificial intelligence;phonetics;2 999 971,25 ?;Commission Europ‚enne;01/04/2021;31/03/2025;;;;;;;31;
INFLANET;Allemagne;ACQUIFER IMAGING GMBH;Acquifer Imaging Gmbh;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 ?;Commission Europ‚enne;01/03/2021;28/02/2025;;;;;;;31;
INFLANET;Espagne;UNIVERSIDAD DE MURCIA;Universidad De Murcia;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 ?;Commission Europ‚enne;01/03/2021;28/02/2025;;;;;;;31;
INFLANET;France;UNIVERSITE DE MONTPELLIER;Universite De Montpellier;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 ?;Commission Europ‚enne;01/03/2021;28/02/2025;;;coordinateur;;;;31;
INFLANET;France;INSTITUT PASTEUR;Institut Pasteur;Macrophages et D‚veloppement de l'Immunit‚;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 ?;Commission Europ‚enne;01/03/2021;28/02/2025;;;;;;;31;
INFLANET;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 ?;Commission Europ‚enne;01/03/2021;28/02/2025;;;;;;;31;
INFLANET;Hongrie;EOTVOS LORAND TUDOMANYEGYETEM;Eotvos Lorand Tudomanyegyetem;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 ?;Commission Europ‚enne;01/03/2021;28/02/2025;;;;;;;31;
INFLANET;Pays-Bas;UNIVERSITEIT LEIDEN;Universiteit Leiden;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 ?;Commission Europ‚enne;01/03/2021;28/02/2025;;;;;;;31;
INFLANET;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 ?;Commission Europ‚enne;01/03/2021;28/02/2025;;;;;;;31;
INFLANET;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 ?;Commission Europ‚enne;01/03/2021;28/02/2025;;;;;;;31;
INFLANET;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 ?;Commission Europ‚enne;01/03/2021;28/02/2025;;;;;;;18;
INFLANET;Slovaquie;SLOVENSKA TECHNICKA UNIVERZITA V BRATISLAVE;Slovenska Technicka Univerzita V Bratislave;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 ?;Commission Europ‚enne;01/03/2021;28/02/2025;;;;;;;18;
INFLANET;Slovaquie;TATRAMED SOFTWARE SRO;Tatramed Software Sro;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 ?;Commission Europ‚enne;01/03/2021;28/02/2025;;;;;;;18;
ImageInLife;Allemagne;ACQUIFER AGÿ;Acquifer Agÿ;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Allemagne;DITABIS DIGITAL BIOMEDICAL IMAGING SYSTEMS AG;Ditabis Digital Biomedical Imaging Systems Ag;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Allemagne;CARL ZEISS NTS GMBH;Carl Zeiss Nts Gmbh;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Allemagne;UNIVERSITATSKLINIKUM HEIDELBERG;Universitatsklinikum Heidelberg;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Belgique;Union Biometrica BVBA;Union Biometrica Bvba;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Espagne;FUNDACIO INSTITUT DE CIENCIES FOTONIQUES;Fundacio Institut De Ciencies Fotoniques;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Espagne;4D - NATURE IMAGING CONSULTING SL;4D - Nature Imaging Consulting Sl;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;France;UNIVERSITE DE MONTPELLIER;Universite De Montpellier;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;coordinateur;;;;18;
ImageInLife;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;France;INSTITUT PASTEUR;Institut Pasteur;Macrophages et D‚veloppement de l'Immunit‚;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;France;PHASEVIEWÿ;Phaseviewÿ;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;France;UNIVERSITE PARIS-SACLAY;Universite Paris-Saclay;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;France;SORBONNE UNIVERSITE;Sorbonne Universite;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Pays-Bas;UNIVERSITEIT LEIDEN;Universiteit Leiden;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Royaume-Uni;THE MANCHESTER METROPOLITAN UNIVERSITY;The Manchester Metropolitan University;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;Interactive Computing E-Infrastructure for the Human Brain Project | ICEI Project | H2020 | CORDIS | European Commission (europa.eu);;
ImageInLife;Slovaquie;SLOVENSKA TECHNICKA UNIVERZITA V BRATISLAVE;Slovenska Technicka Univerzita V Bratislave;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;;
ImageInLife;Slovaquie;TATRAMED SOFTWARE SRO;Tatramed Software Sro;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 ?;Commission Europ‚enne;01/01/2017;30/06/2021;;;;;;;;
TRACeR-TB;Belgique;Sciensano;Sciensano;;Transcriptional Response for AntimiCrobial Resistance detection in TB;Projet scientifique;tuberculosis;antibioresistance;diagnostic;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;;
TRACeR-TB;France;Institut Pasteur;Institut Pasteur;Pathog‚nomique mycobact‚rienne integr‚e;Transcriptional Response for AntimiCrobial Resistance detection in TB;Projet scientifique;tuberculosis;antibioresistance;diagnostic;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
TRACeR-TB;France;Institut Pasteur de Lille;Institut Pasteur De Lille;;Transcriptional Response for AntimiCrobial Resistance detection in TB;Projet scientifique;tuberculosis;antibioresistance;diagnostic;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
TRACeR-TB;Russie;Institut Pasteur de Saint-Petersbourg;Institut Pasteur De Saint-Petersbourg;;Transcriptional Response for AntimiCrobial Resistance detection in TB;Projet scientifique;tuberculosis;antibioresistance;diagnostic;;;250 000,00 ?;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
TranSYS;Allemagne;BIOMAX INFORMATICS AG;Biomax Informatics Ag;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 ?;Commission Europ‚enne;01/09/2019;31/08/2023;;;;;;;;
TranSYS;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 ?;Commission Europ‚enne;01/09/2019;31/08/2023;;;;;;;;
TranSYS;Allemagne;LIFEGLIMMER GMBH;Lifeglimmer Gmbh;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 ?;Commission Europ‚enne;01/09/2019;31/08/2023;;;;;;;;
TranSYS;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 ?;Commission Europ‚enne;01/09/2019;31/08/2023;;;coordinateur;;;;;
TranSYS;Espagne;FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III;Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 ?;Commission Europ‚enne;01/09/2019;31/08/2023;;;;;;;;
TranSYS;Espagne;BARCELONA SUPERCOMPUTING CENTER-CENTRO NACIONAL DE SUPERCOMPUTACION;Barcelona Supercomputing Center-Centro Nacional De Supercomputacion;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 ?;Commission Europ‚enne;01/09/2019;31/08/2023;;;;;;;;
TranSYS;France;INSTITUT PASTEUR;Institut Pasteur;Biologie computationnelle;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 ?;Commission Europ‚enne;01/09/2019;31/08/2023;;;;;;;;
TranSYS;Luxembourg;UNIVERSITE DU LUXEMBOURG;Universite Du Luxembourg;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 ?;Commission Europ‚enne;01/09/2019;31/08/2023;;;;;;;;
TranSYS;Pays-Bas;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Erasmus Universitair Medisch Centrum Rotterdam;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 ?;Commission Europ‚enne;01/09/2019;31/08/2023;;;;;;;;
TranSYS;Pays-Bas;ACADEMISCH ZIEKENHUIS GRONINGEN;Academisch Ziekenhuis Groningen;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 ?;Commission Europ‚enne;01/09/2019;31/08/2023;;;;;;;;
TranSYS;Royaume-Uni;THE GOLDEN HELIX FOUNDATION;The Golden Helix Foundation;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 ?;Commission Europ‚enne;01/09/2019;31/08/2023;;;;;;;;
TranSYS;Royaume-Uni;SHIVOM VENTURES LIMITED;Shivom Ventures Limited;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 ?;Commission Europ‚enne;01/09/2019;31/08/2023;;;;;;;;
TranSYS;Slov‚nie;UNIVERZA V LJUBLJANI;Univerza V Ljubljani;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 ?;Commission Europ‚enne;01/09/2019;31/08/2023;;;;;;;;
CLOSPORE;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Finlande;Atria Suomi Oy;Atria Suomi Oy;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Finlande;SaarioinenOy;Saarioinenoy;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Finlande;Snellmanin Lihanjalostus Oy;Snellmanin Lihanjalostus Oy;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Finlande;HKScan Ltd;Hkscan Ltd;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;France;Institut Pasteur;Institut Pasteur;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;France;METABOLIC EXPLORER SA;Metabolic Explorer Sa;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;France;BIOMERIEUX SA;Biomerieux Sa;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Pays-Bas;NIZO FOOD RESEARCH BV;Nizo Food Research Bv;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Pays-Bas;PURAC BIOCHEM BV;Purac Biochem Bv;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Pays-Bas;STICHTING WAGENINGEN RESEARCH;Stichting Wageningen Research;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Portugal;UNIVERSIDADE NOVA DE LISBOA;Universidade Nova De Lisboa;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Royaume-Uni;THE UNIVERSITY OF NOTTINGHAM;The University Of Nottingham;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Royaume-Uni;Green Biologics Ltd.;Green Biologics Ltd.;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Royaume-Uni;ASTELLAS PHARMA EUROPE LTD;Astellas Pharma Europe Ltd;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Royaume-Uni;LANZATECH UK LTD;Lanzatech Uk Ltd;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Royaume-Uni;Ipsen Pharmaceuticals;Ipsen Pharmaceuticals;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 ?;Commission Europ‚enne;01/01/2015;31/12/2018;;;;;;;;
TwinnToInfect;France;INSTITUT PASTEUR;Institut Pasteur;Immunit‚ inn‚e;Unleash IMM?s research excellence in immunity and infection through twinning to infect Lisbon and Portugal with its increase in competitiveness and innovation;Projet scientifique;sustainable science;innovation network;;;;1 000 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2018;;;;;;;;
TwinnToInfect;Portugal;INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES;Instituto De Medicina Molecular Joao Lobo Antunes;;Unleash IMM?s research excellence in immunity and infection through twinning to infect Lisbon and Portugal with its increase in competitiveness and innovation;Projet scientifique;sustainable science;innovation network;;;;1 000 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2018;;;coordinateur;;;;;
TwinnToInfect;Royaume-Uni;THE FRANCIS CRICK INSTITUTE LIMITED;The Francis Crick Institute Limited;;Unleash IMM?s research excellence in immunity and infection through twinning to infect Lisbon and Portugal with its increase in competitiveness and innovation;Projet scientifique;sustainable science;innovation network;;;;1 000 000,00 ?;Commission Europ‚enne;01/01/2016;31/12/2018;;;;;;;;
PDZnet;Allemagne;JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN;Johann Wolfgang Goethe-Universitaet Frankfurt Am Main;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 ?;Commission Europ‚enne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 ?;Commission Europ‚enne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;Allemagne;SYSTASY BIOSCIENCE GMBH;Systasy Bioscience Gmbh;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 ?;Commission Europ‚enne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 ?;Commission Europ‚enne;01/09/2016;31/08/2020;;;coordinateur;;;;;
PDZnet;Danemark;NOVO NORDISK A/S;Novo Nordisk A/S;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 ?;Commission Europ‚enne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 ?;Commission Europ‚enne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;France;CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE;Centre Europeen De Recherche En Biologie Et Medecine;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 ?;Commission Europ‚enne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;France;INSTITUT PASTEUR;Institut Pasteur;Immunit‚ inn‚e;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 ?;Commission Europ‚enne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;Italie;UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA;Universita Degli Studi Di Roma La Sapienza;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 ?;Commission Europ‚enne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;SuŠde;UPPSALA UNIVERSITET;Uppsala Universitet;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 ?;Commission Europ‚enne;01/09/2016;31/08/2020;;;;;;;;
PfAVAL;Br‚sil;Scientific Platform Pasteur - University of Sao Paulo;Scientific Platform Pasteur - University Of Sao Paulo;;Validation of Plasmodium falciparum antigens targeted by human CD8+ T cells using T Cell Receptor-expressing reporter cells.;Projet scientifique;malaria;vaccine;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
PfAVAL;France;Institut Pasteur;Institut Pasteur;Infection et Immunit‚ Palud‚ennes- Malaria Infection and Immunity;Validation of Plasmodium falciparum antigens targeted by human CD8+ T cells using T Cell Receptor-expressing reporter cells.;Projet scientifique;malaria;vaccine;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
PfAVAL;France;Institut Pasteur;Institut Pasteur;Laboratoire commun Institut Pasteur- Theravectys;Validation of Plasmodium falciparum antigens targeted by human CD8+ T cells using T Cell Receptor-expressing reporter cells.;Projet scientifique;malaria;vaccine;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
PfAVAL;France;Institut Pasteur;Institut Pasteur;Biologie des Interactions H“te-Parasite;Validation of Plasmodium falciparum antigens targeted by human CD8+ T cells using T Cell Receptor-expressing reporter cells.;Projet scientifique;malaria;vaccine;;;;250 000,00 ?;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
VEO;Allemagne;FRIEDRICH LOEFFLER INSTITUT - BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT;Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer Tiergesundheit;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Allemagne;FRIEDRICH LOEFFLER INSTITUT - BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT;Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer Tiergesundheit;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Danemark;DANMARKS TEKNISKE UNIVERSITET;Danmarks Tekniske Universitet;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Danemark;DANMARKS TEKNISKE UNIVERSITET;Danmarks Tekniske Universitet;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Espagne;AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS;Agencia Estatal Consejo Superior De Investigaciones Cientificas;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Espagne;AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS;Agencia Estatal Consejo Superior De Investigaciones Cientificas;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;France;INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER;Institut Francais De Recherche Pour L'Exploitation De La Mer;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;France;INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER;Institut Francais De Recherche Pour L'Exploitation De La Mer;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;France;Institut Pasteur;Institut Pasteur;Mod‚lisation math‚matique des maladies infectieuses;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;GrŠce;ARISTOTELIO PANEPISTIMIO THESSALONIKIS;Aristotelio Panepistimio Thessalonikis;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;GrŠce;ARISTOTELIO PANEPISTIMIO THESSALONIKIS;Aristotelio Panepistimio Thessalonikis;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Hongrie;EOTVOS LORAND TUDOMANYEGYETEM;Eotvos Lorand Tudomanyegyetem;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Hongrie;EOTVOS LORAND TUDOMANYEGYETEM;Eotvos Lorand Tudomanyegyetem;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Italie;ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA;Alma Mater Studiorum - Universita Di Bologna;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Italie;UNIVERSITA DEGLI STUDI DI PADOVA;Universita Degli Studi Di Padova;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Italie;ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA;Alma Mater Studiorum - Universita Di Bologna;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Italie;UNIVERSITA DEGLI STUDI DI PADOVA;Universita Degli Studi Di Padova;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Pays-Bas;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Erasmus Universitair Medisch Centrum Rotterdam;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;coordinateur;;;;;
VEO;Pays-Bas;RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU;Rijksinstituut Voor Volksgezondheid En Milieu;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Pays-Bas;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM;Academisch Medisch Centrum Bij De Universiteit Van Amsterdam;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Pays-Bas;CENTRAAL BUREAU VOOR DE STATISTIEK;Centraal Bureau Voor De Statistiek;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Pays-Bas;RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU;Rijksinstituut Voor Volksgezondheid En Milieu;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Pays-Bas;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM;Academisch Medisch Centrum Bij De Universiteit Van Amsterdam;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Pays-Bas;CENTRAAL BUREAU VOOR DE STATISTIEK;Centraal Bureau Voor De Statistiek;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Royaume-Uni;THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;The Secretary Of State For Environment, Food And Rural Affairs;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Royaume-Uni;THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;The Secretary Of State For Environment, Food And Rural Affairs;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;SuŠde;UPPSALA UNIVERSITET;Uppsala Universitet;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;SuŠde;UPPSALA UNIVERSITET;Uppsala Universitet;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
VEO;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 ?;Commission Europ‚enne;01/01/2020;31/12/2024;;;;;;;;
ViBrANT;Allemagne;JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN;Johann Wolfgang Goethe-Universitaet Frankfurt Am Main;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Allemagne;EBERHARD KARLS UNIVERSITAET TUEBINGEN;Eberhard Karls Universitaet Tuebingen;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;France;INSTITUT PASTEUR;Institut Pasteur;Bio-Informatique Structurale;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;France;BIOMERIEUX SA;Biomerieux Sa;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;NorvŠge;UNIVERSITETET I OSLO;Universitetet I Oslo;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Portugal;UNIVERSIDADE DO MINHO;Universidade Do Minho;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Portugal;CENTITVC - CENTRO DE NANOTECNOLOGIA E MATERIAIS TECNICOS FUNCIONAIS E INTELIGENTES ASSOCIACAO;Centitvc - Centro De Nanotecnologia E Materiais Tecnicos Funcionais E Inteligentes Associacao;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Portugal;BIOMODE 2, S.A.;Biomode 2, S.A.;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Royaume-Uni;UNIVERSITY OF LEEDS;University Of Leeds;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;coordinateur;;;;;
ViBrANT;Royaume-Uni;UNIVERSITY OF HULL;University Of Hull;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Royaume-Uni;Eluceda Ltd;Eluceda Ltd;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Royaume-Uni;ELISHA SYSTEMS LIMITED;Elisha Systems Limited;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Royaume-Uni;Digitronix Ltd;Digitronix Ltd;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;SuŠde;LUNDS UNIVERSITET;Lunds Universitet;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 ?;Commission Europ‚enne;01/01/2018;30/06/2022;;;;;;;;
Virus-X;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;Allemagne;UNIVERSITY OF STUTTGART;University Of Stuttgart;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;Allemagne;UNIVERSITAET BIELEFELD;Universitaet Bielefeld;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;France;UNIVERSITE CLERMONT AUVERGNE;Universite Clermont Auvergne;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;France;INSTITUT PASTEUR;Institut Pasteur;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;Islande;MATIS OHF;Matis Ohf;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;coordinateur;;;;;
Virus-X;Islande;PROKAZYME EHF.ÿ;Prokazyme Ehf.ÿ;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;NorvŠge;UNIVERSITETET I BERGEN;Universitetet I Bergen;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;NorvŠge;ArcticZymes AS;Arcticzymes As;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;Pays-Bas;BIO-PRODICT BV;Bio-Prodict Bv;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;;;;;12;
Virus-X;Pologne;A&A BIOTECHNOLOGY SC;A&A Biotechnology Sc;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;;;;;12;
Virus-X;Pologne;UNIWERSYTET GDANSKI;Uniwersytet Gdanski;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;;;;;12;
Virus-X;Royaume-Uni;UNIVERSITY OF DURHAM;University Of Durham;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;;;;;12;
Virus-X;SuŠde;SAROMICS BIOSTRUCTURES AB;Saromics Biostructures Ab;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;;;;;12;
Virus-X;SuŠde;LUNDS UNIVERSITET;Lunds Universitet;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 ?;Commission Europ‚enne;01/04/2016;31/03/2020;;;;;;;12;
ZikaPLAN;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;12;
ZikaPLAN;Belgique;PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE;Prins Leopold Instituut Voor Tropische Geneeskunde;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;12;
ZikaPLAN;Br‚sil;FUNDACAO DE APOIO A UNIVERSIDADE DE SAO PAULO;Fundacao De Apoio A Universidade De Sao Paulo;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;12;
ZikaPLAN;Br‚sil;INSTITUTO BUTANTAN;Instituto Butantan;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;12;
ZikaPLAN;Br‚sil;ASSOCIACAO TECNICO CIENTIFICA ESTUDO COLABORATIVO LATINO AMERICANO DE MALFORMACAO CONGENITAS;Associacao Tecnico Cientifica Estudo Colaborativo Latino Americano De Malformacao Congenitas;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;12;
ZikaPLAN;Br‚sil;FUNDACAO OSWALDO CRUZ;Fundacao Oswaldo Cruz;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;12;
ZikaPLAN;Br‚sil;FUNDACAO UNIVERSIDADE DE PERNAMBUCO;Fundacao Universidade De Pernambuco;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;Colombie;FUNDACION UNIVERSIDAD DEL NORTE;Fundacion Universidad Del Norte;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;Colombie;UNIVERSIDAD DEL VALLE;Universidad Del Valle;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;Cuba;INSTITUTO DE MEDICINA TROPICAL PEDRO KOURI;Instituto De Medicina Tropical Pedro Kouri;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;Etats-Unis;LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY;La Jolla Institute For Allergy And Immunology;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;Etats-Unis;THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL;The University Of North Carolina At Chapel Hill;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;France;INSTITUT PASTEUR;Institut Pasteur;Interactions Virus-Insectes;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;France;FONDATION MERIEUX;Fondation Merieux;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;Pays-Bas;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Erasmus Universitair Medisch Centrum Rotterdam;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;Royaume-Uni;LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER;London School Of Hygiene And Tropical Medicine Royal Charter;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;Royaume-Uni;UNIVERSITY OF ULSTER;University Of Ulster;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;Royaume-Uni;THE UNIVERSITY OF LIVERPOOL;The University Of Liverpool;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;Royaume-Uni;ST GEORGE'S HOSPITAL MEDICAL SCHOOL;St George'S Hospital Medical School;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;15;
ZikaPLAN;S‚n‚gal;INSTITUT PASTEUR DE DAKAR;Institut Pasteur De Dakar;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;4;
ZikaPLAN;SuŠde;UMEA UNIVERSITET;Umea Universitet;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;coordinateur;;;;4;
ZikaPLAN;Suisse;SCHWEIZERISCHES TROPEN- UND PUBLIC HEALTH-INSTITUT;Schweizerisches Tropen- Und Public Health-Institut;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 ?;Commission Europ‚enne;01/10/2016;31/03/2021;;;;;;;4;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
